In Re: Opana ER Antitrust Litigation
Plaintiff: Rochester Drug Co-Operative, Inc., Value Drug Company, Kim Mahaffay, Fraternal Order of Police, Miami Lodge 20 Insurance Trust Fund, Massachusetts Bricklayers & Masons Health and Welfare Fund, Plumbers & Pipefitters Local 178 Health & Welfare Trust Fund, Wisconsin Masons' Health Care Fund, Pennsylvania Employees Benefit Trust Fund, Louisiana Health Service and Indemnity Company doing business as Blue Cross Blue Shield of Louisiana, Meijer, Inc., Walgreen Co, The Kroger Co., Safeway Inc., HEB Grocery Company L.P., Albertsons LLC, Rite Aid Corporation, Rite Aid Hdqtrs. Corp., International Union of Operating Engineers, Local 138 Welfare Fund, Mary Davenport, Direct Purchaser Plaintiffs, End-Payor Plaintiffs, (Direct Purchaser and End-Payor), CVS Pharmacy, Inc., All Plaintiffs and Defendants, Meijer Distribution, Inc. and Retailer Plaintiffs
Defendant: Impax Laboratories, Inc., Endo Health Solutions Inc., Endo Pharmaceuticals Inc. and Penwest Pharmaceuticals Co.
In Re: Opana ER Antitrust Litigation
Case Number: 1:2014cv10150
Filed: December 12, 2014
Court: US District Court for the Northern District of Illinois
Office: Chicago Office
County: XX US, Outside the State of IL
Presiding Judge: Harry D Leinenweber
Nature of Suit: Other Statutory Actions
Cause of Action: 28 U.S.C. § 1331 Federal Question
Jury Demanded By: Defendant
RSS RSS Track this Docket
Docket Report

This docket was last retrieved on December 15, 2022. A more recent docket listing may be available from PACER.

Date Filed Document Text
December 15, 2022 Opinion or Order Filing 1091 ENTER ORDER GRANTING FINAL JUDGMENT AND ORDER OF DISMISSAL APPROVING END-PAYOR PLAINTIFFS' CLASS SETTLEMENT AND DISMISSING END-PAYOR PLAINTIFFS'CLASS CLAIMS AGAINST IMPAX LABORATORIES, INC. Signed by the Honorable Harry D. Leinenweber on 12/15/2022: Mailed notice(maf)
December 15, 2022 Opinion or Order Filing 1090 MINUTE entry before the Honorable Harry D. Leinenweber: Final approval hearing held via telephone conference. Motions granted [1077, 1088]. Mailed notice(maf)
November 17, 2022 Opinion or Order Filing 1089 TRANSCRIPT OF PROCEEDINGS held on 11/3/22 before the Honorable Harry D. Leinenweber. Order Number: 44499. Court Reporter Contact Information: Joseph Rickhoff, 312-435-5562, joseph_rickhoff@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 12/8/2022. Redacted Transcript Deadline set for 12/19/2022. Release of Transcript Restriction set for 2/15/2023. (Rickhoff, Joseph)
November 15, 2022 Opinion or Order Filing 1088 MOTION by Plaintiff End-Payor Plaintiffs for Final Approval of Proposed Settlement (Attachments: #1 Declaration of Eric J. Miller)(Wozniak, Robert)
November 14, 2022 Opinion or Order Filing 1087 TRANSCRIPT OF PROCEEDINGS held on 8/24/22 before the Honorable Harry D. Leinenweber. Order Number: 44500. Court Reporter Contact Information: Frances Ward - wardofficialtranscripts@gmail.com - 312.435.5561. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 12/5/2022. Redacted Transcript Deadline set for 12/15/2022. Release of Transcript Restriction set for 2/13/2023. (Ward, Frances)
November 11, 2022 Opinion or Order Filing 1086 Notice of Clarification Regarding End-Payor Plaintiffs' Motion for Payment of Attorneys' Fees, Reimbursement of Expenses, and Class Representative Service Awards (ECF No. 1077) by End-Payor Plaintiffs (Wozniak, Robert)
November 3, 2022 Opinion or Order Filing 1085 ENTER ORDER GRANTING FINAL JUDGMENT AND ORDER OF DISMISSAL APPROVING DIRECT PURCHASER CLASS SETTLEMENT AND DISMISSING DIRECT PURCHASER CLASS CLAIMS AGAINST IMPAX LABORATORIES, INC. Signed by the Honorable Harry D. Leinenweber on 11/3/2022: Mailed notice (maf)
November 3, 2022 Opinion or Order Filing 1084 MINUTE entry before the Honorable Harry D. Leinenweber: Telephonic ruling om motion hearing held. Motion for attorney fees #1072 and Motion to approve the settlement as set forth on the record #1080 are both granted. A further Telephone Conference is set for 2/23/23 at 9:30 a.m. re: motions [1048, 1063]. Mailed notice(maf)
November 1, 2022 Opinion or Order Filing 1083 MINUTE entry before the Honorable Harry D. Leinenweber: The following motions are hereby stayed until further order of the Court [1048, 1063]. Motions [1072, 1080] will be heard via telephonic conference set for 11/3/22 at 9:30 a.m. Dial: 888-684-8852 or 215-446-0155, access code: 9582710#. Motion #1077 will be heard via telephonic conference set for 12/15/22 at 10:00 a.m. Dial: 888-684-8852 or 215-446-0155, access code: 9582710#. Mailed notice(maf)
October 24, 2022 Opinion or Order Filing 1082 AFFIDAVIT by Plaintiff Direct Purchaser Plaintiffs in Support of MOTION by Plaintiff Direct Purchaser Plaintiffs for settlement Motion for Final Approval of Proposed Settlement #1080 Declaration of Bruce E. Gerstein in Support of Direct Purchaser Class Plaintiffs' Motion for Final Approval of Proposed Order (Attachments: #1 Exhibit Ex. 1, #2 Exhibit Ex. 2, #3 Exhibit Ex. 3, #4 Exhibit Ex. 4, #5 Exhibit Ex. 5, #6 Exhibit Ex. 6, #7 Exhibit Ex. 7)(Gerstein, Jonathan)
October 24, 2022 Opinion or Order Filing 1081 MEMORANDUM motion for settlement #1080 by Direct Purchaser Plaintiffs Direct Purchaser Class Plaintiffs' Memorandum of Law in Support of Motion for Final Approval of Proposed Settlement (Gerstein, Jonathan)
October 24, 2022 Opinion or Order Filing 1080 MOTION by Plaintiff Direct Purchaser Plaintiffs for settlement Motion for Final Approval of Proposed Settlement (Attachments: #1 Text of Proposed Order)(Gerstein, Jonathan)
October 12, 2022 Opinion or Order Filing 1079 MINUTE entry before the Honorable Harry D. Leinenweber: Motion for leave to file excess pages #1076 is granted. Motion to reduce Endo's bill of costs #1063 set for 10/25/22 will be heard telephonically on 11/3/22 at 9:30 a.m. Fairness hearing set for 11/3/22 at 9:30 a.m. will proceed via telephonic conference. Dial: 888-684-8852 or 215-446-0155, access code: 9582710#. Mailed notice (maf)
October 11, 2022 Opinion or Order Filing 1077 MOTION by Plaintiff End-Payor Plaintiffs for attorney fees Motion for Payment of Attorneys' Fees, Reimbursement of Expenses, and Class Representative Service Awards (Attachments: #1 Joint Declaration of Karin E. Garvey and Robert J. Wozniak, #2 Exhibits A-P)(Wozniak, Robert)
October 11, 2022 Opinion or Order Filing 1076 MOTION by Plaintiff End-Payor Plaintiffs for leave to file excess pages (Wozniak, Robert)
October 5, 2022 Opinion or Order Filing 1075 Letter by Direct Purchaser Plaintiffs requesting that the November 3, 2022 final fairness hearing be conducted telephonically (Curley, Andrew)
September 22, 2022 Opinion or Order Filing 1078 MINUTE entry before the Honorable Harry D. Leinenweber: Telephonic status hearing held. Direct Purchaser Class Counsel's motion for attorneys' fees #1072 is entered and continued until the 12/15/2022 final approval hearing. Plaintiffs are directed to keep the Court informed as to whether there are objections to the settlement agreement that would necessitate an in-person hearing. Mailed notice(maf)
September 22, 2022 Opinion or Order Filing 1074 NOTICE by Archana Tamoshunas of Change of Address (Tamoshunas, Archana)
September 20, 2022 Opinion or Order Filing 1073 MINUTE entry before the Honorable Harry D. Leinenweber: Telephonic status hearing set for 9/22/22 at 9:15 a.m. re: MOTION by Plaintiff Direct Purchaser Plaintiffs for attorney fees #1072 . Dial: 888-684-8852 or 215-446-0155, access code: 9582710#. Mailed notice (maf)
September 19, 2022 Opinion or Order Filing 1072 MOTION by Plaintiff Direct Purchaser Plaintiffs for attorney fees DIRECT PURCHASER CLASS COUNSEL'S MOTION FOR AN AWARD OF ATTORNEY'S FEES, REIMBURSEMENT OF EXPENSES AND SERVICE AWARDS FOR THE CLASS REPRESENTATIVES (Attachments: #1 Declaration, #2 Exhibit INDEX OF EXHIBITS, #3 Exhibit A, #4 Exhibit B, #5 Exhibit C, #6 Exhibit D, #7 Exhibit E, #8 Exhibit F, #9 Exhibit G, #10 Exhibit H, #11 Exhibit I, #12 Exhibit J, #13 Exhibit K, #14 Exhibit L)(Curley, Andrew)
September 19, 2022 Opinion or Order Filing 1071 NOTICE by End-Payor Plaintiffs of Filing Updated Long Form Notice to End-Payor Plaintiff Class Members (Attachments: #1 Updated Long Form Notice to EPP Class Members)(Wozniak, Robert)
August 29, 2022 Opinion or Order Filing 1070 WITHDRAWING Monica L. Kiley as counsel for Plaintiffs CVS Pharmacy, Inc., Rite Aid Corporation, Rite Aid Hdqtrs. Corp. and substituting Eric L. Bloom as counsel of record (Bloom, Eric)
August 24, 2022 Opinion or Order Filing 1069 Enter Order preliminarily approving End-Payor Class Plaintiffs' settlement with defendant Impax Laboratories, Inc. Final approval hearing via video conference is set 12/15/22 at 10:00 a.m. Signed by the Honorable Harry D. Leinenweber on 8/24/22: Mailed notice(maf)
August 24, 2022 Opinion or Order Filing 1068 MINUTE entry before the Honorable Harry D. Leinenweber: Telephonic motion hearing held. The Court grants the motion for preliminary approval of proposed settlement #1060 . Order to follow. The Court continues the motion to reduce Endo's bill of costs #1063 to 10/25/22 at 9:30 a.m. Telephonic status hearing set for 10/25/22 at 9:30 a.m. Dial: 888-684-8852 or 215-446-0155, access code: 9582710#. Mailed notice (maf)
August 22, 2022 Opinion or Order Filing 1067 ENTER SECOND AMENDED JUDGMENT. Signed by the Honorable Harry D. Leinenweber on 8/22/2022: Mailed notice(maf)
August 22, 2022 Opinion or Order Filing 1066 MINUTE entry before the Honorable Harry D. Leinenweber: Motion to amend/correct the judgment #1049 is granted. Mailed notice(maf)
August 18, 2022 Opinion or Order Filing 1065 MINUTE entry before the Honorable Harry D. Leinenweber: Telephone Conference set for 8/24/22 at 9:30 a.m. re: motions [1060, 1063]. Dial: 888-684-8852 or 215-446-0155, access code: 9582710#. Mailed notice(maf)
August 17, 2022 Opinion or Order Filing 1064 NOTICE by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. of Suggestion of Bankruptcy and Automatic Stay of Proceedings (Attachments: #1 Exhibit A)(Chapman, Julia)
August 15, 2022 Opinion or Order Filing 1063 SEALED MOTION by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs PLAINTIFFS' MOTION TO REDUCE ENDO'S BILL OF COSTS AND STAY ENFORCEMENT (Curley, Andrew)
August 15, 2022 Opinion or Order Filing 1062 DECLARATION of Julia Chapman in Support of Endo's Bill of Costs (Public Copy of Dkt. 1057) (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I)(Chapman, Julia)
August 15, 2022 Opinion or Order Filing 1061 NOTICE by Kenneth A. Wexler of Change of Address (Wexler, Kenneth)
August 12, 2022 Opinion or Order Filing 1060 MOTION by Plaintiff End-Payor Plaintiffs for Preliminary Approval of Proposed Settlement, Form and Manner of Notice to the Classes, and Proposed Schedule for a Final Fairness Hearing (Attachments: #1 Index of Exhibits, #2 Exhibit 1 - Settlement Agreement, #3 Exhibit 2 - Plan of Allocation, #4 Exhibit 3 - Declaration of Linda V. Young, #5 Exhibit 4 - Declaration of Meredith Rosenthal, Ph.D.)(Wozniak, Robert)
August 8, 2022 Opinion or Order Filing 1059 RESPONSE by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. to MOTION by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to amend/correct entered judgment #1047 #1049 (Unopposed) (Attachments: #1 Exhibit A)(Chapman, Julia)
August 2, 2022 Opinion or Order Filing 1058 Notice by Direct Purchaser Plaintiffs of Supplemental Declaration of Jeffrey J. Leitzinger Ph.D. Related to Proposed Allocation Plan and Net Settlement Fund Allocation (Attachments: #1 Exhibit A)(Gerstein, Bruce)
August 1, 2022 Opinion or Order Filing 1057 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. Declaration of Julia Chapman in Support of Endo's Bill of Costs (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I)(Chapman, Julia)
August 1, 2022 Opinion or Order Filing 1056 BILL of Costs of Endo Pharmaceuticals Inc., Endo Health Solutions Inc., and Penwest Pharmaceuticals Co. (Chapman, Julia)
August 1, 2022 Opinion or Order Filing 1053 MINUTE entry before the Honorable Harry D. Leinenweber: Pursuant to the Stipulated Briefing Schedule for Plaintiffs' Post-Trial Motion for Judgment as a Matter of Law or for a New Trial, Plaintiffs' Post-Trial Motion for Judgment as a Matter of Law or for a New Trial #1048 is entered and briefed as follows: response by 8/31/22, reply by 9/21/22. The Court will rule by mail. Mailed notice(maf)
July 29, 2022 Opinion or Order Filing 1052 STIPULATION (Proposed) Briefing Schedule for Plaintiffs' Post-Trial Motion for Judgment as a Matter of Law or for a New Trial (Chapman, Julia)
July 29, 2022 Opinion or Order Filing 1051 MINUTE entry before the Honorable Harry D. Leinenweber: Plaintiffs' Post-Trial Motion for Judgment as a Matter of Law or for a New Trial #1048 is entered and briefed as follows: response by 8/15/22, reply by 8/22/22. The Court will rule by mail. Mailed notice(maf)
July 29, 2022 Opinion or Order Filing 1049 MOTION by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to amend/correct entered judgment #1047 (Attachments: #1 [Proposed] Second Amended Judgment)(Curley, Andrew)
July 28, 2022 Opinion or Order Filing 1055 Enter Exhibit B: Preliminary Approval Order of Settlement Notice and Fairness Hearing. Signed by the Honorable Harry D. Leinenweber on 7/28/2022: Mailed notice (maf)
July 28, 2022 Opinion or Order Filing 1054 Enter Preliminary Approval Order of Settlement Notice and Fairness Hearing. Signed by the Honorable Harry D. Leinenweber on 7/28/2022:Mailed notice (maf)
July 28, 2022 Opinion or Order Filing 1050 MINUTE entry before the Honorable Harry D. Leinenweber: Telephonic ruling on motion hearing held. Motion for Preliminary Approval of Proposed Settlement, Approval of the Form and Manner of Notice to the Class #1041 is granted. In person fairness hearing is set for 11/3/22 at 9:30 a.m. Mailed notice(maf)
July 27, 2022 Opinion or Order Filing 1048 MOTION by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs for judgment Plaintiffs' Post-Trial Motion for Judgment as a Matter of Law or for a New Trial (Refsin, Barry)
July 26, 2022 Opinion or Order Filing 1047 ENTER AMENDED JUDGMENT. Signed by the Honorable Harry D. Leinenweber on 7/26/2022: Mailed notice (maf)
July 26, 2022 Opinion or Order Filing 1046 MINUTE entry before the Honorable Harry D. Leinenweber: Motion to amend/correct the judgment #1006 is granted. Amended judgment order to follow. Unopposed Motion for Leave to File Post-Trial Motion in Excess of Page Limitations is granted as to all parties #1045 . Mailed notice(maf)
July 25, 2022 Opinion or Order Filing 1045 MOTION by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs for leave to file excess pages Plaintiffs' Unopposed Motion for Leave to File Post-Trial Motion in Excess of Page Limitations (Refsin, Barry)
July 25, 2022 Opinion or Order Filing 1044 MINUTE entry before the Honorable Harry D. Leinenweber: Documents [1039, 1040] are moot. Motion for Preliminary Approval of Proposed Settlement, Approval of the Form and Manner of Notice to the Class #1041 will be heard via Telephone Conference set for 7/28/2022 at 9:00 a.m. Dial: 888-684-8852 or 215-446-0155, access code: 9582710#. Mailed notice(maf)
July 19, 2022 Opinion or Order Filing 1043 DECLARATION of Bruce E. Gerstein regarding motion for settlement, #1041 in Support of Direct Purchaser Class Plaintiffs' Motion for Preliminary Approval of Proposed Settlement, Approval of the Form and Manner of Notice to the Class and Proposed Schedule for a Fairness Hearing (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3)(Gerstein, Jonathan)
July 19, 2022 Opinion or Order Filing 1042 MEMORANDUM by Direct Purchaser Plaintiffs in support of motion for settlement, #1041 Direct Purchaser Class Plaintiffs' Memorandum of Law in Support of Motion for Preliminary Approval of Proposed Settlement, Approval of the Form and Manner of Notice to the Class and Proposed Schedule for a Fairness Hearing (Gerstein, Jonathan)
July 19, 2022 Opinion or Order Filing 1041 MOTION by Plaintiff Direct Purchaser Plaintiffs for settlement Notice of Direct Purchaser Class Plaintiffs' Motion for Preliminary Approval of Proposed Settlement, Approval of the Form and Manner of Notice to the Class and Proposed Schedule for a Fairness Hearing (Gerstein, Jonathan)
July 19, 2022 Opinion or Order Filing 1040 MEMORANDUM Direct Purchaser Class Plaintiffs' Memorandum of Law in Support of Motion for Preliminary Approval of Proposed Settlement, Approval of the Form and Manner of Notice to the Class and Proposed Schedule for a Fairness Hearing (Gerstein, Jonathan)
July 19, 2022 Opinion or Order Filing 1039 Notice of Direct Purchaser Class Plaintiffs' Motion for Preliminary Approval of Proposed Settlement, Approval of the Form and Manner of Notice to the Class and Proposed Schedule for a Fairness Hearing NOTICE of Motion by Jonathan M Gerstein for presentment of (Gerstein, Jonathan)
July 11, 2022 Opinion or Order Filing 1038 TRANSCRIPT OF PROCEEDINGS held on 7-1-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 16. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1037 TRANSCRIPT OF PROCEEDINGS held on 6-30-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 15B. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1036 TRANSCRIPT OF PROCEEDINGS held on 6-30-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 15A. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1035 TRANSCRIPT OF PROCEEDINGS held on 6-29-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 14. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1034 TRANSCRIPT OF PROCEEDINGS held on 6-28-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 13B. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1033 TRANSCRIPT OF PROCEEDINGS held on 6-28-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 13A. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1032 TRANSCRIPT OF PROCEEDINGS held on 6-27-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 12B. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1031 TRANSCRIPT OF PROCEEDINGS held on 6-27-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 12A. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1030 TRANSCRIPT OF PROCEEDINGS held on 6-24-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 11B. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1029 TRANSCRIPT OF PROCEEDINGS held on 6-24-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 11A. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1028 TRANSCRIPT OF PROCEEDINGS held on 6-23-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 10B. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1027 TRANSCRIPT OF PROCEEDINGS held on 6-23-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 10A. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1026 TRANSCRIPT OF PROCEEDINGS held on 6-22-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 9B. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1025 TRANSCRIPT OF PROCEEDINGS held on 6-22-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 9A. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1024 TRANSCRIPT OF PROCEEDINGS held on 6-21-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 8B. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1023 TRANSCRIPT OF PROCEEDINGS held on 6-21-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 8A. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1022 TRANSCRIPT OF PROCEEDINGS held on 6-17-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 7B. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1021 TRANSCRIPT OF PROCEEDINGS held on 6-17-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 7A. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1020 TRANSCRIPT OF PROCEEDINGS held on 6-16-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 6B. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1019 TRANSCRIPT OF PROCEEDINGS held on 6-16-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 6A. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1018 TRANSCRIPT OF PROCEEDINGS held on 6-15-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 5B. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1017 TRANSCRIPT OF PROCEEDINGS held on 6-15-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 5A. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1016 TRANSCRIPT OF PROCEEDINGS held on 6-14-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 4B. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1015 TRANSCRIPT OF PROCEEDINGS held on 6-14-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 4A. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1014 TRANSCRIPT OF PROCEEDINGS held on 6-13-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 3B. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1013 TRANSCRIPT OF PROCEEDINGS held on 6-13-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 3A. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1012 TRANSCRIPT OF PROCEEDINGS held on 6-10-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 2B. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1011 TRANSCRIPT OF PROCEEDINGS held on 6-10-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 2A. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1010 TRANSCRIPT OF PROCEEDINGS held on 6-9-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 1B. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 11, 2022 Opinion or Order Filing 1009 TRANSCRIPT OF PROCEEDINGS held on 6-9-22 before the Honorable Harry D. Leinenweber. JURY TRIAL - VOLUME 1A. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/1/2022. Redacted Transcript Deadline set for 8/11/2022. Release of Transcript Restriction set for 10/10/2022. (Mullin, Sandra)
July 6, 2022 Opinion or Order Filing 1007 WITHDRAWING James Boone Baxter as counsel for Plaintiff Value Drug Company and substituting Russell A. Chorush as counsel of record (Chorush, Russell)
July 1, 2022 Opinion or Order Filing 1006 MOTION by Plaintiff (Direct Purchaser and End-Payor) to amend/correct entered judgment #1003 TO LIMIT TO DEFENDANTS ENDO HEALTH SOULTIONS, INC., ENDO PHARMACEUTICALS, INC., AND PENWEST PHARMACEUTICALS CO. (Curley, Andrew)
July 1, 2022 Opinion or Order Filing 1005 JURY Verdict entered in favor of defendants and against plaintiff. (Mailed Notice) (RESTRICTED) (cxr, )
July 1, 2022 Opinion or Order Filing 1004 FINAL JURY Instructions (cxr, )
July 1, 2022 Opinion or Order Filing 1003 ENTERED JUDGMENT. Signed by the Honorable Harry D. Leinenweber on 7/1/2022:Mailed notice (maf)
July 1, 2022 Opinion or Order Filing 1002 MINUTE entry before the Honorable Harry D. Leinenweber: Deliberations completed on 7/1/2022. Trial ends - jury. The jury returns a verdict in favor of the defendants and against the plaintiff. Judgment entered on the verdict. Civil case closed. Mailed notice(maf)
June 30, 2022 Opinion or Order Filing 1001 MINUTE entry before the Honorable Harry D. Leinenweber: Jury trial held and concluded on 6/30/22. Deliberations held and continued to 7/1/22 at 8:30 a.m. Mailed notice (maf)
June 30, 2022 Opinion or Order Filing 1000 PROPOSED Jury Instructions by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs (Attachments: #1 Exhibit Plaintiffs' Proposed Revisions to the Court's Jury Instructions and Verdict Form)(Refsin, Barry)
June 30, 2022 Opinion or Order Filing 998 PROPOSED Jury Instructions by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. (Attachments: #1 Redline)(Chapman, Julia)
June 29, 2022 Opinion or Order Filing 999 MINUTE entry before the Honorable Harry D. Leinenweber: Jury trial held and continued to 6/30/22 at 9:45 a.m. in Courtroom 1203. Mailed notice (maf)
June 29, 2022 Opinion or Order Filing 997 VIDEO DEPOSITION TESTIMONY OF ALAN LEVIN PLAYED ON JUNE 28, 2022 by All Plaintiffs and Defendants (Chapman, Julia)
June 28, 2022 Opinion or Order Filing 996 MINUTE entry before the Honorable Harry D. Leinenweber: Jury trial held and continued to 6/29/22 at 9:45 a.m. in Courtroom 1203. Mailed notice (maf)
June 28, 2022 Opinion or Order Filing 995 VIDEO DEPOSITION TESTIMONY OF MOLLIE CARBY PLAYED ON JUNE 24, 2022 by All Plaintiffs and Defendants (Chapman, Julia)
June 28, 2022 Opinion or Order Filing 994 OBJECTIONS by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. to proposed jury instructions, #991 PROPOSED Jury Instructions by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs (Chapman, Julia)
June 28, 2022 Opinion or Order Filing 993 PLAINTIFFS' STATEMENT IN SUPPORT OF PLAINTIFFS' PROPOSED VERDICT FORM AND OBJECTIONS TO DEFENDANTS' PROPOSED VERDICT FORMS by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs (Curley, Andrew)
June 28, 2022 Opinion or Order Filing 992 PLAINTIFFS' STATEMENT IN SUPPORT OF THEIR PROPOSED JURY INSTRUCTIONS AND OBJECTIONS TO DEFENDANTS' PROPOSED JURY INSTRUCTIONS by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs (Curley, Andrew)
June 28, 2022 Opinion or Order Filing 991 PROPOSED Jury Instructions by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs (Attachments: #1 Revised Phase I Jury Instructions, #2 Revised Phase I Verdict Form, #3 Phase II Jury Instructions, #4 Phase II Verdict Form)(Curley, Andrew)
June 28, 2022 Opinion or Order Filing 989 PROPOSED Liability Phase Verdict Form by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. (Attachments: #1 Exhibit A, #2 Exhibit B)(Chapman, Julia)
June 28, 2022 Opinion or Order Filing 988 PROPOSED Jury Instructions by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. (Attachments: #1 Exhibit 1)(Chapman, Julia)
June 27, 2022 Opinion or Order Filing 990 MINUTE entry before the Honorable Harry D. Leinenweber: Jury trial held and continued to 6/28/22 at 9:45 a.m. in Courtroom 1203. Mailed notice (maf)
June 27, 2022 Opinion or Order Filing 987 PROPOSED Jury Instructions by All Plaintiffs and Defendants (Curley, Andrew)
June 26, 2022 Opinion or Order Filing 985 RESPONSE by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co.in Opposition to MOTION by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to Strike and For Curative Instruction #984 (Chapman, Julia)
June 26, 2022 Opinion or Order Filing 984 MOTION by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to Strike and For Curative Instruction (Wozniak, Robert)
June 25, 2022 Opinion or Order Filing 983 VIDEO DEPOSITION TESTIMONY OF DAVID ALAN MYERS, JR. PLAYED ON JUNE 24, 2022 by All Plaintiffs and Defendants (Curley, Andrew)
June 25, 2022 Opinion or Order Filing 982 VIDEO DEPOSITION TESTIMONY OF TARA CHAPMAN PLAYED ON JUNE 23, 2022 AND JUNE 24, 2022 by All Plaintiffs and Defendants (Curley, Andrew)
June 24, 2022 Opinion or Order Filing 1008 MINUTE entry before the Honorable Harry D. Leinenweber: Upon consideration of Retailer Plaintiffs' Motion to Dismiss Claims Against Defendant Impax Laboratories, Inc., Retailer Plaintiffs' Motion is GRANTED #981 , and all claims of the Retailer Plaintiffs in these actions against Impax Laboratories, Inc. are DISMISSED. The Court retains jurisdiction to enforce the parties' confidential settlement agreement. Mailed notice(maf)
June 24, 2022 Opinion or Order Filing 986 MINUTE entry before the Honorable Harry D. Leinenweber: Jury trial held and continued to 6/27/22 at 9:45 a.m. in Courtroom 1203. Mailed notice (maf)
June 24, 2022 Opinion or Order Filing 981 MOTION by Plaintiffs Albertsons LLC, CVS Pharmacy, Inc., HEB Grocery Company L.P., Rite Aid Corporation, Rite Aid Hdqtrs. Corp., Safeway Inc., The Kroger Co., Walgreen Co to Dismiss Claims Against Defendant Impax Labs., Inc. (Attachments: #1 Text of Proposed Order)(Perwin, Scott)
June 23, 2022 Opinion or Order Filing 980 MINUTE entry before the Honorable Harry D. Leinenweber: Jury trial held and continued to 6/24/22 at 9:45 a.m. in Courtroom 1203. Mailed notice (maf)
June 23, 2022 Opinion or Order Filing 979 STIPULATION Amended Stipulations of Fact and Law (Attachments: #1 Exhibit 1)(Refsin, Barry)
June 22, 2022 Opinion or Order Filing 978 MINUTE entry before the Honorable Harry D. Leinenweber: Jury trial held and continued to 6/23/22 at 9:45 a.m. in Courtroom 1203. Mailed notice (maf)
June 22, 2022 Opinion or Order Filing 977 RESPONSE by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co.in Opposition to SEALED MOTION by Plaintiff End-Payor Plaintiffs to Preclude Endo From Offering Evidence or Argument Relating to Rebates During Phase 1 of Trial #973 (Chapman, Julia)
June 22, 2022 Opinion or Order Filing 976 RESPONSE by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. to sealed document #972 Direct Purchaser Plaintiffs' Motion to Admit Exhibits PTX 1664 and 1667 (Chapman, Julia)
June 21, 2022 Opinion or Order Filing 975 MINUTE entry before the Honorable Harry D. Leinenweber: Jury trial held and continued to 6/22/22 at 9:45 a.m. in Courtroom 1203. Mailed notice (maf)
June 21, 2022 Opinion or Order Filing 974 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. to Preclude Plaintiffs From Calling Three More Economists (Chapman, Julia)
June 21, 2022 Opinion or Order Filing 973 SEALED MOTION by Plaintiff End-Payor Plaintiffs to Preclude Endo From Offering Evidence or Argument Relating to Rebates During Phase 1 of Trial (Wozniak, Robert)
June 21, 2022 Opinion or Order Filing 972 SEALED DOCUMENT by Plaintiff Direct Purchaser Plaintiffs MOTION TO ADMIT EXHIBITS PTX 1664 AND 1667 PURSUANT TO RULE 1006 (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Curley, Andrew)
June 21, 2022 Opinion or Order Filing 971 REPLY by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to Response, #968 Plaintiffs' Opposition to Defendant Endo's Second Attempt to Preclude James Bruno (Refsin, Barry)
June 21, 2022 Opinion or Order Filing 970 NOTICE by Robert Samuel Kitchenoff of Change of Address (Kitchenoff, Robert)
June 20, 2022 Opinion or Order Filing 968 RESPONSE by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. to sealed document #966 Plaintiffs' Memorandum in Support of Their Deposition Designations of Joseph Camargo and John Anthony (Chapman, Julia)
June 20, 2022 Opinion or Order Filing 967 VIDEO DEPOSITION TESTIMONY OF BRIAN LORTIE PLAYED ON JUNE 17, 2022 by All Plaintiffs and Defendants (Curley, Andrew)
June 20, 2022 Opinion or Order Filing 966 SEALED DOCUMENT by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs Plaintiffs' Memorandum in Support of Their Deposition Designations of Joseph Camargo and John Anthony (Gerstein, Bruce)
June 20, 2022 Opinion or Order Filing 965 VIDEO DEPOSITION TESTIMONY OF CAROLINE MANOGUE PLAYED ON JUNE 17, 2022 by All Plaintiffs and Defendants (Curley, Andrew)
June 18, 2022 Opinion or Order Filing 964 VIDEO DEPOSITION TESTIMONY OF ROBERT COBUZZI, JR. PLAYED ON JUNE 16, 2022 by All Plaintiffs and Defendants (Curley, Andrew)
June 18, 2022 Opinion or Order Filing 963 VIDEO DEPOSITION TESTIMONY OF ROBERTO CUCA PLAYED ON JUNE 15, 2022 AND JUNE 16, 2022 by All Plaintiffs and Defendants (Curley, Andrew)
June 17, 2022 Opinion or Order Filing 969 MINUTE entry before the Honorable Harry D. Leinenweber: Jury trial held and continued to 6/21/22 at 9:45 a.m. in Courtroom 1203. Mailed notice (maf)
June 17, 2022 Opinion or Order Filing 962 VIDEO DEPOSITION TESTIMONY OF GUY DONATIELLO PLAYED ON JUNE 15, 2022 by All Plaintiffs and Defendants (Curley, Andrew)
June 17, 2022 Opinion or Order Filing 961 VIDEO DEPOSITION TESTIMONY OF AHMET DEMIR BINGOL PLAYED ON JUNE 15, 2022 by All Plaintiffs and Defendants (Curley, Andrew)
June 17, 2022 Opinion or Order Filing 960 VIDEO DEPOSITION TESTIMONY OF CHRISTOPHER MENGLER PLAYED ON JUNE 14, 2022 AND JUNE 15, 2022 by All Plaintiffs and Defendants (Curley, Andrew)
June 16, 2022 Opinion or Order Filing 959 MINUTE entry before the Honorable Harry D. Leinenweber: Jury trial held and continued to 6/17/22 at 9:45 a.m. in Courtroom 1203. Mailed notice (maf)
June 16, 2022 Opinion or Order Filing 958 VIDEO DEPOSITION TESTIMONY OF TODD ENGLE PLAYED ON JUNE 14, 2022 by All Plaintiffs and Defendants (Curley, Andrew)
June 15, 2022 Opinion or Order Filing 957 MINUTE entry before the Honorable Harry D. Leinenweber: Jury trial held and continued to 6/16/22 at 9:45 a.m. in Courtroom 1203. Mailed notice (maf)
June 15, 2022 Opinion or Order Filing 956 RESPONSE by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to objections #955 PLAINTIFFS' RESPONSE TO DEFENDANTS' OBJECTION TO DESIGNATIONS TO DEPOSITION OF MELISSA FLAX, ESQ. (Curley, Andrew)
June 15, 2022 Opinion or Order Filing 955 OBJECTIONS by Defendants to Designations to the Deposition of Melissa Flax, Esq. (Chapman, Julia)
June 14, 2022 Opinion or Order Filing 954 MINUTE entry before the Honorable Harry D. Leinenweber: Jury trial held and continued to 6/15/22 at 10:00 a.m. in Courtroom 1203. Mailed notice (maf)
June 14, 2022 Opinion or Order Filing 953 VIDEO DEPOSITION TESTIMONY OF DR. LARRY HSU PLAYED ON JUNE 10, 2022 by All Plaintiffs and Defendants (Curley, Andrew)
June 13, 2022 Opinion or Order Filing 952 MINUTE entry before the Honorable Harry D. Leinenweber: Jury trial held and continued to 6/14/22 at 10:00 a.m. in Courtroom 1203. Mailed notice (maf)
June 10, 2022 Opinion or Order Filing 951 MINUTE entry before the Honorable Harry D. Leinenweber: Jury trial held and continued to 6/13/22 at 9:45 a.m. in Courtroom 1203. Mailed notice (maf)
June 10, 2022 Opinion or Order Filing 950 MINUTE entry before the Honorable Harry D. Leinenweber: Jury trial set for 6/10/22 at 10:00 a.m. is re-set to 6/10/22 at 9:30 a.m. in Courtroom 1203. Mailed notice (maf)
June 9, 2022 Opinion or Order Filing 949 MINUTE entry before the Honorable Harry D. Leinenweber: Voir dire held and completed on 6/9/2022. Trial begins - jury. Jury trial continued to 6/10/2022 at 10:00 a.m. in Courtroom 1203. Mailed notice(maf)
June 7, 2022 Opinion or Order Filing 947 REPLY by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to Motion in Limine to Preclude Certain Testimony From Melissa Flax Regarding the Underlying Patent Litigation (Defendants' MIL No. 15) #815 (Public Version of Dkt. 897) (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2)(Chapman, Julia)
June 7, 2022 Opinion or Order Filing 946 REPLY by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to Motion in Limine to Preclude Evidence or Argument Disparaging the USPTO or its Examiners (Defendants' MIL No. 14) #814 (Public Version of Dkt. 896) (Chapman, Julia)
June 7, 2022 Opinion or Order Filing 945 REPLY by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to SEALED MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. in Limine to Preclude Evidence or Argument Referring to Consumer Harm (Defendants' MIL NO. 16) #829 (Public Version of Sealed ECF No. 907) (Allon, Devora)
June 7, 2022 Opinion or Order Filing 944 DECLARATION of Patrick J. Gallagher regarding sealed document, #906 (Public Version of Sealed ECF No. 906) (Attachments: #1 Exhibit 3)(Gallagher, Patrick)
June 7, 2022 Opinion or Order Filing 943 REPLY by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to SEALED MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. in Limine to Preclude Evidence or Argument Referring to At-Risk Launch Theory (Defendants' MIL No. 2) #827 (Public Version of Sealed ECF No. 905) (Allon, Devora)
June 7, 2022 Opinion or Order Filing 942 REPLY by Impax Laboratories, Inc. to SEALED MOTION by Defendant Impax Laboratories, Inc. in Limine to Preclude Evidence or Argument Referring to Post-Settlement Development and Co-Promotion Agreement Conduct (IMPAX MIL NO. 3) #822 (Public Version of Sealed ECF No. 902) (Allon, Devora)
June 7, 2022 Opinion or Order Filing 941 DECLARATION of Patrick J. Gallagher regarding sealed document #901 (Public Version of Sealed ECF No. 901) (Attachments: #1 Exhibit 4)(Gallagher, Patrick)
June 7, 2022 Opinion or Order Filing 940 REPLY by Impax Laboratories, Inc. to SEALED MOTION by Defendant Impax Laboratories, Inc. in Limine to Preclude Evidence or Argument Referring to $102 Million Payment (IMPAX MIL NO. 2) #820 (Public Version of Sealed ECF No. 900) (Allon, Devora)
June 6, 2022 Opinion or Order Filing 939 TRANSCRIPT OF PROCEEDINGS held on 6-2-22 before the Honorable Harry D. Leinenweber. Pretrial Conference. Court Reporter Contact Information: Sandra M. Tennis 312-554-8244, Sandra_Tennis@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 6/27/2022. Redacted Transcript Deadline set for 7/7/2022. Release of Transcript Restriction set for 9/5/2022. (Mullin, Sandra)
June 6, 2022 Opinion or Order Filing 938 MINUTE entry before the Honorable Harry D. Leinenweber: In Court hearing set for 6/9/2022 at 9:30 a.m. in Courtroom 1203. Overflow Courtroom for the trial will be available for viewing in Courtroom 1944(D). Mailed notice(maf)
June 6, 2022 Opinion or Order Filing 937 MINUTE entry before the Honorable Harry D. Leinenweber: As set forth during the Pretrial Conference, the Court grants the following pretrial motions in limine: #802 , #817 , #819 , #810 . The Court denies the following pretrial motions in limine: #801 , #827 Parts 4 and 5 of #803 , #804 , #805 , #814 , #815 , #829 , #818 , #820 , #822 , #824 , #825 , #806 , #807 , #808 , Parts A, B, C, and E of #811 , #812 , #813 . The Court also denies Plaintiff's oral motion in limine to use deposition testimony even if the witness is available. The Court grants in part and denies in part the following motions: Part 6 + 10 of #803 . The Court finds the following motions moot per the parties agreement: Parts 7, 8, 9, and 11 of #803 , #831 , #809 Part D of #811 . For many of the motions, the Court expects the parties to work together to avoid the concerns raised by the opposing party. The Court will entertain objections at side bar if parties feel that the opposing party is not acting in good faith or has opened the door to additional evidence. Mailed notice (maf)
June 4, 2022 Opinion or Order Filing 936 MEMORANDUM reply, #904 by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs Public Redacted Version of Reply in Further Support of Plaintiffs' Motion in Limine No. 5 to Exclude Endo's Expert Reports from the Underlying Patent Litigation as Evidence (Curley, Andrew)
June 4, 2022 Opinion or Order Filing 935 MEMORANDUM sealed response,, #869 by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs Public Redacted Version of Plaintiffs' Opposition to Defendants' Joint Motion in Limine No. 1 to Preclude Data on Reformulated Opana ER's Effect on Abuse and Related FDA Actions (Curley, Andrew)
June 4, 2022 Opinion or Order Filing 934 MEMORANDUM sealed response, #868 by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs Public Redacted Version of Plaintiffs' Opposition to Defendants' Joint Motion in Limine No. 13 to Preclude References to Damages in Liability Phase (Curley, Andrew)
June 4, 2022 Opinion or Order Filing 933 MEMORANDUM sealed response,, #850 by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs Public Redacted Version of Plaintiffs' Opposition to Defendants' Motion in Limine No. 15 to Preclude Certain Testimony from Melissa Flax regarding the Underlying Patent Litigation (Curley, Andrew)
June 4, 2022 Opinion or Order Filing 932 MEMORANDUM sealed response, #849 by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs Public Redacted Version of Plaintiffs' Opposition to Defendants' Motion in Limine No. 14 to Preclude Evidence or Argument Disparaging the USPTO or its Examiners (Curley, Andrew)
June 4, 2022 Opinion or Order Filing 931 MEMORANDUM sealed response,, #847 by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs Public Redacted Version of Plaintiffs' Opposition to Defendants' Motion in Limine No. 2 to Preclude Evidence or Argument Referring to At-Risk Launch Theory (Curley, Andrew)
June 4, 2022 Opinion or Order Filing 930 MEMORANDUM sealed document, #844 by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs Public Redacted Version of Plaintiffs' Opposition to Defendants' Motions in Limine to Preclude Evidence Related to FTC Investigation and Litigation (Endo's MIL No. 1; Impax's MIL No. 1) (Gerstein, Bruce)
June 4, 2022 Opinion or Order Filing 929 MEMORANDUM sealed response,, #841 by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs Public Redacted Version of Plaintiffs' Opposition to Defendants' Motion in Limine No. 16 to Preclude Evidence or Argument Referring to Consumer Harm (Gerstein, Bruce)
June 4, 2022 Opinion or Order Filing 928 MEMORANDUM sealed response, #840 by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs Public Redacted Version of Plaintiffs' Opposition to Impax's Motion in Limine No. 2 to Preclude Evidence or Argument Referring to $102 Million Payment (Gerstein, Bruce)
June 4, 2022 Opinion or Order Filing 927 MEMORANDUM sealed response,, #838 by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs Public Redacted Version of Plaintiffs' Opposition to Impax's Motion in Limine No. 3 to Exclude Evidence or Argument Referring to Post-Settlement Development and Co-Promotion Agreement Conduct (Gerstein, Bruce) Text of the docket entry modified on 6/6/2022 (maf).
June 4, 2022 Opinion or Order Filing 926 MEMORANDUM Sealed motion #810 by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs Public Redacted Version of Plaintiffs' Motion in Limine No. 5 to Exclude Endo's Expert Reports from the Underlying Patent Litigation as Evidence (Gerstein, Bruce)
June 4, 2022 Opinion or Order Filing 925 MEMORANDUM Sealed motion, #809 by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs Public Redacted Version of Plaintiffs' Motion in Limine No. 4 to Exclude Evidence or Argument Regarding FDA Risk Management Programs (Gerstein, Bruce)
June 4, 2022 Opinion or Order Filing 924 MEMORANDUM Sealed motion, #807 by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs Public Redacted Version of Plaintiffs' Motion in Limine No. 2. to Exclude Evidence or Argument Contrary to the Definition of "Large" in Actavis (Gerstein, Bruce)
June 2, 2022 Opinion or Order Filing 948 ENTER JOINT STIPULATION REGARDING DUPLICATE EXHIBITS, FINAL DEPOSITION DESIGNATIONS AND ORDER OF WITNESSES. Signed by the Honorable Harry D. Leinenweber on 6/2/2022: Mailed notice(maf)
June 2, 2022 Opinion or Order Filing 923 PROPOSED Voir Dire by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. (Chapman, Julia)
June 2, 2022 Opinion or Order Filing 922 PROPOSED Voir Dire by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs (Refsin, Barry)
June 2, 2022 Opinion or Order Filing 921 MINUTE entry before the Honorable Harry D. Leinenweber: Final pretrial conference held. Mailed notice(maf)
June 2, 2022 Opinion or Order Filing 920 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. Declaration of Benjamin M. Greenblum in Support of Defendants' Reply in Support of Their Motion to Strike New Expert Disclosure of Retailer Expert Keith Leffler (Attachments: #1 Exhibit 4)(Chapman, Julia)
June 2, 2022 Opinion or Order Filing 919 REPLY by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to motion to strike, #915 in Support of Their Motion to Strike New Expert Disclosure of Retailer Expert Keith Leffler (Chapman, Julia)
June 1, 2022 Opinion or Order Filing 918 MOTION by Plaintiff End-Payor Plaintiffs Motion in Limine No. 8 to Preclude Defendants From Offfering Evidence or Argument Concerning: (1) Any Purported "Pass-On" of Overcharges in the Form of Higher Premiums or Contributions; (2) Medicare Part D Plans or Patients Being Former Class Members and Their Alleged Non-Injury or Negative Damages [PUBLIC VERSION of ECF No. 813] (Attachments: #1 Exhibits 1-5)(Wozniak, Robert)
June 1, 2022 Opinion or Order Filing 917 MEMORANDUM by Albertsons LLC, CVS Pharmacy, Inc., HEB Grocery Company L.P., Rite Aid Corporation, Rite Aid Hdqtrs. Corp., Safeway Inc., The Kroger Co., Walgreen Co in Opposition to motion to strike, #915 Keith Leffler's Additional Damage Calculations (Perwin, Scott)
May 31, 2022 Opinion or Order Filing 916 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. Declaration of Benjamin M. Greenblum in Support of Motion to Strike New Expert Disclosure of Retailer Expert Keith Leffler (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3)(Chapman, Julia)
May 31, 2022 Opinion or Order Filing 915 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to strike New Expert Disclosure of Retailer Expert Keith Leffler (Attachments: #1 Text of Proposed Order)(Chapman, Julia)
May 31, 2022 Opinion or Order Filing 914 RESPONSE by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to sealed response, #864 , Sealed motion, #809 (Public Version of Sealed ECF No. 864) (Allon, Devora)
May 31, 2022 Opinion or Order Filing 913 RESPONSE by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to sealed response, #863 , Sealed motion, #807 (Public Version of Sealed ECF No. 863) (Allon, Devora)
May 31, 2022 Opinion or Order Filing 912 RESPONSE by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to SEALED MOTION by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs MOTION IN LIMINE NO. 5 TO EXCLUDE ENDO'S EXPERT REPORTS FROM THE UNDERLYING PATENT LITIGATION AS EVIDENCE #810 (Public Version of Dkt. 858) (Chapman, Julia)
May 31, 2022 Opinion or Order Filing 911 RESPONSE by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co.in Opposition to MOTION by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffsin limine Plaintiffs' Motion in Limine No. 3 to Exclude Evidence or Argument of "Risk Aversion" to Justify Endo's Reverse Payments #808 (Public Version of Dkt. 854) (Chapman, Julia)
May 31, 2022 Opinion or Order Filing 910 MINUTE entry before the Honorable Harry D. Leinenweber: Jury trial set for 6/7/22 is re-set to 6/9/22 in Courtroom 1203 at 10:00 AM. Mailed notice(maf)
May 25, 2022 Opinion or Order Filing 909 ORDER: Telephonic status hearing held. The Court does not have a problem with daily rapid testing for witnesses who will be traveling and entering the courtroom for less than two days, but the Court defers to the COVID-19 protocols established by the Dirksen Courthouse and will seek further clarification on alternative testing. The parties are directed to meet and confer regarding the estimated length of openings and be ready to provide this information to this Court at the pretrial conference. Plaintiffs' oral motion to be permitted to show video testimony of available defense witnesses is entered and continued until the pretrial conference. Telephonic final pretrial conference set for 6/2/22 at 10:00 a.m. is re-set to 6/2/22 at 1:00 p.m. Dial: 888-684-8852 or 215-446-0155, access code: 9582710#. Pro hac vice motions are granted #878 , #879 , #908 . Signed by the Honorable Harry D. Leinenweber on 5/25/2022. Mailed notice (aee, )
May 25, 2022 Opinion or Order Filing 908 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number AILNDC-19502230. (Egervary, Alexander)
May 24, 2022 Opinion or Order Filing 907 SEALED REPLY by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to SEALED MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. in Limine to Preclude Evidence or Argument Referring to Consumer Harm (Defendants' MIL NO. 16) #829 (Allon, Devora)
May 24, 2022 Opinion or Order Filing 906 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. / Declaration of Patrick J. Gallagher in Support of Defendants' Reply in Support of Defendants' Joint Motion in Limine No. 2 (Attachments: #1 Exhibit 3)(Gallagher, Patrick)
May 24, 2022 Opinion or Order Filing 905 SEALED REPLY by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to SEALED MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. in Limine to Preclude Evidence or Argument Referring to At-Risk Launch Theory (Defendants' MIL No. 2) #827 (Allon, Devora)
May 24, 2022 Opinion or Order Filing 904 SEALED REPLY by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to SEALED MOTION by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs MOTION IN LIMINE NO. 5 TO EXCLUDE ENDO'S EXPERT REPORTS FROM THE UNDERLYING PATENT LITIGATION AS EVIDENCE #810 in Further Support of Plaintiffs' Motion in Limine No. 5 to Exclude Endo's Expert Reports from the Underlying Patent Litigation as Evidence (Gerstein, Bruce)
May 24, 2022 Opinion or Order Filing 903 REPLY by Defendant Impax Laboratories, Inc. to motion in limine #825 in Support of its Motion in Limine No. 4 to Preclude Evidence or Argument Referring to the "Opioid Epidemic" (IMPAX MIL NO. 4) (Allon, Devora)
May 24, 2022 Opinion or Order Filing 902 SEALED REPLY by Impax Laboratories, Inc. to SEALED MOTION by Defendant Impax Laboratories, Inc. in Limine to Preclude Evidence or Argument Referring to Post-Settlement Development and Co-Promotion Agreement Conduct (IMPAX MIL NO. 3) #822 (Allon, Devora)
May 24, 2022 Opinion or Order Filing 901 SEALED DOCUMENT by Defendant Impax Laboratories, Inc. / Declaration of Patrick J. Gallagher in Support of Impax Laboratories, Inc.'s Reply in Support of its Motion in Limine No. 2 (Attachments: #1 Exhibit 4)(Allon, Devora)
May 24, 2022 Opinion or Order Filing 900 SEALED REPLY by Impax Laboratories, Inc. to SEALED MOTION by Defendant Impax Laboratories, Inc. in Limine to Preclude Evidence or Argument Referring to $102 Million Payment (IMPAX MIL NO. 2) #820 (Allon, Devora)
May 24, 2022 Opinion or Order Filing 899 REPLY by Defendant Impax Laboratories, Inc. to motion in limine #819 in Support of its Motion in Limine No. 1 to Preclude Evidence or Argument Referring to FTC Investigation and Litigation (IMPAX MIL NO. 1) (Allon, Devora)
May 24, 2022 Opinion or Order Filing 898 REPLY by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to motion in limine #811 in Support of Plaintiffs' Motion in Limine No. 6 to Preclude Defendants from Offering Irrelevant and Unduly Prejudicial Evidence (Gerstein, Bruce)
May 24, 2022 Opinion or Order Filing 897 SEALED REPLY by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co.in limine to Preclude Certain Testimony From Melissa Flax Regarding the Underlying Patent Litigation (Defendants' MI #815 (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2)(Chapman, Julia)
May 24, 2022 Opinion or Order Filing 896 SEALED REPLY by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co.in limine to Preclude Evidence or Argument Disparaging the USPTO or its Examiners (Defendants' MIL No. 14) #814 (Chapman, Julia)
May 24, 2022 Opinion or Order Filing 895 PROPOSED Pretrial Order (Attachments: #1 Exhibit Index of Exhibits, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11, #13 Exhibit 12, #14 Exhibit 13, #15 Exhibit 14, #16 Exhibit 15, #17 Exhibit 16, #18 Exhibit 17, #19 Exhibit 18, #20 Exhibit 19, #21 Exhibit 20, #22 Exhibit 21, #23 Exhibit 22, #24 Exhibit 23, #25 Exhibit 24, #26 Exhibit 25, #27 Exhibit 26, #28 Exhibit 27, #29 Exhibit 28, #30 Exhibit 29, #31 Exhibit 30, #32 Exhibit 31, #33 Exhibit 32, #34 Exhibit 33, #35 Exhibit 34, #36 Exhibit 35, #37 Exhibit 36, #38 Exhibit 37)(Curley, Andrew)
May 24, 2022 Opinion or Order Filing 894 REPLY by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to motion in limine, #805 in Support of Defendants' Motion in Limine No. 13 to Preclude References to Damages in Liability Phase (Chapman, Julia)
May 24, 2022 Opinion or Order Filing 893 REPLY by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to motion in limine, #804 in Support of Defendants' Motion in Limine No. 12 to Preclude References to the Financial Condition of Defendants and Their Employees (Chapman, Julia)
May 24, 2022 Opinion or Order Filing 892 REPLY by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to motion in limine,, #803 in Support of Defendants' Motions in Limine Nos. 4-11 to Preclude Certain Trial Matters (Chapman, Julia)
May 24, 2022 Opinion or Order Filing 891 REPLY by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to motion in limine, #802 in Support of Defendants' Motion in Limine No. 3 to Preclude Irrelevant Allegations and Evidence of Other Alleged Endo or Impax "Pay for Delay" Deals (Chapman, Julia)
May 24, 2022 Opinion or Order Filing 890 REPLY by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to motion in limine, #801 in Support of Defendants' Motion in Limine No. 1 to Preclude Data on Reformulated Opana ER's Effect on Abuse and Related FDA Actions (Chapman, Julia)
May 24, 2022 Opinion or Order Filing 889 REPLY by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. to motion in limine, #818 in Support of Endo's Motion in Limine No. 2 to Preclude Evidence or Argument Referring to Endo as Having a "Patent Monopoly" (Chapman, Julia)
May 24, 2022 Opinion or Order Filing 888 REPLY by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. to motion in limine, #817 in Support of Endo's Motion in Limine No. 1 to Preclude Any Mention of, or the Introduction of Documents Related to, FTC Investigations/Proceedings Involving Opana ER (Chapman, Julia)
May 24, 2022 Opinion or Order Filing 887 REPLY by Plaintiffs Direct Purchaser Plaintiffs, Retailer Plaintiffs to motion in limine #812 REPLY IN FURTHER SUPPORT OF DIRECT PURCHASER AND RETAILER PLAINTIFFS' MOTION IN LIMINE NO. 7 TO EXCLUDE EVIDENCE AND ARGUMENT OF "PASS ON" (ECF NO. 812) (Curley, Andrew)
May 24, 2022 Opinion or Order Filing 886 REPLY by Plaintiff End-Payor Plaintiffs to Sealed motion, #813 in Support of Motion in Limine No. 8 to Preclude Defendants From Offering Evidence or Argument Concerning: (1) Any Purported "Pass-On" of Overcharges in the Form of Higher Premiums or Contributions; (2) Medicare Part D Plans or Patients Being Former Class Members and Their Alleged Non-Injury or Negative Damages (Attachments: #1 Exhibit 1)(Wozniak, Robert)
May 24, 2022 Opinion or Order Filing 885 REPLY by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to motion in limine, #806 in Support of Plaintiffs' Motion in Limine No. 1 to Exclude Evidence or Argument that the Broad License or Later-Issued Patents Allegedly Justify Endo's Reverse Payments (Gerstein, Bruce)
May 24, 2022 Opinion or Order Filing 884 ATTORNEY Appearance for Plaintiff End-Payor Plaintiffs by Tyler J. Story (Story, Tyler)
May 24, 2022 Opinion or Order Filing 883 REPLY by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to motion in limine, #808 in Support of Plaintiffs' Motion in Limine No 3 to Exclude Evidence or Argument of "Risk Aversion" (Refsin, Barry)
May 24, 2022 Opinion or Order Filing 882 REPLY by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to Sealed motion, #807 in Support of Plaintiffs' Motion in Limine No. 2 to Exclude Evidence or Argument Contrary to the Definition of "Large" in Actavis (Refsin, Barry)
May 24, 2022 Opinion or Order Filing 881 NOTICE by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs re SEALED MOTION by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs Motion in Limine No. 4 to Exclude Evidence or Argument Regarding FDA Risk Management Programs #809 Plaintiffs' Notice Regarding Mootness of Plaintiffs' Motion in Limine No. 4 to Exclude Evidence or Argument Regarding FDA Risk Management Programs (Gerstein, Bruce)
May 24, 2022 Opinion or Order Filing 880 ATTORNEY Appearance for Plaintiff End-Payor Plaintiffs by Eaghan Seumas Davis (Davis, Eaghan)
May 24, 2022 Opinion or Order Filing 879 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number AILNDC-19497087. (Ford, Samuel)
May 24, 2022 Opinion or Order Filing 878 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number AILNDC-19496954. (Lorentson, Kari)
May 19, 2022 Opinion or Order Filing 877 ATTORNEY Appearance for Defendant Impax Laboratories, Inc. by Patrick J Gallagher (Gallagher, Patrick)
May 19, 2022 Opinion or Order Filing 876 ATTORNEY Appearance for Defendant Impax Laboratories, Inc. by Kevin Michael Neylan (Neylan, Kevin)
May 19, 2022 Opinion or Order Filing 875 Enter Joint Stipulation in Connection with the Parties' Motions in Limine. Signed by the Honorable Harry D. Leinenweber on 5/19/2022: Mailed notice(maf)
May 19, 2022 Opinion or Order Filing 874 ORDER: Pro hac vice motion is granted #871 . Signed by the Honorable Harry D. Leinenweber on 5/19/2022. Mailed notice (aee, )
May 19, 2022 Opinion or Order Filing 873 ORDER: Pro hac vice motion is granted #870 , #871 . Signed by the Honorable Harry D. Leinenweber on 5/19/2022. Mailed notice (aee, )
May 19, 2022 Opinion or Order Filing 872 ORDER: Pro hac vice motion is granted #870 . Signed by the Honorable Harry D. Leinenweber on 5/19/2022. Mailed notice (aee, )
May 19, 2022 Opinion or Order Filing 871 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number AILNDC-19482067. (Gallagher, Patrick)
May 18, 2022 Opinion or Order Filing 870 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number AILNDC-19481200. (Attachments: #1 Exhibit A - Addendum)(Neylan, Kevin)
May 17, 2022 Opinion or Order Filing 869 SEALED RESPONSE by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co.in limine to Preclude Data on Reformulated Opana ER's Effect on Abuse and Related FDA Actions (Defendants' MIL #801 Plaintiffs' Opposition to Defendants' Joint Motion in Limine No. 1 to Preclude Data on Reformulated Opana ER's Effect on Abuse and Related FDA Actions (Gerstein, Bruce)
May 17, 2022 Opinion or Order Filing 868 SEALED RESPONSE by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co.in limine to Preclude References to Damages in Liability Phase (Defendants' MIL No. 13) #805 Plaintiffs' Opposition to Defendants' Joint Motion in Limine No. 13 to Preclude References to Damages in Liability Phase (Gerstein, Bruce)
May 17, 2022 Opinion or Order Filing 867 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. in Opposition to motion in limine #811 Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., and Penwest Pharmaceuticals' Memorandum of Law in Opposition to Plaintiffs' Motion in Limine No. 6 to Preclude Defendants from Offering Irrelevant and Unduly Prejudicial Evidence (Allon, Devora)
May 17, 2022 Opinion or Order Filing 866 DECLARATION of Devora W. Allon, P.C. in Support of Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., and Penwest Pharmaceuticals' Memorandum of Law in Response to Plaintiffs' Motion in Limine No. 4 to Exclude Evidence or Argument Regarding FDA Risk Management Programs regarding sealed response, #864 , Sealed motion, #809 (Attachments: #1 Exhibit 1)(Allon, Devora)
May 17, 2022 Opinion or Order Filing 865 RESPONSE by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to Sealed motion, #831 IN LIMINE NO. 17 TO PRECLUDE MARTIN LESSEM TESTIMONY (Curley, Andrew)
May 17, 2022 Opinion or Order Filing 864 SEALED RESPONSE by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to SEALED MOTION by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs Motion in Limine No. 4 to Exclude Evidence or Argument Regarding FDA Risk Management Programs #809 (Allon, Devora)
May 17, 2022 Opinion or Order Filing 863 SEALED RESPONSE by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to SEALED MOTION by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs Plaintiffs' Motion in Limine No. 2 to Exclude Evidence or Argument Contrary to the Definition of "Large" in Actavis #807 (Allon, Devora)
May 17, 2022 Opinion or Order Filing 862 MEMORANDUM by Impax Laboratories, Inc. in Opposition to motion in limine, #806 / Defendant Impax Laboratories, Inc.'s Memorandum of Law in Opposition to Plaintiffs' Motion in Limine No. 1 to Exclude Evidence or Argument that the Broad License or Later-Issued Patents Allegedly Justify Endo's Reverse Payments (Allon, Devora)
May 17, 2022 Opinion or Order Filing 861 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. Declaration of Forrest Lovett in Support of Endo's Opposition to Plaintiffs' Motion in Limine No. 1 and Defendants' Oppositions to Plaintiffs' Motions in Limine Nos. 3, 5, 7-8 (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F)(Chapman, Julia)
May 17, 2022 Opinion or Order Filing 860 RESPONSE by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co.in Opposition to SEALED MOTION by Plaintiff End-Payor Plaintiffs Motion in Limine No. 8 to Preclude Defendants From Offfering Evidence or Argument Concerning: (1) Any Purported "Pass-On" of Overcharges in the Form of Higher Premiums or Contributions; (2) #813 (Chapman, Julia)
May 17, 2022 Opinion or Order Filing 859 RESPONSE by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co.in Opposition to MOTION by Plaintiffs Direct Purchaser Plaintiffs, Retailer Plaintiffsin limine NO. 7 TO EXCLUDE EVIDENCE AND ARGUMENT OF "PASS ON" #812 (Chapman, Julia)
May 17, 2022 Opinion or Order Filing 858 SEALED RESPONSE by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to SEALED MOTION by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs MOTION IN LIMINE NO. 5 TO EXCLUDE ENDO'S EXPERT REPORTS FROM THE UNDERLYING PATENT LITIGATION AS EVIDENCE #810 (Chapman, Julia)
May 17, 2022 Opinion or Order Filing 857 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. in support of Sealed motion, #831 (Public Versions of Sealed ECF No.'s 831 and 832) (Attachments: #1 Declaration of Devora W. Allon, P.C., #2 Exhibit 1, #3 Exhibit 2)(Allon, Devora)
May 17, 2022 Opinion or Order Filing 856 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. in support of Sealed motion, #829 (Public Versions of Sealed ECF No.'s 829 and 830) (Attachments: #1 Declaration of Devora W. Allon, P.C., #2 Exhibit 1)(Allon, Devora)
May 17, 2022 Opinion or Order Filing 855 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. in support of Sealed motion, #827 (Public Versions of Sealed ECF No.'s 827 and 828) (Attachments: #1 Declaration of Devora W. Allon, P.C., #2 Exhibit 1, #3 Exhibit 2)(Allon, Devora)
May 17, 2022 Opinion or Order Filing 854 SEALED RESPONSE by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to MOTION by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffsin limine Plaintiffs' Motion in Limine No. 3 to Exclude Evidence or Argument of "Risk Aversion" to Justify Endo's Reverse Payments #808 (Chapman, Julia)
May 17, 2022 Opinion or Order Filing 853 MEMORANDUM by Impax Laboratories, Inc. in support of Sealed motion, #822 (Public Versions of Sealed ECF No.'s 822 and 823) (Attachments: #1 Declaration of Devora W. Allon, P.C., #2 Exhibit 1)(Allon, Devora)
May 17, 2022 Opinion or Order Filing 852 MEMORANDUM by Impax Laboratories, Inc. in support of Sealed motion #820 (Public Versions of Sealed ECF No.'s 820 and 821). (Attachments: #1 Declaration of Devora W. Allon, P.C., #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3)(Allon, Devora)
May 17, 2022 Opinion or Order Filing 851 RESPONSE by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co.in Opposition to MOTION by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffsin limine No. 1 To Exclude Evidence or Argument That The Broad License or Later-Issues Patents Allegedly Justify Endo's Reverse Payments #806 (Chapman, Julia)
May 17, 2022 Opinion or Order Filing 850 SEALED RESPONSE by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co.in limine to Preclude Certain Testimony From Melissa Flax Regarding the Underlying Patent Litigation (Defendants' MI #815 Plaintiffs' Opposition to Defendants' Motion in Limine No. 15 (Attachments: #1 Exhibit Index of Exhibits, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4)(Curley, Andrew)
May 17, 2022 Opinion or Order Filing 849 SEALED RESPONSE by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co.in limine to Preclude Evidence or Argument Disparaging the USPTO or its Examiners (Defendants' MIL No. 14) #814 Plaintiffs' Opposition to Defendants' Motion in Limine No. 14 (Curley, Andrew)
May 17, 2022 Opinion or Order Filing 848 RESPONSE by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffsin Opposition to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co.in limine to Preclude Evidence or Argument Referring to Endo as Having a "Patent Monopoly" (Endo MIL No. 2) #818 Plaintiffs' Opposition to Endo's Motion in Limine No. 2 (Curley, Andrew)
May 17, 2022 Opinion or Order Filing 847 SEALED RESPONSE by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to SEALED MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. in Limine to Preclude Evidence or Argument Referring to At-Risk Launch Theory (Defendants' MIL No. 2) #827 Plaintiffs' Opposition to Defendants' Motion in Limine No. 2 to Preclude Evidence or Argument Referring to At-Risk Launch Theory (Gerstein, Bruce)
May 17, 2022 Opinion or Order Filing 846 RESPONSE by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffsin Opposition to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co.in limine to Preclude References to the Financial Condition of Defendants and Their Employees (Defendants' MIL No. 1 #804 Plaintiffs' Opposition to Defendants' Joint Motion in Limine No. 12 (Curley, Andrew)
May 17, 2022 Opinion or Order Filing 845 RESPONSE by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffsin Opposition to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co.in limine to Preclude Certain Trial Matters (Defendants' MIL Nos. 4-11) #803 Plaintiffs' Opposition to Defendants' Joint Motions in Limine Nos. 4-11 (Attachments: #1 Exhibits 1-3)(Wozniak, Robert)
May 17, 2022 Opinion or Order Filing 844 SEALED DOCUMENT by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs Plaintiffs' Opposition to Motions in Limine to Preclude Evidence Related to FTC Investigation & Litigation (Endo MIL No. 1, ECF No. 817; Impax MIL No. 1, ECF No. 819) (Attachments: #1 Exhibits 1-9)(Wozniak, Robert)
May 17, 2022 Opinion or Order Filing 843 RESPONSE by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffsin Opposition to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co.in limine to Preclude Irrelevant Allegations and Evidence of Other Alleged Endo or Impax "Pay for Delay" Deals #802 Plaintiffs' Opposition to Defendants' Joint Motion in Limine No. 3 (Wozniak, Robert)
May 17, 2022 Opinion or Order Filing 842 RESPONSE by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to MOTION by Defendant Impax Laboratories, Inc.in limine to Preclude Evidence or Argument Referring to the "Opioid Epidemic" (IMPAX MIL NO. 4) #825 (Wozniak, Robert)
May 17, 2022 Opinion or Order Filing 841 SEALED RESPONSE by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to SEALED MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. in Limine to Preclude Evidence or Argument Referring to Consumer Harm (Defendants' MIL NO. 16) #829 Plaintiffs' Opposition to Defendants' Motion in Limine No. 16 to Preclude Evidence or Argument Referring to Consumer Harm (Refsin, Barry)
May 17, 2022 Opinion or Order Filing 840 SEALED RESPONSE by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to SEALED MOTION by Defendant Impax Laboratories, Inc. in Limine to Preclude Evidence or Argument Referring to $102 Million Payment (IMPAX MIL NO. 2) #820 Plaintiffs' Opposition to Impax's Motion in Limine No. 2 to Preclude Evidence or Argument Referring to $102 Million Payment (Refsin, Barry)
May 17, 2022 Opinion or Order Filing 839 AFFIDAVIT by Plaintiffs (Direct Purchaser and End-Payor), Albertsons LLC, CVS Pharmacy, Inc., HEB Grocery Company L.P., Rite Aid Corporation, Rite Aid Hdqtrs. Corp., Safeway Inc., The Kroger Co., Walgreen Co in Opposition to SEALED MOTION by Defendant Impax Laboratories, Inc. in Limine to Preclude Evidence or Argument Referring to Post-Settlement Development and Co-Promotion Agreement Conduct (IMPAX MIL NO. 3) #822 Declaration of Lauren C. Ravkind in Opposition to Impax Laboratories, Inc.'s Motion in Limine No. 3 (Attachments: #1 Exhibit 1)(Ravkind, Lauren)
May 17, 2022 Opinion or Order Filing 838 SEALED RESPONSE by (Direct Purchaser and End-Payor), Albertsons LLC, CVS Pharmacy, Inc., HEB Grocery Company L.P., Rite Aid Corporation, Rite Aid Hdqtrs. Corp., Safeway Inc., The Kroger Co., Walgreen Co to SEALED MOTION by Defendant Impax Laboratories, Inc. in Limine to Preclude Evidence or Argument Referring to Post-Settlement Development and Co-Promotion Agreement Conduct (IMPAX MIL NO. 3) #822 Plaintiffs' Opposition to Impax's Motion in Limine No. 3 to Exclude Evidence or Argument Referring to Post-Settlement Development and Co-Promotion Agreement Conduct (Ravkind, Lauren)
May 16, 2022 Opinion or Order Filing 837 MINUTE entry before the Honorable Harry D. Leinenweber: Telephonic status hearing held and continued to 5/25/22 at 9:00 a.m. Dial: 888-684-8852 or 215-446-0155, access code: 9582710#. Mailed (maf)
May 12, 2022 Opinion or Order Filing 836 ATTORNEY Appearance for Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. by Forrest Lovett (Lovett, Forrest)
May 10, 2022 Opinion or Order Filing 835 MINUTE entry before the Honorable Harry D. Leinenweber: Telephonic status hearing held and continued to 5/16/22 at 11:00 a.m. Dial: 888-684-8852 or 215-446-0155, access code: 9582710#. Mailed (maf)
May 5, 2022 Opinion or Order Filing 834 MINUTE entry before the Honorable Harry D. Leinenweber: Telephonic status hearing held and continued to 5/10/22 at 12:00 p.m. Dial: 888-684-8852 or 215-446-0155, access code: 9582710#. Mailed (maf)
May 4, 2022 Opinion or Order Filing 833 MINUTE entry before the Honorable Harry D. Leinenweber: Telephonic status hearing held and continued to 5/5/22 at 9:30 a.m. Dial: 888-684-8852 or 215-446-0155, access code: 9582710#. Mailed (maf)
May 3, 2022 Opinion or Order Filing 832 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. / Declaration of Devora W. Allon, P.C. in Support of Defendants' Motion in Limine No. 17 (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Allon, Devora)
May 3, 2022 Opinion or Order Filing 831 SEALED MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. in Limine to Preclude Martin Lessem Testimony (Defendants' MIL NO. 17) (Attachments: #1 Text of Proposed Order)(Allon, Devora)
May 3, 2022 Opinion or Order Filing 830 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. / Declaration of Devora W. Allon, P.C. in Support of Defendants' Motion in Limine No. 16 (Attachments: #1 Exhibit 1)(Allon, Devora)
May 3, 2022 Opinion or Order Filing 829 SEALED MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. in Limine to Preclude Evidence or Argument Referring to Consumer Harm (Defendants' MIL NO. 16) (Attachments: #1 Text of Proposed Order)(Allon, Devora)
May 3, 2022 Opinion or Order Filing 828 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. / Declaration of Devora W. Allon, P.C. in Support of Defendants' Motion in Limine No. 2 (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Allon, Devora)
May 3, 2022 Opinion or Order Filing 827 SEALED MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. in Limine to Preclude Evidence or Argument Referring to At-Risk Launch Theory (Defendants' MIL No. 2) (Attachments: #1 Text of Proposed Order)(Allon, Devora)
May 3, 2022 Opinion or Order Filing 826 DECLARATION of Devora W. Allon, P.C. regarding motion in limine #825 / Declaration of Devora W. Allon, P.C. in Support of Impax Laboratories, Inc.'s Motion in Limine No. 4 (Attachments: #1 Exhibit 1)(Allon, Devora)
May 3, 2022 Opinion or Order Filing 825 MOTION by Defendant Impax Laboratories, Inc.in limine to Preclude Evidence or Argument Referring to the "Opioid Epidemic" (IMPAX MIL NO. 4) (Attachments: #1 Text of Proposed Order)(Allon, Devora)
May 3, 2022 Opinion or Order Filing 824 SEALED MOTION by Defendant Impax Laboratories, Inc. in Limine to Preclude Evidence or Argument Referring to the "Opioid Epidemic" (IMPAX MIL NO. 4) (Attachments: #1 Text of Proposed Order)(Allon, Devora)
May 3, 2022 Opinion or Order Filing 823 SEALED DOCUMENT by Defendant Impax Laboratories, Inc. / Declaration of Devora W. Allon, P.C. in Support of Impax Laboratories, Inc.'s Motion in Limine No. 3 (Attachments: #1 Exhibit 1)(Allon, Devora)
May 3, 2022 Opinion or Order Filing 822 SEALED MOTION by Defendant Impax Laboratories, Inc. in Limine to Preclude Evidence or Argument Referring to Post-Settlement Development and Co-Promotion Agreement Conduct (IMPAX MIL NO. 3) (Attachments: #1 Text of Proposed Order)(Allon, Devora)
May 3, 2022 Opinion or Order Filing 821 SEALED DOCUMENT by Defendant Impax Laboratories, Inc. / Declaration of Devora W. Allon, P.C. in Support of Impax Laboratories, Inc.'s Motion in Limine No. 2 (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3)(Allon, Devora)
May 3, 2022 Opinion or Order Filing 820 SEALED MOTION by Defendant Impax Laboratories, Inc. in Limine to Preclude Evidence or Argument Referring to $102 Million Payment (IMPAX MIL NO. 2) (Attachments: #1 Text of Proposed Order)(Allon, Devora)
May 3, 2022 Opinion or Order Filing 819 MOTION by Defendant Impax Laboratories, Inc.in limine to Preclude Evidence or Argument Referring to FTC Investigation and Litigation (IMPAX MIL NO. 1) (Attachments: #1 Text of Proposed Order)(Allon, Devora)
May 3, 2022 Opinion or Order Filing 818 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co.in limine to Preclude Evidence or Argument Referring to Endo as Having a "Patent Monopoly" (Endo MIL No. 2) (Attachments: #1 Text of Proposed Order)(Chapman, Julia)
May 3, 2022 Opinion or Order Filing 817 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co.in limine to Preclude Any Mention of, or the Introduction of Documents Related to, FTC Investigations/Proceedings Involving Opana ER (Endo MIL No. 1) (Attachments: #1 Text of Proposed Order)(Chapman, Julia)
May 3, 2022 Opinion or Order Filing 816 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. Declaration of Julia Chapman in Support of Endo's Motions in Limine Nos. 1-2, And Defendants' Motions in Limine Nos. 1, 3-15 (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Exhibit J, #11 Exhibit K, #12 Exhibit L, #13 Exhibit M, #14 Exhibit N, #15 Exhibit O, #16 Exhibit P, #17 Exhibit Q, #18 Exhibit R, #19 Exhibit S, #20 Exhibit T, #21 Exhibit U, #22 Exhibit V, #23 Exhibit W, #24 Exhibit X, #25 Exhibit Y, #26 Exhibit Z, #27 Exhibit AA, #28 Exhibit BB, #29 Exhibit CC, #30 Exhibit DD, #31 Exhibit EE)(Chapman, Julia)
May 3, 2022 Opinion or Order Filing 815 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co.in limine to Preclude Certain Testimony From Melissa Flax Regarding the Underlying Patent Litigation (Defendants' MIL No. 15) (Attachments: #1 Text of Proposed Order)(Chapman, Julia)
May 3, 2022 Opinion or Order Filing 814 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co.in limine to Preclude Evidence or Argument Disparaging the USPTO or its Examiners (Defendants' MIL No. 14) (Attachments: #1 Text of Proposed Order)(Chapman, Julia)
May 3, 2022 Opinion or Order Filing 813 SEALED MOTION by Plaintiff End-Payor Plaintiffs Motion in Limine No. 8 to Preclude Defendants From Offfering Evidence or Argument Concerning: (1) Any Purported "Pass-On" of Overcharges in the Form of Higher Premiums or Contributions; (2) Medicare Part D Plans or Patients Being Former Class Members and Their Alleged Non-Injury or Negative Damages (Attachments: #1 Exhibits 1-5)(Wozniak, Robert)
May 3, 2022 Opinion or Order Filing 812 MOTION by Plaintiffs Direct Purchaser Plaintiffs, Retailer Plaintiffsin limine NO. 7 TO EXCLUDE EVIDENCE AND ARGUMENT OF "PASS ON" (Curley, Andrew)
May 3, 2022 Opinion or Order Filing 811 MOTION by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffsin limine Motion in Limine No. 6 to Preclude Defendants From Offering Irrelevant and Unduly Prejudicial Evidence (Wozniak, Robert)
May 3, 2022 Opinion or Order Filing 810 SEALED MOTION by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs MOTION IN LIMINE NO. 5 TO EXCLUDE ENDO'S EXPERT REPORTS FROM THE UNDERLYING PATENT LITIGATION AS EVIDENCE (Curley, Andrew)
May 3, 2022 Opinion or Order Filing 809 SEALED MOTION by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs Motion in Limine No. 4 to Exclude Evidence or Argument Regarding FDA Risk Management Programs (Attachments: #1 Exhibits 1-2)(Wozniak, Robert)
May 3, 2022 Opinion or Order Filing 808 MOTION by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffsin limine Plaintiffs' Motion in Limine No. 3 to Exclude Evidence or Argument of "Risk Aversion" to Justify Endo's Reverse Payments (Refsin, Barry)
May 3, 2022 Opinion or Order Filing 807 SEALED MOTION by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs Plaintiffs' Motion in Limine No. 2 to Exclude Evidence or Argument Contrary to the Definition of "Large" in Actavis (Refsin, Barry)
May 3, 2022 Opinion or Order Filing 806 MOTION by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffsin limine No. 1 To Exclude Evidence or Argument That The Broad License or Later-Issues Patents Allegedly Justify Endo's Reverse Payments (Gerstein, Bruce)
May 3, 2022 Opinion or Order Filing 805 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co.in limine to Preclude References to Damages in Liability Phase (Defendants' MIL No. 13) (Attachments: #1 Text of Proposed Order)(Chapman, Julia)
May 3, 2022 Opinion or Order Filing 804 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co.in limine to Preclude References to the Financial Condition of Defendants and Their Employees (Defendants' MIL No. 12) (Attachments: #1 Text of Proposed Order)(Chapman, Julia)
May 3, 2022 Opinion or Order Filing 803 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co.in limine to Preclude Certain Trial Matters (Defendants' MIL Nos. 4-11) (Attachments: #1 Text of Proposed Order Defendants' MIL No. 4, #2 Text of Proposed Order Defendants' MIL No. 5, #3 Text of Proposed Order Defendants' MIL No. 6, #4 Text of Proposed Order Defendants' MIL No. 7, #5 Text of Proposed Order Defendants' MIL No. 8, #6 Text of Proposed Order Defendants' MIL No. 9, #7 Text of Proposed Order Defendants' MIL No. 10, #8 Text of Proposed Order Defendants' MIL No. 11)(Chapman, Julia)
May 3, 2022 Opinion or Order Filing 802 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co.in limine to Preclude Irrelevant Allegations and Evidence of Other Alleged Endo or Impax "Pay for Delay" Deals (Defendants' MIL No. 3) (Attachments: #1 Text of Proposed Order)(Chapman, Julia)
May 3, 2022 Opinion or Order Filing 801 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co.in limine to Preclude Data on Reformulated Opana ER's Effect on Abuse and Related FDA Actions (Defendants' MIL No. 1) (Attachments: #1 Text of Proposed Order)(Chapman, Julia)
May 3, 2022 Opinion or Order Filing 800 ORDER: Pro hac vice motion is granted #799 . Signed by the Honorable Harry D. Leinenweber on 5/3/2022. Mailed notice (cxr, )
May 2, 2022 Opinion or Order Filing 799 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number AILNDC-19408213. (Crevier, Jonathan)
May 2, 2022 Opinion or Order Filing 798 NOTICE by Christopher Alden Yeager of Change of Address (Yeager, Christopher)
April 29, 2022 Opinion or Order Filing 797 NOTICE by Heidi K Hubbard of Change of Address (Hubbard, Heidi)
April 29, 2022 Opinion or Order Filing 796 NOTICE by Benjamin M Greenblum of Change of Address (Greenblum, Benjamin)
April 29, 2022 Opinion or Order Filing 795 NOTICE by Katherine A Trefz of Change of Address (Trefz, Katherine)
April 29, 2022 Opinion or Order Filing 794 NOTICE by Elise M. Baumgarten of Change of Address (Baumgarten, Elise)
April 21, 2022 Opinion or Order Filing 793 ORDER: For the reasons stated herein, Plaintiff's Motion to Bifurcate (Dkt. No. 779) is denied. Signed by the Honorable Harry D. Leinenweber on 4/21/2022: Mailed notice (maf)
April 7, 2022 Opinion or Order Filing 792 MINUTE entry before the Honorable Harry D. Leinenweber: Telephonic motion hearing and oral argument held. The Court will rule on Plaintiff's motion #779 through a written opinion. The Court adopts the parties' stipulations and trial procedures and directs further motions to be completed on those timelines. Telephone Conference set for 5/4/2022 at 10:00 a.m. The Court strikes the date of 5/5/2022, stated on the record. Dial: 888-684-8852 or 215-446-0155, access code: 9582710#. Mailed notice(maf)
March 29, 2022 Opinion or Order Filing 791 MINUTE entry before the Honorable Harry D. Leinenweber: Telephone Conference set for 4/7/2022 at 9:15 a.m. Dial: 888-684-8852 or 215-446-0155, access code: 9582710#. Mailed notice(maf)
March 18, 2022 Opinion or Order Filing 790 REPLY by (Direct Purchaser and End-Payor), Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to response in opposition to motion, #787 , MOTION by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to bifurcate #779 (Perwin, Scott)
March 15, 2022 Opinion or Order Filing 789 MINUTE entry before the Honorable Harry D. Leinenweber: MOTION by Attorney Joanna Travalini to withdraw as attorney for Impax Laboratories, Inc. #788 is granted. Mailed notice(maf)
March 14, 2022 Opinion or Order Filing 788 MOTION by Attorney Joanna Travalini to withdraw as attorney for Impax Laboratories, Inc.. No party information provided (Rurka, Maureen)
March 12, 2022 Opinion or Order Filing 787 RESPONSE by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co.in Opposition to MOTION by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to bifurcate #779 (Liu, Angela)
March 9, 2022 Opinion or Order Filing 786 ORDER: Motion to amend/correct #784 is moot. Motion to amend/correct #785 is granted. Enter order granting corrected motion to amend appointment of co-lead counsel for the End-Payor Plaintiff Classes. Signed by the Honorable Harry D. Leinenweber on 3/9/2022: Mailed notice (maf)
March 8, 2022 Opinion or Order Filing 785 MOTION by Plaintiff End-Payor Plaintiffs to amend/correct Appointment of Co-Lead Counsel for the End-Payor Plaintiff Classes (Asciolla, Gregory)
March 7, 2022 Opinion or Order Filing 784 MOTION by Plaintiff (Direct Purchaser and End-Payor) to amend/correct Order (Attachments: #1 Text of Proposed Order)(Asciolla, Gregory)
February 28, 2022 Opinion or Order Filing 783 MINUTE entry before the Honorable Harry D. Leinenweber: MOTION to bifurcate #779 is entered and briefed as follows: response by 3/11/22, reply by 3/18/22. Telephone Conference set for 3/9/22 is re-set to 4/7/22 at 9:45 a.m. Dial: 888-684-8852 or 215-446-0155, access code: 9582710#. Mailed notice(maf)
February 28, 2022 Opinion or Order Filing 782 ORDER: Pro hac vice motion is granted #780 . Signed by the Honorable Harry D. Leinenweber on 2/28/2022. Mailed notice (aee, )
February 28, 2022 Opinion or Order Filing 781 MINUTE entry before the Honorable Harry D. Leinenweber: Telephone Conference set for 3/9/2022 at 9:45 a.m. re: MOTION to bifurcate #779 . Dial: 888-684-8852 or 215-446-0155, access code: 9582710#. Mailed notice(maf)
February 26, 2022 Opinion or Order Filing 780 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-19194845. (Hubbard, Heidi)
February 25, 2022 Opinion or Order Filing 779 MOTION by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to bifurcate (Attachments: #1 Text of Proposed Order)(Perwin, Scott)
February 24, 2022 Opinion or Order Filing 778 ORDER : Pro hac vice motions are granted #776 , #777 . Signed by the Honorable Harry D. Leinenweber on 2/24/2022. Mailed notice (aee, )
February 24, 2022 Opinion or Order Filing 777 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-19186412. (Trefz, Katherine)
February 24, 2022 Opinion or Order Filing 776 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-19186403. (Baumgarten, Elise)
February 4, 2022 Opinion or Order Filing 775 ATTORNEY Appearance for Plaintiff Value Drug Company by Deborah Elman (Elman, Deborah)
January 5, 2022 Opinion or Order Filing 774 DECLARATION of Eric J. Miller Regarding (A) Mailing of Postcard Notice; (B) Publication of Summary Notice; and (C) Report on Requests for Exclusion Received to Date (Wozniak, Robert)
December 31, 2021 Opinion or Order Filing 773 MINUTE entry before the Honorable Harry D. Leinenweber: Motion by Endo to withdraw Craig G. Falls as one of the attorneys of record #772 is granted. Mailed notice(maf)
December 30, 2021 Opinion or Order Filing 772 MOTION by Attorney Craig G. Falls to withdraw as attorney for Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co.. No party information provided (Liu, Angela)
December 22, 2021 Opinion or Order Filing 771 TRANSCRIPT OF PROCEEDINGS held on December 2, 2021 before the Honorable Harry D. Leinenweber. Order Number: 42166. Court Reporter Contact Information: Annette Montalvo, annette.montalvo@gmail.com. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 1/12/2022. Redacted Transcript Deadline set for 1/24/2022. Release of Transcript Restriction set for 3/22/2022. (Montalvo, Annette)
December 10, 2021 Opinion or Order Filing 770 MEMORANDUM by End-Payor Plaintiffs in Opposition to Defendants' Motion [ECF 759] to Exclude the Opinions and Testimony of Dr. Meredith Rosenthal Regarding Damages [Public Redacted Version of ECF 763 - Exhibits Remain Under Seal] (Freed, Michael)
December 10, 2021 Opinion or Order Filing 769 MEMORANDUM by Direct Purchaser Plaintiffs in Opposition to Defendants' (Renewed) Motion #757 to Partially Exclude the Opinions and Proposed Testimony of Dr. Jeffrey Leitzinger [Public Redacted Version] (Attachments: #1 Declaration of Andrew C. Curley, #2 Exhibit A, #3 Exhibit B)(Curley, Andrew)
December 9, 2021 Opinion or Order Filing 768 DECLARATION of Tina Chiango, RG/2 Claims Administration LLC regarding order on motion for miscellaneous relief,,,,,, terminate motions, #751 Regarding Notice to the Direct Purchaser Class (Attachments: #1 Exhibit A, #2 Exhibit B)(Curley, Andrew)
December 7, 2021 Opinion or Order Filing 767 MEMORANDUM in Support of Defendants' Second Motion to Exclude the Opinions and Testimony of Dr. Meredith Rosenthal Regarding Damages (Public version of sealed ECF No. 760) (Attachments: #1 Declaration of Devora W. Allon, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7)(Allon, Devora)
December 7, 2021 Opinion or Order Filing 766 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. of Law in Support of Defendants' Renewed Motion to Partially Exclude the Opinions and Proposed Testimony of Dr. Jeffrey Leitzinger (Public Redacted Version) (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6)(Liu, Angela)
December 2, 2021 Opinion or Order Filing 765 MINUTE entry before the Honorable Harry D. Leinenweber: Telephonic conference and ruling on motion hearing held. For the reasons stated on the record, the Court denies Defendants' motion to partially exclude the opinions and proposed testimony of Dr. Jeffery Leitzinger #757 and Defendants' motion to exclude the opinions and proposed testimony of Dr. Meredith Rosenthal #759 . Mailed notice(maf)
December 1, 2021 Opinion or Order Filing 764 MINUTE entry before the Honorable Harry D. Leinenweber: Defendants' motions #757 and #759 set for a Telephone Conference on 12/2/21 at 9:45 a.m. is re-set to 12/2/21 at 9:30 a.m. Dial: 888-684-8852 or 215-446-0155, access code: 9582710#. Security code (if asked): 8115. Mailed notice(maf)
December 1, 2021 Opinion or Order Filing 763 SEALED RESPONSE by End-Payor Plaintiffs to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to Exclude the Opinions and Testimony of Dr. Meredith Rosenthal Regarding Damages #759 (Attachments: #1 Index of Exhibits & Exhibits A-C)(Freed, Michael)
December 1, 2021 Opinion or Order Filing 762 SEALED RESPONSE by Direct Purchaser Plaintiffs to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to Partially Exclude the Opinions and Proposed Testimony of Dr. Jeffrey Leitzinger (Renewed) #757 DIRECT PURCHASER CLASS PLAINTIFFS' OPPOSITION TO DEFENDANTS' RENEWED MOTION TO PARTIALLY EXCLUDE THE OPINIONS AND PROPOSED TESTIMONY OF DR. JEFFREY LEITZINGER (FILED UNDER SEAL) (Attachments: #1 Declaration of Andrew C. Curley, #2 Exhibit A, #3 Exhibit B)(Curley, Andrew)
November 23, 2021 Opinion or Order Filing 761 MINUTE entry before the Honorable Harry D. Leinenweber: Defendants' motions #757 and #759 will be heard via Telephone Conference set for 12/2/2021 at 9:45 AM. Dial: 888-684-8852 or 215-446-0155, access code: 9582710#. Security code (if asked): 8115. Mailed notice(maf)
November 23, 2021 Opinion or Order Filing 760 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. / Memorandum in Support of Defendants' Second Motion to Exclude the Opinions and Testimony of Dr. Meredith Rosenthal Regarding Damages (Attachments: #1 Declaration of Devora W. Allon, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7)(Allon, Devora)
November 23, 2021 Opinion or Order Filing 759 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to Exclude the Opinions and Testimony of Dr. Meredith Rosenthal Regarding Damages (Attachments: #1 Text of Proposed Order)(Allon, Devora)
November 23, 2021 Opinion or Order Filing 758 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. Memorandum of Law in Support of Defendants' Renewed Motion to Partially Exclude the Opinions and Proposed Testimony of Dr. Jeffrey Leitzinger (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6)(Liu, Angela)
November 23, 2021 Opinion or Order Filing 757 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to Partially Exclude the Opinions and Proposed Testimony of Dr. Jeffrey Leitzinger (Renewed) (Attachments: #1 Text of Proposed Order)(Liu, Angela)
November 3, 2021 Opinion or Order Filing 756 Notice of Firm Name Change by End-Payor Plaintiffs (Boley, Justin)
November 3, 2021 Opinion or Order Filing 755 Notice of Firm Name Change by End-Payor Plaintiffs (Wexler, Kenneth)
October 18, 2021 Opinion or Order Filing 754 SEALED DOCUMENT by Plaintiff End-Payor Plaintiffs Errata to Supplemental Expert Report of Meredith Rosenthal Ph.D. - Ex. A to ECF 753 (Freed, Michael)
October 18, 2021 Opinion or Order Filing 753 NOTICE by End-Payor Plaintiffs re sealed document #740 Errata to Supplemental Damage Report (Attachments: #1 Exhibit A (Filed Separately Under Seal))(Freed, Michael)
September 23, 2021 Opinion or Order Filing 752 ORDER: End-Payor Plaintiffs' motion to appoint notice administrator and approve notice plan #748 is granted. Telephonic status and ruling set for 9/28/2021 is stricken. See attached order. Signed by the Honorable Harry D. Leinenweber on 9/23/2021: Mailed notice (maf)
September 23, 2021 Opinion or Order Filing 751 ORDER: As Defendants have no further objections, the Court grants Direct Purchaser Plaintiffs' motion to approve the form and manner of notice #738 , as revised in the parties' joint stipulation #749 . See attached order. Signed by the Honorable Harry D. Leinenweber on 9/23/2021: Mailed notice(maf)
September 15, 2021 Opinion or Order Filing 750 RESPONSE by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to MOTION by Plaintiff End-Payor Plaintiffs to Appoint Notice Administrator and Approve Notice Plan #748 (Chapman, Julia)
September 15, 2021 Opinion or Order Filing 749 STIPULATION regarding motion for miscellaneous relief #738 STIPULATION CONCERNING THE DIRECT PURCHASER CLASS PLAINTIFFS' PROPOSED FORM AND MANNER OF NOTICE TO THE DIRECT PURCHASER CLASS (Attachments: #1 Exhibit A)(Curley, Andrew)
August 25, 2021 Opinion or Order Filing 748 MOTION by Plaintiff End-Payor Plaintiffs to Appoint Notice Administrator and Approve Notice Plan (Attachments: #1 Exhibits 1 & 2, #2 Declaration of Linda V. Young with Exhibits A-C)(Freed, Michael)
August 11, 2021 Opinion or Order Filing 747 MINUTE entry before the Honorable Harry D. Leinenweber: End Payor Plaintiffs shall file a motion to approve the form and manner of notice to the End Payor Class by 8/25/2021. Defendants shall meet and confer with both Plaintiff classes and respond to the motions for form and manner of notice by 9/15/2021. Telephonic status hearing and ruling is set for 9/28/2021 at 9:30 a.m. Dial: 888-684-8852 or 215-446-0155, access code: 9582710#. Security code (if asked): 8115. Mailed notice (maf)
August 11, 2021 Opinion or Order Filing 746 ORDER: For the reasons stated in the attached order, The Court amends its June 4, 2021 order certifying class to include End Payor Plaintiff's proposed exclusions to the class definition. All other portions of the order remain intact. Signed by the Honorable Harry D. Leinenweber on 8/11/2021: Mailed notice(maf)
August 9, 2021 Opinion or Order Filing 745 ORDER: Pro hac vice motions are granted #741 , #742 . Signed by the Honorable Harry D. Leinenweber on 8/9/2021. Mailed notice (aee, )
July 30, 2021 Opinion or Order Filing 743 ORDER: Upon consideration of the AMENDED MOTION BY PLAINTIFFS-RESPONDENTS TO MAINTAIN CERTAIN PORTIONS OF VOLUME II OF APPENDIX TO DEFENDANTS' RULE 23 PETITION UNDER SEAL, filed on July 26, 2021, by counsel for the respondents, IT IS ORDERED that the amended motion to seal is GRANTED. The clerk of this court shall maintain under seal volume II of the appendix to the petition for permission to appeal (docket no. 2-3). The clerk shall also file in the public record the redacted copy of volume II of the appendix tendered with this motion. IT IS FURTHER ORDERED that the clerk of this court shall unseal the filings in this appeal that are currently under seal, except volume II of the appendix by U.S. Court of Appeals for the Seventh Circuit, Appeal no. 21-8017. (jn, )
July 30, 2021 Opinion or Order Filing 742 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-18516730. (Sobol, Thomas)
July 30, 2021 Opinion or Order Filing 741 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-18516692. (Barnes, Lauren)
July 29, 2021 Opinion or Order Filing 744 MINUTE entry before the Honorable Harry D. Leinenweber: Telephonic status hearing held on 7/29/2021. For the reasons stated on the record, pretrial conference set for 10/26/2021 is reset for 6/2/2022 at 10:30 a.m. Jury trial set for 11/1/2021 is reset for 6/7/2022 at 10:00 a.m. Pretrial order is due 14 days prior to trial. Motions in limine due 28 days prior to trial. Notice schedule for class certification shall be set with the issuance of a further order. Mailed notice(maf)
July 26, 2021 Opinion or Order Filing 740 SEALED DOCUMENT by Plaintiff End-Payor Plaintiffs (Supplemental Expert Report of Meredith Rosenthal, Ph.D. - Ex. A to ECF 739) (Freed, Michael)
July 26, 2021 Opinion or Order Filing 739 NOTICE by End-Payor Plaintiffs of Supplemental Expert Damage Report (Attachments: #1 Exhibit A (Filed Separately Under Seal))(Freed, Michael)
July 26, 2021 Opinion or Order Filing 738 MOTION by Plaintiff Direct Purchaser PlaintiffsTO APPROVE THE FORM AND MANNER OF NOTICE TO THE DIRECT PURCHASER CLASS (Attachments: #1 Exhibit 1 (Proposed Notice), #2 Memorandum, #3 Text of Proposed Order)(Curley, Andrew)
July 21, 2021 Opinion or Order Filing 737 PAYMENT by Impax Laboratories, Inc. of Filing fee $ 505, receipt number 0752-18479931. (Allon, Devora)
July 21, 2021 Opinion or Order FORWARDED copy of document 737 to the USCA (jh, )
July 20, 2021 Opinion or Order Filing 736 MINUTE entry before the Honorable Harry D. Leinenweber: Telephone Status Conference set for 7/29/21 at 9:00 a.m. Dial: 888-684-8852 or 215-446-0155, access code: 9582710#. Security code (if asked): 8115. Mailed notice(maf)
July 19, 2021 Opinion or Order Filing 735 Joint Letter Requesting Status Conference by Direct Purchaser Plaintiffs (Curley, Andrew)
July 13, 2021 Opinion or Order Filing 734 CERTIFIED copy of order dated 7/13/2021 from the 7th Circuit ; Appellate case no. : 21-8017; IT IS ORDERED that the petition for leave to appeal pursuant to Federal Rule of Civil Procedure 23(f) is GRANTED. The petitioners shall pay the $500 appellate filing fee by July 23, 2021. (aee, )
July 7, 2021 Opinion or Order Filing 733 MINUTE entry before the Honorable Harry D. Leinenweber: The Court denies Plaintiffs' joint motion for reconsideration [729, 730, 731]. To clarify, Plaintiffs may not include Actavis, Inc.'s generic product in any capacity in its damages model. Plaintiffs' citation to cartel law is inapplicable here. Unlike U.S. Gypsum Company v. Indiana Gas Company, 350 F.3d 623, 627 (7th Cir. 2003), Actavis, Inc. was not an inadvertently affected nondefendant nonconspirator or "fringe firm." While the alleged illegal restraint between Endo Pharmaceuticals and Impax Laboratories artificially increased the price of the product in the market, the introduction of Actavis's patent infringing product artificially decreased the price of the product. To allow Actavis's product to be included in the damages model would permit the plaintiffs to receive a windfall. Although Actavis' behavior was legal insofar as the company cannot be later held liable for selling at-risk, it does not follow that Plaintiffs can, years later, benefit from Actavis' mistaken belief in the invalidity of the later-acquired patents. The Court will not entertain further briefing on this matter. Mailed notice(maf)
July 6, 2021 Opinion or Order Filing 732 STIPULATION [Proposed] Stipulated Briefing Schedule (Chapman, Julia)
July 1, 2021 Opinion or Order Filing 731 MOTION by Plaintiff End-Payor Plaintiffs to clarify or reconsider the Court's June 4, 2021 Order (ECF No. 725) and Joinder in Motions filed by Retailer Plaintiffs (ECF No. 729) and Direct Purchaser Class Plaintiffs (ECF No. 730) (Freed, Michael)
July 1, 2021 Opinion or Order Filing 730 JOINDER by Direct Purchaser Plaintiffs in Retailer Plaintiffs' Motion for Clarification or Reconsideration of the Court's June 4, 2021 Memorandum Opinion and Order (ECF NO. 725) and JUNE 22, 2021 Minute Order (ECF NO. 728) (Gerstein, Bruce)
July 1, 2021 Opinion or Order Filing 729 MOTION by Plaintiff Retailer Plaintiffs to clarify or for Reconsideration of Court's June 4, 2021 Memorandum Opinion and Order (ECF No. 725) and June 22, 2021 Minute Order (ECF No. 728) (Refsin, Barry)
June 22, 2021 Opinion or Order Filing 728 MINUTE entry before the Honorable Harry D. Leinenweber: The Court grants Defendants' motion to clarify #727 as follows: Plaintiffs may not include generic products that were later found to be patent protected in Federal Court as a part of any of their damages models. Defendants' motion is otherwise denied. Mailed notice(maf)
June 18, 2021 Opinion or Order Filing 727 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to clarify / reconsider certain motions to exclude decisions from the Court's Memorandum Opinion and Order, ECF No. 725 (Chapman, Julia)
June 4, 2021 Opinion or Order Filing 726 ORDER: For the reasons stated in the attached order, End Payor Plaintiffs' motion to certify class (Dkt. No. 438) and Direct Purchaser Plaintiffs' motion to certify class (Dkt. No. 436) are granted. Signed by the Honorable Harry D. Leinenweber on 6/4/2021: Mailed notice(maf)
June 4, 2021 Opinion or Order Filing 725 MEMORANDUM Opinion and Order: For the reasons stated herein, the Court rules as follows: 1.Defendants' Daubert motions to exclude Ms. DeLeon (Dkt. No. 513), Mr. Molina (Dkt. No. 516), and Dr. Rosenthal (Dkt. No. 545) are granted. 2. Defendants' Daubert motions to exclude Dr. Leitzinger (Dkt. No. 529) and Dr. Leffler (Dkt. No. 552) are granted in part and denied in part. 3. All of Defendants' other Daubert motions (Dkt. No. 510, Dkt. No. 537, Dkt. No. 541, Dkt. No. 546, Dkt. No. 550, Dkt. No. 556) are denied. 4.Plaintiffs' motions to exclude Dr. Patel (Dkt. No. 519), Mr. Figg (Dkt. No. 521), Dr. Fassihi (Dkt. No. 524), Dr. Green (Dkt. No. 527), and Dr. Berneman (Dkt. No. 528) are granted. 5. Defendants' Daubert motions to exclude Dr. Addanki (Dkt. No. 526) and Mr. Singer (Dkt. No. 520) are granted in part and denied in part. 6.All of Plaintiffs' other Daubert motions (Dkt. No. 522, Dkt. No. 525, Dkt. No. 523) are denied. 7.Defendants' motion for summary judgment as to the state claims is granted but denied as to all other claims in Defendants' summary judgment motions. (Dkt. No. 532, Dkt. No. 539). Signed by the Honorable Harry D. Leinenweber on 6/4/2021: Mailed notice (maf)
May 27, 2021 Opinion or Order Filing 724 MINUTE entry before the Honorable Harry D. Leinenweber: Telephone Conference set for 6/2/2021 is vacated. The Court will set a future date at a later time. Mailed notice(maf)
May 27, 2021 Opinion or Order Filing 723 RESPONSE by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to other #722 / Defendants' Response to Plaintiffs' Notice of Supplemental Authority Relevant to End-Payor Class Plaintiffs' Pending Motion for Class Certification (Allon, Devora)
May 18, 2021 Opinion or Order Filing 722 Notice of Supplemental Authority in Support of Motion for Class Certification by End-Payor Plaintiffs (Attachments: #1 Exhibit A)(Wozniak, Robert)
April 20, 2021 Opinion or Order Filing 721 RESPONSE by Plaintiff (Direct Purchaser and End-Payor) to other, #718 / DIRECT PURCHASER CLASS PLAINTIFFS' AND END-PAYOR CLASS PLAINTIFFS' RESPONSE TO DEFENDANTS' NOTICE OF SUPPLEMENTAL AUTHORITY (Curley, Andrew)
April 20, 2021 Opinion or Order Filing 720 RESPONSE by Defendant Impax Laboratories, Inc. to notice of filing #719 / Defendants' Response to Plaintiffs' Notice of Supplemental Authority Relevant to Pending Summary Judgment and Daubert Motions (Allon, Devora)
April 15, 2021 Opinion or Order Filing 719 NOTICE by (Direct Purchaser and End-Payor), Retailer Plaintiffs of Supplemental Authority Relevant to Pending Summary Judgement and Daubert Motions (Attachments: #1 Exhibit A)(Gerstein, Jonathan)
April 13, 2021 Opinion or Order Filing 718 Defendants' Notice of Supplemental Authority in Support of Their Oppositions to End-Payor and Direct Purchaser Class Plaintiffs' Motions for Class Certification by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. (Attachments: #1 Exhibit 1)(Liu, Angela)
March 31, 2021 Opinion or Order Filing 717 MINUTE entry before the Honorable Harry D. Leinenweber: MOTION by Attorney Anne Schmidt to withdraw as attorney for Direct Purchaser Plaintiffs #716 is granted. Mailed notice(maf)
March 31, 2021 Opinion or Order Filing 716 MOTION by Attorney Anne Schmidt to withdraw as attorney for Direct Purchaser Plaintiffs. No party information provided (Kelly, Andrew)
March 17, 2021 Opinion or Order Filing 715 NOTICE by Natalie Finkelman Bennett of Change of Address Change of Firm Affiliation and Email (Bennett, Natalie)
March 2, 2021 Opinion or Order Filing 714 MINUTE entry before the Honorable Harry D. Leinenweber: Telephone Conference held and continued to 6/2/2021 at 9:30 a.m. Dial: 888-684-8852 or 215-446-0155, access code: 9582710#. Security code (if asked): 8115. Mailed notice(maf)
February 19, 2021 Opinion or Order Filing 713 Notice of Supplemental Authority in Support of Motion for Class Certification by End-Payor Plaintiffs (Attachments: #1 Exhibit A, #2 Exhibit B)(Freed, Michael)
December 22, 2020 Opinion or Order Filing 712 MINUTE entry before the Honorable Harry D. Leinenweber: Plaintiffs' motion for a revised schedule #709 is granted. Pretrial conference set for 6/3/21 is re-set to 10/26/21 at 10:30 a.m. Jury trial set for 6/7/21 is re-set to 11/1/21 at 10:00 a.m. Pretrial order is due 14 days prior to trial. Motions in limine due 28 days prior to trial. Telephone conference set for 3/2/21 at 9:45 a.m. Parties are instructed to dial: 888-684-8852 or 215-446-0155, access code: 9582710#. Security code (if asked): 8115. Mailed notice(maf)
December 17, 2020 Opinion or Order Filing 711 OBJECTIONS by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. to MOTION by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs for Revised Schedule #709 (Attachments: #1 Text of Proposed Order)(Liu, Angela)
December 14, 2020 Opinion or Order Filing 710 MINUTE entry before the Honorable Harry D. Leinenweber: Plaintiffs' motion for a revised schedule #709 will be heard via telephone conference on 12/22/20 at 9:45 a.m. Objections shall be filed by 12/17/20. Parties are instructed to dial: 888-684-8852 or 215-446-0155, access code: 9582710#. Security code (if asked): 8115. Mailed notice(maf)
December 11, 2020 Opinion or Order Filing 709 MOTION by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs for Revised Schedule (Attachments: #1 Text of Proposed Order)(Curley, Andrew)
December 1, 2020 Opinion or Order Filing 708 MINUTE entry before the Honorable Harry D. Leinenweber: MOTION by Attorney Christopher Stow-Serge to withdraw as attorney for Direct Purchaser Plaintiffs #707 is granted. Mailed notice(maf)
December 1, 2020 Opinion or Order Filing 707 MOTION by Attorney Christopher Stow-Serge to withdraw as attorney for Direct Purchaser Plaintiffs. No party information provided (Kelly, Andrew)
November 4, 2020 Opinion or Order Filing 706 MINUTE entry before the Honorable Harry D. Leinenweber: The Court orders Defendants to refile the sealed versions of their memorandum in support of motion for partial summary judgment with respect to certain patent issues #562 and memorandum in support of causation/damages motion for summary judgment #581 along with all supporting documents on or before 11/11/2020. Mailed notice(maf)
August 24, 2020 Opinion or Order Filing 705 NOTICE by Direct Purchaser Plaintiffs Notice of Supplemental Authority in Support of Motion for Class Certification (Attachments: #1 Exhibit 1)(Curley, Andrew)
August 19, 2020 Opinion or Order Filing 704 REPLY by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to Sealed motion #524 to Exclude One of the Opinions of Dr. Reza Fassihi (Public Version of Dkt. 667) (Baxter, James)
August 19, 2020 Opinion or Order Filing 703 NOTICE by Direct Purchaser Plaintiffs, End-Payor Plaintiffs Notice of Supplemental Authority in Support of Motions for Class Certification (Attachments: #1 Exhibit 1)(Curley, Andrew)
August 19, 2020 Opinion or Order Filing 702 MINUTE entry before the Honorable Harry D. Leinenweber: In Court Hearing set for 9/24/20 is vacated. The Court takes the motions under consideration and will advise if an oral argument is needed. Mailed notice(maf)
August 18, 2020 Opinion or Order Filing 701 REPLY by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to motion for miscellaneous relief, #552 In Support of Motion to Partially Exclude Opinions and Proposed Testimony of Dr. Keith Leffler (Public Version of Dkt. 672) (Attachments: #1 Declaration in Support, #2 Exhibit A, #3 Exhibit B, #4 Exhibit 10)(Liu, Angela)
August 18, 2020 Opinion or Order Filing 700 REPLY by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. to motion for miscellaneous relief #546 in Support of Motion to Exclude the Opinions and Proposed Testimony of Stephen Byrn (Public Version of Dkt. 675) (Attachments: #1 Declaration in Support, #2 Exhibit 10, #3 Exhibit 11)(Liu, Angela)
August 18, 2020 Opinion or Order Filing 699 REPLY by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. to motion for summary judgment #532 with respect to certain patent issues (Public Version of Dkt. 673) (Attachments: #1 Declaration in Support, #2 Exhibit 47)(Liu, Angela)
August 18, 2020 Opinion or Order Filing 698 REPLY by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. to motion for miscellaneous relief #541 in Support of Motion to Partially Exclude the Opinions and Proposed Testimony of Glen Belvis (Public Version of Dkt. 651) (Attachments: #1 Declaration in Support, #2 Exhibit 8, #3 Exhibit 9, #4 Exhibit 10, #5 Exhibit 11, #6 Exhibit 12)(Liu, Angela)
August 18, 2020 Opinion or Order Filing 697 RESPONSE by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. to sealed response,,,, #615 (Public Version of Dkt. 674) (Liu, Angela)
August 18, 2020 Opinion or Order Filing 696 REPLY by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to motion for summary judgment #539 (Causation/Damages) (Public Version of Dkt. 668) (Liu, Angela)
August 18, 2020 Opinion or Order Filing 695 REPLY by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to motion for miscellaneous relief, #513 in Further Support of Motion to Partially Exclude the Opinions and Proposed Testimony of Janet K. DeLeon (Public Version of Dkt. 657) (Attachments: #1 Declaration in Support, #2 Exhibit 13, #3 Exhibit 14)(Liu, Angela)
August 18, 2020 Opinion or Order Filing 694 REPLY by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to motion for miscellaneous relief, #510 in Further Support of Motion to Exclude The Opinions and Proposed Testimony of John R. Tupman, Jr. (Public Version of Dkt. 655) (Liu, Angela)
August 18, 2020 Opinion or Order Filing 693 RESPONSE by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to sealed document,, #618 (Public Version of Dkt. 676) (Attachments: #1 Appendix in Support, #2 Exhibit 58, #3 Exhibit 59, #4 Exhibit 60, #5 Exhibit 61, #6 Exhibit 62, #7 Exhibit 63, #8 Exhibit 64, #9 Exhibit 65, #10 Exhibit 66, #11 Exhibit 67, #12 Exhibit 68, #13 Exhibit 69, #14 Exhibit 70, #15 Exhibit 71, #16 Exhibit 72, #17 Exhibit 73, #18 Exhibit 74, #19 Exhibit 75, #20 Exhibit 76, #21 Exhibit 77, #22 Exhibit 78, #23 Exhibit 79)(Liu, Angela)
August 18, 2020 Opinion or Order Filing 692 REPLY by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to sealed motion #520 to Plaintiffs' Reply Brief in Support of Plaintiffs' Motion to Exclude Certain Opinions of Mr. Jonathan Singer (Public Version of Dkt. 669) (Curley, Andrew)
August 18, 2020 Opinion or Order Filing 691 REPLY by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to motion for miscellaneous relief, #550 (Public Version of Dkt. 664) (Attachments: #1 Declaration of Devora W. Allon, #2 Exhibit)(Allon, Devora)
August 18, 2020 Opinion or Order Filing 690 REPLY by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to Sealed motion #528 (Public version of sealed ECF No. 656) (Refsin, Barry)
August 18, 2020 Opinion or Order Filing 689 REPLY by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to Sealed motion #526 (Public version of sealed ECF No. 654) (Refsin, Barry)
August 18, 2020 Opinion or Order Filing 688 DECLARATION of Andrew C. Curley regarding reply, #656 , reply #667 , reply, #658 , reply, #654 , reply, #665 in Support of Replies in Support of Plaintiffs' Motions to Exclude Various Expert Opinions (ECF Nos. 654, 656, 658, 665 and 667) (Public Version of Dkt. 670) (Attachments: #1 Exhibit 91, #2 Exhibit 92, #3 Exhibit 93, #4 Exhibit 95, #5 Exhibit 97)(Curley, Andrew)
August 18, 2020 Opinion or Order Filing 687 REPLY by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to motion for miscellaneous relief, #545 (Public Version of Dkt. 663) (Allon, Devora)
August 18, 2020 Opinion or Order Filing 686 REPLY by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to motion for miscellaneous relief, #556 (Public Version of Dkt. 662) (Attachments: #1 Declaration of Devora W. Allon, #2 Exhibit)(Allon, Devora)
August 18, 2020 Opinion or Order Filing 685 REPLY by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to motion for miscellaneous relief, #537 (Public Version of Dkt. 661) (Allon, Devora)
August 18, 2020 Opinion or Order Filing 684 REPLY by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to Sealed motion #525 (Public version of sealed ECF No. 652) (Kiley, Monica)
August 18, 2020 Opinion or Order Filing 683 REPLY by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to Sealed motion #522 to Exclude One of the Opinions of Dr. Anthony Lowman (Public Version of Dkt. 666) (Baxter, James)
August 18, 2020 Opinion or Order Filing 682 REPLY by Plaintiffs (Direct Purchaser and End-Payor), End-Payor Plaintiffs, Retailer Plaintiffs to Sealed motion #521 (Public version of sealed ECF No. 660) (Raphael, David)
August 18, 2020 Opinion or Order Filing 681 REPLY by Plaintiffs (Direct Purchaser and End-Payor), Retailer Plaintiffs to Sealed motion #519 to Exclude the Expert Opinions of Dr. Nita Patel (Public, Redacted Version of ECF No. 671) (Maas, Thomas)
August 18, 2020 Opinion or Order Filing 680 REPLY by Plaintiffs (Direct Purchaser and End-Payor), Retailer Plaintiffs to Sealed motion #523 Plaintiffs' Daubert Motion to Exclude Certain Expert Opinions Concerning Patents and Lawsuits That Post-Date the Challenged Reverse Payment Agreement (Public Version of Dkt. 658) (Gerstein, Jonathan)
August 18, 2020 Opinion or Order Filing 679 REPLY by Plaintiffs (Direct Purchaser and End-Payor), Retailer Plaintiffs to Sealed motion #527 to Exclude the Expert Opinions of Dr. Jody L. Green (Public, Redacted Version of ECF No. 665) (Stow-Serge, Christopher)
August 18, 2020 Opinion or Order Filing 678 REPLY by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to motion for miscellaneous relief, #516 in Further Support of Motion to Exclude the Opinions and Proposed Testimony of Luis A. Molina (Public Version of Dkt. 659) (Attachments: #1 Declaration in Support, #2 Exhibit 17)(Liu, Angela)
August 18, 2020 Opinion or Order Filing 677 REPLY by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to motion for miscellaneous relief, #529 in Further Support of Motion to Partially Exclude the Opinions and Proposed Testimony of Dr. Jeffrey Leitzinger (Public Version of Dkt. 653) (Attachments: #1 Declaration in Support, #2 Exhibit 11)(Liu, Angela)
August 4, 2020 Opinion or Order Filing 676 SEALED RESPONSE by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to sealed document,, #618 (Attachments: #1 Appendix of Exhibits, #2 Exhibit 58, #3 Exhibit 59, #4 Exhibit 60, #5 Exhibit 61, #6 Exhibit 62, #7 Exhibit 63, #8 Exhibit 64, #9 Exhibit 65, #10 Exhibit 66, #11 Exhibit 67, #12 Exhibit 68, #13 Exhibit 69, #14 Exhibit 70, #15 Exhibit 71, #16 Exhibit 72, #17 Exhibit 73, #18 Exhibit 74, #19 Exhibit 75, #20 Exhibit 76, #21 Exhibit 77, #22 Exhibit 78, #23 Exhibit 79)(Liu, Angela)
August 4, 2020 Opinion or Order Filing 675 SEALED REPLY by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. To Exclude the Opinions and Proposed Testimony of Stephen Byrn #546 (Attachments: #1 Declaration in Support, #2 Exhibit 10, #3 Exhibit 11)(Liu, Angela)
August 4, 2020 Opinion or Order Filing 674 SEALED RESPONSE by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. to sealed response,,,, #615 (Liu, Angela)
August 4, 2020 Opinion or Order Filing 673 SEALED REPLY by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. to MOTION by Defendants Penwest Pharmaceuticals Co., Endo Pharmaceuticals Inc., Endo Health Solutions Inc. for summary judgment with respect to certain patent issues #532 (Attachments: #1 Declaration in Support, #2 Exhibit 47)(Liu, Angela)
August 4, 2020 Opinion or Order Filing 672 SEALED REPLY by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. Motion to Partially Exclude the Opinions and Proposed Testimony of Dr. Keith Leffler #552 (Attachments: #1 Declaration in Support, #2 Exhibit A, #3 Exhibit B, #4 Exhibit 10)(Liu, Angela)
August 4, 2020 Opinion or Order Filing 671 SEALED REPLY by (Direct Purchaser and End-Payor), Retailer Plaintiffs to sealed response,, #608 (Reply in Support of Plaintiffs' Daubert Motion to Exclude the Opinions of Dr. Nita Patel) (Maas, Thomas)
August 4, 2020 Opinion or Order Filing 670 SEALED DOCUMENT by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs Declaration of Andrew C. Curley in Support of Replies in Support of Plaintiffs' Motions to Exclude Various Expert Opinions (ECF Nos. 654, 656, 658, 665 and 667) (Attachments: #1 Exhibit 91, #2 Exhibit 92, #3 Exhibit 93, #4 Exhibit 94, #5 Exhibit 95, #6 Exhibit 96, #7 Exhibit 97, #8 Exhibit 98)(Curley, Andrew)
August 4, 2020 Opinion or Order Filing 669 SEALED REPLY by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to SEALED MOTION by Plaintiff (Direct Purchaser and End-Payor) Plaintiffs' Daubert Motion to Exclude Certain Opinions of Mr. Jonathan Singer #520 (Curley, Andrew)
August 4, 2020 Opinion or Order Filing 668 SEALED REPLY by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to MOTION by Defendants Penwest Pharmaceuticals Co., Impax Laboratories, Inc., Endo Pharmaceuticals Inc., Endo Health Solutions Inc. for summary judgment (Causation/Damages) #539 (Liu, Angela)
August 4, 2020 Opinion or Order Filing 667 SEALED REPLY by (Direct Purchaser and End-Payor) to SEALED MOTION by Plaintiff (Direct Purchaser and End-Payor) Plaintiffs' Daubert Motion to Exclude One of the Opinions of Dr. Reza Fassihi #524 (Baxter, James)
August 4, 2020 Opinion or Order Filing 666 SEALED REPLY by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to SEALED MOTION by Plaintiff (Direct Purchaser and End-Payor) Plaintiffs' Daubert Motion to Exclude One of the Opinions of Dr. Anthony Lowman #522 (Baxter, James)
August 4, 2020 Opinion or Order Filing 665 SEALED REPLY by (Direct Purchaser and End-Payor), Retailer Plaintiffs to SEALED MOTION by Plaintiff (Direct Purchaser and End-Payor) Plaintiffs' Daubert Motion to Exclude the Expert Opinions of Dr. Jody L. Green #527 (Stow-Serge, Christopher)
August 4, 2020 Opinion or Order Filing 664 SEALED REPLY by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. To Exclude the Opinions and Proposed Testimony of Patricia Zettler and Martin Lessem #550 (Attachments: #1 Declaration of Devora W. Allon, #2 Exhibit)(Allon, Devora)
August 4, 2020 Opinion or Order Filing 663 SEALED REPLY by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. To Exclude The Opinions and Proposed Testimony of Meredith Rosenthal Regarding Damages #545 (Allon, Devora)
August 4, 2020 Opinion or Order Filing 662 SEALED REPLY by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. To Partially Exclude the Opinions and Proposed Testimony of Dr. Thomas McGuire #556 (Attachments: #1 Declaration of Devora W. Allon, #2 Exhibit)(Allon, Devora)
August 4, 2020 Opinion or Order Filing 661 SEALED REPLY by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. To Exclude The Opinions and Proposed Testimony of James Bruno #537 (Allon, Devora)
August 4, 2020 Opinion or Order Filing 660 SEALED REPLY by (Direct Purchaser and End-Payor), End-Payor Plaintiffs, Retailer Plaintiffs to SEALED MOTION by Plaintiff (Direct Purchaser and End-Payor) Plaintiffs' Daubert Motion to Exclude Certain Opinions of Mr. Anthony Figg #521 (Raphael, David)
August 4, 2020 Opinion or Order Filing 659 SEALED REPLY by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. To Exclude the Opinions and Proposed Testimony of Luis A. Molina #516 (Attachments: #1 Declaration in Support, #2 Exhibit 17)(Liu, Angela)
August 4, 2020 Opinion or Order Filing 658 SEALED REPLY by (Direct Purchaser and End-Payor), Retailer Plaintiffs to SEALED MOTION by Plaintiff (Direct Purchaser and End-Payor) Plaintiffs' Daubert Motion to Exclude Certain Expert Opinions Concerning Patents and Lawsuits That Post-Date the Challenged Reverse Payment Agreement #523 (Gerstein, Jonathan)
August 4, 2020 Opinion or Order Filing 657 SEALED REPLY by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. To Partially Exclude the Opinions and Proposed Testimony of Janet K. DeLeon #513 (Attachments: #1 Declaration in Support, #2 Exhibit 13, #3 Exhibit 14)(Liu, Angela)
August 4, 2020 Opinion or Order Filing 656 SEALED REPLY by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to SEALED MOTION by Plaintiff (Direct Purchaser and End-Payor) Plaintiffs' Daubert Motion to Exclude the Expert Opinion of Dr. Louis Berneman Regarding "Fair Value" #528 (Refsin, Barry)
August 4, 2020 Opinion or Order Filing 655 SEALED REPLY by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. To Exclude The Opinions and Proposed Testimony of John R. Tupman, Jr. #510 (Liu, Angela)
August 4, 2020 Opinion or Order Filing 654 SEALED REPLY by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to SEALED MOTION by Plaintiff (Direct Purchaser and End-Payor) Plaintiffs' Daubert Motion to Exclude Certain Opinions of Dr. Sumanth Addanki #526 (Refsin, Barry)
August 4, 2020 Opinion or Order Filing 653 SEALED REPLY by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. To Partially Exclude the Opinions and Proposed Testimony of Dr. Jeffrey Leitzinger #529 (Attachments: #1 Declaration in Support, #2 Exhibit 11)(Liu, Angela)
August 4, 2020 Opinion or Order Filing 652 SEALED REPLY by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to SEALED MOTION by Plaintiff (Direct Purchaser and End-Payor) Plaintiffs' Daubert Motion to Exclude Certain Expert Opinions of Dr. Christopher J. Gilligan #525 (Kiley, Monica)
August 4, 2020 Opinion or Order Filing 651 SEALED REPLY by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. To Partially Exclude the Opinions and Proposed Testimony of Glen Belvis #541 (Attachments: #1 Declaration in Support, #2 Exhibit 8, #3 Exhibit 9, #4 Exhibit 10, #5 Exhibit 11, #6 Exhibit 12)(Liu, Angela)
July 30, 2020 Opinion or Order Filing 650 NOTICE by Direct Purchaser Plaintiffs, End-Payor Plaintiffs Notice of Supplemental Authority in Support of Motion for Class Certification (Attachments: #1 Exhibit 1)(Curley, Andrew)
July 2, 2020 Opinion or Order Filing 649 RESPONSE by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to sealed response, #605 [PUBLIC VERSION] Plaintiffs' Opposition to Endo's Daubert Motion to Partially Exclude the Opinions and Testimony of Glen Belvis (Attachments: #1 Declaration of J. Boone Baxter [PUBLIC VERSION], #2 Exhibit Slipsheet for Exhibits [FILED UNDER SEAL])(Baxter, James)
July 2, 2020 Opinion or Order Filing 648 RESPONSE by (Direct Purchaser and End-Payor), Retailer Plaintiffsin Opposition to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. To Exclude the Opinions and Proposed Testimony of Patricia Zettler and Martin Lessem #550 (public version of sealed ECF No. 614) (Attachments: #1 Declaration of T. Maas, #2 Exhibit (Sealed Coversheet))(Maas, Thomas)
July 2, 2020 Opinion or Order Filing 647 RESPONSE by Plaintiffs (Direct Purchaser and End-Payor), Retailer Plaintiffs to motion for miscellaneous relief, #510 (Public version of sealed ECF No. 600) (Attachments: #1 Declaration of B. Refsin, #2 Exhibit 1 - 2 (sealed cover sheet))(Refsin, Barry)
July 2, 2020 Opinion or Order Filing 646 RESPONSE by Plaintiff End-Payor Plaintiffs to sealed document, #560 [PUBLIC VERSION OF DKT 598] (Attachments: #1 Declaration of Michael J. Freed & Exhibits 1-3)(Freed, Michael)
July 2, 2020 Opinion or Order Filing 645 RESPONSE by Plaintiffs (Direct Purchaser and End-Payor), Retailer Plaintiffs to sealed document,, #515 (Public version of sealed ECF No. 602) (Attachments: #1 Declaration of M. Kiley, #2 Exhibit 1 - 5 (sealed cover sheet))(Kiley, Monica)
July 2, 2020 Opinion or Order Filing 644 RESPONSE by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to sealed response #617 (Attachments: #1 [PUBLIC VERSION] Rule 56.1 Statement of Additional Facts, #2 [PUBLIC VERSION] Plf Response to Def. Rule 56.1 Statement, #3 Appendix Exhibits to Rule 56.1 Statement, #4 Exhibit Slipsheet of Exhibits Filed Under Seal, #5 Exhibit 22, #6 Exhibit 58, #7 Exhibit 69, #8 Exhibit 74, #9 Exhibit 79, #10 Exhibit 81, #11 Exhibit 82)(Gerstein, Bruce)
July 2, 2020 Opinion or Order Filing 643 RESPONSE by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs #516 Public version of sealed ECF No. 603 (Attachments: #1 Declaration of David Raphael, #2 Exhibit Exhibits 1-8 (Sealed Cover Sheet), #3 Exhibit 9)(Raphael, David) (Docket text modified by Clerk's Office)
July 2, 2020 Opinion or Order Filing 642 RESPONSE by Direct Purchaser Plaintiffs, End-Payor Plaintiffsin Opposition to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. To Partially Exclude the Opinions and Proposed Testimony of Dr. Jeffrey Leitzinger #529 [Public Version of ECF No. 609] (Attachments: #1 Declaration, #2 Exhibits 1-11)(Schwartz, Richard)
July 2, 2020 Opinion or Order Filing 641 RESPONSE by Plaintiffs (Direct Purchaser and End-Payor), Retailer Plaintiffs to motion for miscellaneous relief #546 (Public version of sealed ECF No. 616) (Attachments: #1 Declaration of A. Kelly, #2 Exhibit 3, #3 Exhibit 4, #4 Exhibit 1-2 and 5-15 (Sealed Cover Sheet))(Kelly, Andrew)
July 2, 2020 Opinion or Order Filing 640 RESPONSE by Plaintiffs (Direct Purchaser and End-Payor), Retailer Plaintiffs to motion for miscellaneous relief, #537 (Public version of sealed ECF No. 604) (Attachments: #1 Declaration of C. Stow-Serge, #2 Exhibit (Sealed Cover Sheet))(Stow-Serge, Christopher)
July 2, 2020 Opinion or Order Filing 639 RESPONSE by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to sealed response,,,, #615 Plaintiffs' Opposition to Endo's Motion for Partial Summary Judgment with Respect to Certain Patent Issues (Attachments: #1 Rule 56.1 Statement [PUBLIC VERSION], #2 Responsive Rule 56.1 Statement [PUBLIC VERSION], #3 Appendix [PUBLIC VERSION], #4 Exhibit Slipsheet for Exhibits [UNDER SEAL], #5 Exhibit 10 [PUBLIC VERSION], #6 Exhibit 11 [PUBLIC VERSION], #7 Exhibit 12 [PUBLIC VERSION], #8 Exhibit 13 [PUBLIC VERSION], #9 Exhibit 14 [PUBLIC VERSION], #10 Exhibit 19 [PUBLIC VERSION], #11 Exhibit 23 [PUBLIC VERSION], #12 Exhibit 24 [PUBLIC VERSION], #13 Exhibit 26 [PUBLIC VERSION], #14 Exhibit 33 [PUBLIC VERSION], #15 Exhibit 35 [PUBLIC VERSION])(Baxter, James)
July 2, 2020 Opinion or Order Filing 638 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. in Opposition to motion for miscellaneous relief #571 [PUBLIC VERSION OF DKT 607] (Attachments: #1 Declaration in Support, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8)(Liu, Angela)
July 2, 2020 Opinion or Order Filing 637 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. in Opposition to motion for miscellaneous relief #566 [PUBLIC VERSION OF DKT 601] (Attachments: #1 Declaration in Support, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8)(Liu, Angela)
July 2, 2020 Opinion or Order Filing 636 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. in Opposition to Sealed motion #528 PUBLIC REDACTED VERSION of Dkt. 612 (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4)(Allon, Devora)
July 2, 2020 Opinion or Order Filing 635 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. in Opposition to Sealed motion #526 PUBLIC REDACTED VERSION OF Dkt. 610 (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3)(Allon, Devora)
July 2, 2020 Opinion or Order Filing 634 MEMORANDUM by Impax Laboratories, Inc. in Opposition to Sealed motion #519 PUBLIC REDACTED VERSION of Dkt. 608 (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11)(Allon, Devora)
July 2, 2020 Opinion or Order Filing 633 MEMORANDUM by Impax Laboratories, Inc. in Opposition to Sealed motion #521 PUBLIC REDACTED VERSION of Dkt. 606 (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3)(Allon, Devora)
July 2, 2020 Opinion or Order Filing 632 AFFIDAVIT by Plaintiffs Albertsons LLC, CVS Pharmacy, Inc., HEB Grocery Company L.P., Rite Aid Corporation, Rite Aid Hdqtrs. Corp., Safeway Inc., The Kroger Co., Walgreen Co in Opposition to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. Motion to Partially Exclude the Opinions and Proposed Testimony of Dr. Keith Leffler #552 [PUBLIC VERSION] Declaration of Scott E. Perwin (Perwin, Scott)
July 2, 2020 Opinion or Order Filing 631 RESPONSE by Albertsons LLC, CVS Pharmacy, Inc., HEB Grocery Company L.P., Rite Aid Corporation, Rite Aid Hdqtrs. Corp., Safeway Inc., The Kroger Co., Walgreen Coin Opposition to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. Motion to Partially Exclude the Opinions and Proposed Testimony of Dr. Keith Leffler #552 [PUBLIC VERSION] (Perwin, Scott)
July 2, 2020 Opinion or Order Filing 630 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. in Opposition to motion for miscellaneous relief #576 [PUBLIC VERSION OF DKT 597] (Attachments: #1 Declaration in Support, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11, #13 Exhibit 12, #14 Exhibit 13, #15 Exhibit 14, #16 Exhibit 15)(Liu, Angela)
July 2, 2020 Opinion or Order Filing 629 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. in Opposition to motion for miscellaneous relief #573 [PUBLIC VERSION OF DKT 599] (Attachments: #1 Declaration in Support, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11, #13 Exhibit 12, #14 Exhibit 13, #15 Exhibit 14, #16 Exhibit 15, #17 Exhibit 16)(Liu, Angela)
July 2, 2020 Opinion or Order Filing 628 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. in Opposition to motion for miscellaneous relief #572 [PUBLIC VERSION OF DKT 596] (Attachments: #1 Declaration in Support, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11, #13 Exhibit 12)(Liu, Angela)
July 2, 2020 Opinion or Order Filing 627 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. in Opposition to motion for miscellaneous relief #569 [PUBLIC VERSION OF DKT 595] (Attachments: #1 Declaration in Support, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8)(Liu, Angela)
July 2, 2020 Opinion or Order Filing 626 MINUTE entry before the Honorable Harry D. Leinenweber: Docket entry #611 and #613 are hereby vacated as entered in error. Mailed notice(maf)
July 1, 2020 Opinion or Order Filing 625 RESPONSE by Plaintiff (Direct Purchaser and End-Payor) to sealed response, #622 [PUBLIC VERSION] Plaintiffs' Opposition to Defendants' Motion to Partially Exclude the Opinions and Proposed Testimony of Dr. Thomas McGuire (Attachments: #1 Gerstein Declaration [PUBLIC VERSION], #2 Exhibit Slipsheet for Exhibits 1-4 [UNDER SEAL])(Gerstein, Bruce) Modified on 7/2/2020 (maf, ).
July 1, 2020 Opinion or Order Filing 624 [Public Version] [ECF No. 623] Notice of Supplemental Authority in Support of Their Motion for Class Certification by Direct Purchaser Plaintiffs (Attachments: #1 Exhibit A)(Schwartz, Richard)
June 25, 2020 Opinion or Order Filing 623 SEALED DOCUMENT by Plaintiff Direct Purchaser Plaintiffs NOTICE OF SUPPLEMENTAL AUTHORITY IN SUPPORT OF THEIR MOTION FOR CLASS CERTIFICATION (Attachments: #1 Exhibit A)(Curley, Andrew)
June 19, 2020 Opinion or Order Filing 622 SEALED RESPONSE by (Direct Purchaser and End-Payor) to sealed document, #559 Plaintiffs' Opposition to Defendants' Motion to Partially Exclude the Opinions and Proposed Testimony of Dr. Thomas McGuire (Attachments: #1 Declaration Gerstein Declaration, #2 Exhibit 1 to Gerstein Declaration, #3 Exhibit 2 to Gerstein Declaration, #4 Exhibit 3 to Gerstein Declaration, #5 Exhibit 4 to Gerstein Declaration)(Gerstein, Bruce)
June 19, 2020 Opinion or Order Filing 621 SEALED DOCUMENT by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs Rule 56.1 Statement of Facts Exhibit Index and Exhibits 76-100 (Attachments: #1 Exhibit 76, #2 Exhibit 77, #3 Exhibit 78, #4 Exhibit 79, #5 Exhibit 80, #6 Exhibit 81, #7 Exhibit 82, #8 Exhibit 83, #9 Exhibit 84, #10 Exhibit 85, #11 Exhibit 86, #12 Exhibit 87, #13 Exhibit 88, #14 Exhibit 89, #15 Exhibit 90, #16 Exhibit 91, #17 Exhibit 92, #18 Exhibit 93, #19 Exhibit 94, #20 Exhibit 95, #21 Exhibit 96, #22 Exhibit 97, #23 Exhibit 98, #24 Exhibit 99, #25 Exhibit 100)(Gerstein, Bruce)
June 19, 2020 Opinion or Order Filing 620 SEALED DOCUMENT by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs Rule 56.1 Statement of Facts Exhibit Index and Exhibits 51-75 (Attachments: #1 Exhibit 51, #2 Exhibit 52, #3 Exhibit 53, #4 Exhibit 54, #5 Exhibit 55, #6 Exhibit 56, #7 Exhibit 57, #8 Exhibit 58, #9 Exhibit 59, #10 Exhibit 60, #11 Exhibit 61, #12 Exhibit 62, #13 Exhibit 63, #14 Exhibit 64, #15 Exhibit 65, #16 Exhibit 66, #17 Exhibit 67, #18 Exhibit 68, #19 Exhibit 69, #20 Exhibit 70, #21 Exhibit 71, #22 Exhibit 72, #23 Exhibit 73, #24 Exhibit 74, #25 Exhibit 75)(Gerstein, Bruce)
June 19, 2020 Opinion or Order Filing 619 SEALED DOCUMENT by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs Rule 56.1 Statement of Facts Exhibit Index and Exhibits 26-50 (Attachments: #1 Exhibit 26, #2 Exhibit 27, #3 Exhibit 28, #4 Exhibit 29, #5 Exhibit 30, #6 Exhibit 31, #7 Exhibit 32, #8 Exhibit 33, #9 Exhibit 34, #10 Exhibit 35, #11 Exhibit 36, #12 Exhibit 37, #13 Exhibit 38, #14 Exhibit 39, #15 Exhibit 40, #16 Exhibit 41, #17 Exhibit 42, #18 Exhibit 43, #19 Exhibit 44, #20 Exhibit 45, #21 Exhibit 46, #22 Exhibit 47, #23 Exhibit 48, #24 Exhibit 49, #25 Exhibit 50)(Gerstein, Bruce)
June 19, 2020 Opinion or Order Filing 618 SEALED DOCUMENT by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs Affirmative Rule 56.1 Statement of Facts (Attachments: #1 Pls Responsive Rule 56.1 Statement, #2 56.1 Statement of Facts Exhibit Index, #3 Exhibit 1, #4 Exhibit 2, #5 Exhibit 3, #6 Exhibit 4, #7 Exhibit 5, #8 Exhibit 6, #9 Exhibit 7, #10 Exhibit 8, #11 Exhibit 9, #12 Exhibit 10, #13 Exhibit 11, #14 Exhibit 12, #15 Exhibit 13, #16 Exhibit 14, #17 Exhibit 15, #18 Exhibit 16, #19 Exhibit 17, #20 Exhibit 18, #21 Exhibit 19, #22 Exhibit 20, #23 Exhibit 21, #24 Exhibit 22, #25 Exhibit 23, #26 Exhibit 24, #27 Exhibit 25)(Gerstein, Bruce)
June 18, 2020 Opinion or Order Filing 617 SEALED RESPONSE PLAINTIFFS' OPPOSITION TO DEFENDANTS' CAUSATION/DAMAGES MOTION FOR SUMMARY JUDGMENT (Gerstein, Bruce)
June 18, 2020 Opinion or Order Filing 616 SEALED RESPONSE by (Direct Purchaser and End-Payor), Retailer Plaintiffs to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. To Exclude the Opinions and Proposed Testimony of Stephen Byrn #546 , sealed document, #549 (Plaintiffs' Opposition to Motion) (Attachments: #1 Declaration of A. Kelly, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11, #13 Exhibit 12, #14 Exhibit 13, #15 Exhibit 14, #16 Exhibit 15)(Maas, Thomas)
June 18, 2020 Opinion or Order Filing 615 SEALED RESPONSE by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to sealed document,, #535 Plaintiffs' Opposition to Endo's Motion for Partial Summary Judgment with Respect to Certain Patent Issues (Attachments: #1 Rule 56.1 Statement, #2 Responsive Rule 56.1 Statement, #3 Appendix, #4 Exhibit 1, #5 Exhibit 2, #6 Exhibit 3, #7 Exhibit 4, #8 Exhibit 5, #9 Exhibit 6, #10 Exhibit 7, #11 Exhibit 8, #12 Exhibit 9, #13 Exhibit 10, #14 Exhibit 11, #15 Exhibit 12, #16 Exhibit 13, #17 Exhibit 14, #18 Exhibit 15, #19 Exhibit 16, #20 Exhibit 17, #21 Exhibit 18, #22 Exhibit 19, #23 Exhibit 20, #24 Exhibit 21, #25 Exhibit 22, #26 Exhibit 23, #27 Exhibit 24, #28 Exhibit 25, #29 Exhibit 26, #30 Exhibit 27, #31 Exhibit 28, #32 Exhibit 29, #33 Exhibit 30, #34 Exhibit 31, #35 Exhibit 32, #36 Exhibit 33, #37 Exhibit 34, #38 Exhibit 35, #39 Exhibit 36, #40 Exhibit 37, #41 Exhibit 38)(Baxter, James)
June 18, 2020 Opinion or Order Filing 614 SEALED RESPONSE by (Direct Purchaser and End-Payor), Retailer Plaintiffs to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. To Exclude the Opinions and Proposed Testimony of Patricia Zettler and Martin Lessem #550 , sealed document,, #554 (Plaintiffs' Opposition to Motion) (Attachments: #1 Declaration of T. Maas, #2 Exhibit 1, #3 Exhibit 2, #4 Certificate of Service)(Maas, Thomas)
June 18, 2020 Opinion or Order Filing 613 SEALED RESPONSE by (Direct Purchaser and End-Payor) to sealed document, #559 Plaintiffs' Opposition to Defendants' Motion to Partially Exclude the Opinions and Proposed Testimony of Dr. Thomas McGuire- CORRECTED (Attachments: #1 Declaration In Support, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4)(Gerstein, Bruce)
June 18, 2020 Opinion or Order Filing 612 SEALED RESPONSE by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to SEALED MOTION by Plaintiff (Direct Purchaser and End-Payor) Plaintiffs' Daubert Motion to Exclude the Expert Opinion of Dr. Louis Berneman Regarding "Fair Value" #528 Memorandum of Law in Opposition to Plaintiffs' Motion to Exclude the Expert Opinion of Dr. Louis Berneman Regarding "Fair Value" (Attachments: #1 Declaration of Devora W. Allon, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4)(Allon, Devora)
June 18, 2020 Opinion or Order Filing 611 SEALED RESPONSE by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to sealed document, #559 Plaintiffs' Opposition to Defendants' Motion to Partially Exclude the Opinions and Proposed Testimony of Dr. Thomas McGuire (Attachments: #1 Declaration in Support, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4)(Gerstein, Bruce)
June 18, 2020 Opinion or Order Filing 610 SEALED RESPONSE by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to SEALED MOTION by Plaintiff (Direct Purchaser and End-Payor) Plaintiffs' Daubert Motion to Exclude Certain Opinions of Dr. Sumanth Addanki #526 Memorandum of Law in Opposition to Plaintiffs' Motion to Exclude Certain Opinions of Dr. Sumanth Addanki (Attachments: #1 Declaration of Devora W. Allon, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3)(Allon, Devora)
June 18, 2020 Opinion or Order Filing 609 SEALED DOCUMENT by Plaintiff (Direct Purchaser and End-Payor) Opposition to Defendants' Motion to Partially Exclude Opinions and Proposed Testimony of Jeffrey J. Leitzinger (Attachments: #1 Declaration in Support, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11)(Schwartz, Richard)
June 18, 2020 Opinion or Order Filing 608 SEALED RESPONSE by Impax Laboratories, Inc. to SEALED MOTION by Plaintiff (Direct Purchaser and End-Payor) Plaintiffs' Daubert Motion to Exclude the Opinions of Dr. Nita Patel #519 Memorandum of Law in Opposition to Plaintiffs' Motion to Exclude the Opinions of Dr. Nita Patel (Attachments: #1 Declaration of Devora W. Allon, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11)(Allon, Devora)
June 18, 2020 Opinion or Order Filing 607 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. Defendants' Opposition to Plaintiffs' Daubert Motion to Exclude Certain Expert Opinions Concerning Patents and Lawsuits That Post-Date The Challenged Reverse Payment Agreement (Attachments: #1 Declaration in Support, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8)(Liu, Angela)
June 18, 2020 Opinion or Order Filing 606 SEALED RESPONSE by Impax Laboratories, Inc. to SEALED MOTION by Plaintiff (Direct Purchaser and End-Payor) Plaintiffs' Daubert Motion to Exclude Certain Opinions of Mr. Anthony Figg #521 Memorandum of Law in Opposition to Plaintiffs' Motion to Exclude Certain Opinions of Mr. Anthony Figg (Attachments: #1 Declaration of Devora W. Allon, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3)(Allon, Devora)
June 18, 2020 Opinion or Order Filing 605 SEALED RESPONSE by (Direct Purchaser and End-Payor), Retailer Plaintiffs to sealed document, #544 Plaintiffs' Opposition to Endo's Daubert Motion to Partially Exclude the Opinions and Testimony of Glen Belvis (Attachments: #1 Declaration J. Boone Baxter, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5)(Baxter, James)
June 18, 2020 Opinion or Order Filing 604 SEALED RESPONSE by (Direct Purchaser and End-Payor), Retailer Plaintiffs to sealed document,, #542 , MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. To Exclude The Opinions and Proposed Testimony of James Bruno #537 Plaintiffs' Opposition to Defendants' Motion (Attachments: #1 Declaration of C. Stow-Serge, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4)(Stow-Serge, Christopher)
June 18, 2020 Opinion or Order Filing 603 SEALED RESPONSE by Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. To Exclude the Opinions and Proposed Testimony of Luis A. Molina #516 (Attachments: #1 Declaration of David C. Raphael, Jr., #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9)(Raphael, David)
June 18, 2020 Opinion or Order Filing 602 SEALED RESPONSE by (Direct Purchaser and End-Payor), Retailer Plaintiffs to sealed document,, #515 Plaintiffs' Opposition to Defendants' Motion to Partially Exclude the Opinions and Proposed Testimony of Janet K. DeLeon (Attachments: #1 Declaration in Support, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5)(Kiley, Monica)
June 18, 2020 Opinion or Order Filing 601 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. Endo's Opposition to Plaintiffs' Daubert Motion to Exclude Certain Opinions of Mr. Jonathan Singer (Attachments: #1 Declaration in Support, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8)(Liu, Angela)
June 18, 2020 Opinion or Order Filing 600 SEALED RESPONSE by (Direct Purchaser and End-Payor), Retailer Plaintiffs to sealed document, #512 Plaintiffs' Opposition to Defendants' Motion to Exclude the Opinions and Proposed Testimony of John R. Tupman, Jr. (Attachments: #1 Declaration in Support, #2 Exhibit 1, #3 Exhibit 2)(Refsin, Barry)
June 18, 2020 Opinion or Order Filing 599 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. Endo's Opposition to Plaintiffs' Daubert Motion to Exclude Certain Expert Opinions of Dr. Christopher J. Gilligan (Attachments: #1 Declaration in Support, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11, #13 Exhibit 12, #14 Exhibit 13, #15 Exhibit 14, #16 Exhibit 15, #17 Exhibit 16)(Liu, Angela)
June 18, 2020 Opinion or Order Filing 598 SEALED RESPONSE by End-Payor Plaintiffs to sealed document, #560 Opposition to Defendants' Motion to Exclude the Opinions of Dr. Meredith Rosenthal Regarding Damages (Attachments: #1 Declaration of Michael J. Freed & Exhibits 1-3)(Freed, Michael)
June 18, 2020 Opinion or Order Filing 597 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. Endo's Opposition to Plaintiffs' Daubert Motion to Exclude the Expert Opinions of Dr. Jody L. Green (Attachments: #1 Declaration in Support, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11, #13 Exhibit 12, #14 Exhibit 13, #15 Exhibit 14, #16 Exhibit 15)(Liu, Angela)
June 18, 2020 Opinion or Order Filing 596 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. Memorandum of Law in Opposition to Plaintiffs' Motion to Exclude One of the Opinions of Dr. Reza Fassihi (Attachments: #1 Declaration in Support, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11, #13 Exhibit 12)(Liu, Angela)
June 18, 2020 Opinion or Order Filing 595 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. Memorandum of Law in Opposition to Plaintiffs' Daubert Motion to Exclude One of the Opinions of Dr. Anthony Lowman (Attachments: #1 Declaration in Support, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8)(Liu, Angela)
June 18, 2020 Opinion or Order Filing 594 SEALED DOCUMENT by Plaintiffs Albertsons LLC, CVS Pharmacy, Inc., HEB Grocery Company L.P., Rite Aid Corporation, Rite Aid Hdqtrs. Corp., Safeway Inc., The Kroger Co., Walgreen Co Declaration of Scott E. Perwin in Opposition to Defendants' Motion to Partially Exclude Opinions and Proposed Testimony of Dr. Keith Leffler (Attachments: #1 Exhibit Deposition transcript of Larry Hsu, Ph.D, #2 Exhibit Expert Report of Sumanth Addanki, Ph.D., #3 Exhibit Expert Report of Glen P. Belvis, #4 Exhibit Declaration of Keith Leffler, #5 Exhibit Videotaped deposition transcript of Margaret Guerin-Calvert)(Perwin, Scott)
June 18, 2020 Opinion or Order Filing 593 SEALED RESPONSE by CVS Pharmacy, Inc., Rite Aid Corporation, Rite Aid Hdqtrs. Corp., Walgreen Co to memorandum in support of motion, #583 in opposition to Defendants' motion to partially exclude opinions and proposed testimony of Dr. Keith Leffler (Perwin, Scott)
June 11, 2020 Opinion or Order Filing 592 RESPONSE by Plaintiff End-Payor Plaintiffs to other, #591 (Defendants' Notice of Suppplemental Authority) (Freed, Michael)
June 8, 2020 Opinion or Order Filing 591 Defendants' Notice of Supplemental Authority in Support of their Opposition to End-Payor Class Plaintiffs' Motion for Class Certification by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. (Attachments: #1 Exhibit 1)(Allon, Devora)
May 27, 2020 Opinion or Order Filing 590 Notice of Supplemental Authority in Support of Motion for Class Certification by End-Payor Plaintiffs (Attachments: #1 Exhibit A)(Freed, Michael)
May 15, 2020 Opinion or Order Filing 589 Enter stipulated order. Jury Trial set for 3/15/21 is re-set to 6/7/21 at 10:00 AM. Pretrial Conference set for 3/11/21 is re-set to 6/3/21 at 10:00 AM. Signed by the Honorable Harry D. Leinenweber on 5/15/20:Mailed notice(maf)
May 12, 2020 Opinion or Order Filing 588 ORDER: Pro hac vice motion is granted #509 . Signed by the Honorable Harry D. Leinenweber on 5/12/2020. Mailed notice (aee, )
May 8, 2020 Opinion or Order Filing 587 Notice of Supplemental Authorities in Support of Motions for Class Certification by (Direct Purchaser and End-Payor) (Attachments: #1 Exhibit A, #2 Exhibit B)(Freed, Michael)
May 5, 2020 Opinion or Order Filing 586 RESPONSE by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs to other, #561 (DEFENDANTS' NOTICE OF SUPPLEMENTAL AUTHORITY) (Attachments: #1 Exhibit 1)(Curley, Andrew)
April 29, 2020 Opinion or Order Filing 585 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. in support of motion for miscellaneous relief, #510 [PUBLIC VERSION] (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5)(Liu, Angela)
April 29, 2020 Opinion or Order Filing 584 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. in support of motion for miscellaneous relief, #516 (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11, #13 Exhibit 12, #14 Exhibit 13, #15 Exhibit 14, #16 Exhibit 15, #17 Exhibit 16)(Liu, Angela)
April 29, 2020 Opinion or Order Filing 583 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. in support of motion for miscellaneous relief, #552 [PUBLIC VERSION] (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9)(Liu, Angela)
April 29, 2020 Opinion or Order Filing 582 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. in support of motion for miscellaneous relief, #513 (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11, #13 Exhibit 12)(Liu, Angela)
April 29, 2020 Opinion or Order Filing 581 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. in support of motion for summary judgment #539 [PUBLIC VERSION] (Attachments: #1 Rule 56.1 Statement, #2 Appendix to Rule 56.1 Statement, #3 Exhibit 1, #4 Exhibit 2, #5 Exhibit 3, #6 Exhibit 4, #7 Exhibit 5, #8 Exhibit 6, #9 Exhibit 7, #10 Exhibit 8, #11 Exhibit 9, #12 Exhibit 10, #13 Exhibit 11, #14 Exhibit 12, #15 Exhibit 13, #16 Exhibit 14, #17 Exhibit 15, #18 Exhibit 16, #19 Exhibit 17, #20 Exhibit 18, #21 Exhibit 19, #22 Exhibit 20, #23 Exhibit 21, #24 Exhibit 22, #25 Exhibit 23, #26 Exhibit 24, #27 Exhibit 25, #28 Exhibit 26, #29 Exhibit 27, #30 Exhibit 28, #31 Exhibit 29, #32 Exhibit 30, #33 Exhibit 31, #34 Exhibit 32, #35 Exhibit 33, #36 Exhibit 34, #37 Exhibit 35, #38 Exhibit 36, #39 Exhibit 37, #40 Exhibit 38, #41 Exhibit 39, #42 Exhibit 40, #43 Exhibit 41, #44 Exhibit 42, #45 Exhibit 43, #46 Exhibit 44, #47 Exhibit 45, #48 Exhibit 46, #49 Exhibit 47, #50 Exhibit 48, #51 Exhibit 49, #52 Exhibit 50, #53 Exhibit 51, #54 Exhibit 52, #55 Exhibit 53, #56 Exhibit 54, #57 Exhibit 55, #58 Exhibit 56, #59 Exhibit 57, #60 Exhibit A, #61 Exhibit B, #62 Exhibit C, #63 Exhibit D, #64 Exhibit E, #65 Exhibit F, #66 Exhibit G, #67 Exhibit H, #68 Exhibit I, #69 Exhibit J, #70 Exhibit K, #71 Exhibit L)(Liu, Angela)
April 29, 2020 Opinion or Order Filing 580 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. in support of motion for miscellaneous relief, #529 [PUBLIC VERSION] (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10)(Liu, Angela)
April 29, 2020 Opinion or Order Filing 579 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. in support of motion for miscellaneous relief #546 [PUBLIC VERSION] (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9)(Liu, Angela)
April 29, 2020 Opinion or Order Filing 578 DECLARATION of Andrew C. Curley in Support of Plaintiffs' Motions (ECF Nos. 519-528) to Exclude Various Expert Opinions (Public Version) (Attachments: #1 Exhibit 19, #2 Exhibit 22, #3 Exhibit 24, #4 Exhibit 33, #5 Exhibit 39, #6 Exhibit 44, #7 Exhibit 45, #8 Exhibit 46, #9 Exhibit 47, #10 Exhibit 53, #11 Exhibit 54, #12 Exhibit 55, #13 Exhibit 56, #14 Exhibit 57, #15 Exhibit 65, #16 Exhibit 66, #17 Exhibit 69, #18 Exhibit 71, #19 Exhibit 72, #20 Exhibit 75, #21 Exhibit 78, #22 Exhibit 79, #23 Exhibit 80, #24 Exhibit 84, #25 Exhibit 85, #26 Exhibit 86, #27 Exhibit 87, #28 Exhibit 88, #29 Exhibit 89)(Curley, Andrew)
April 29, 2020 Opinion or Order Filing 577 MOTION by Plaintiff (Direct Purchaser and End-Payor)Plaintiffs' Daubert Motion to Exclude the Expert Opinion of Dr. Louis Berneman Regarding "Fair Value" (Public Version) (Curley, Andrew)
April 29, 2020 Opinion or Order Filing 576 MOTION by Plaintiff (Direct Purchaser and End-Payor)Plaintiffs' Daubert Motion to Exclude the Expert Opinions of Dr. Jody L. Green (Public Version) (Curley, Andrew)
April 29, 2020 Opinion or Order Filing 575 MOTION by Plaintiff (Direct Purchaser and End-Payor)Plaintiffs' Daubert Motion to Exclude Certain Opinions of Dr. Sumanth Addanki (Public Version) (Curley, Andrew)
April 29, 2020 Opinion or Order Filing 574 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. in support of motion for miscellaneous relief, #556 PUBLIC REDACTED VERSION (Attachments: #1 Declaration in Support & Exhibits 1-5 (Public Version))(Allon, Devora)
April 29, 2020 Opinion or Order Filing 573 MOTION by Plaintiff (Direct Purchaser and End-Payor)Plaintiffs' Daubert Motion to Exclude Certain Expert Opinions of Dr. Christopher J. Gilligan (Public Version) (Curley, Andrew)
April 29, 2020 Opinion or Order Filing 572 MOTION by Plaintiff (Direct Purchaser and End-Payor)Plaintiffs' Daubert Motion to Exclude One of the Opinions of Dr. Reza Fassihi (Public Version) (Curley, Andrew)
April 29, 2020 Opinion or Order Filing 571 MOTION by Plaintiff (Direct Purchaser and End-Payor)Plaintiffs' Daubert Motion to Exclude Certain Expert Opinions Concerning Patents and Lawsuits That Post-Date the Challenged Reverse Payment Agreement (Public Version) (Curley, Andrew)
April 29, 2020 Opinion or Order Filing 570 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. in support of motion for miscellaneous relief, #550 PUBLIC REDACTED VERSION (Attachments: #1 Declaration in Support & Exhibits 1-11 (Public Version))(Allon, Devora)
April 29, 2020 Opinion or Order Filing 569 MOTION by Plaintiff (Direct Purchaser and End-Payor)Plaintiffs' Daubert Motion to Exclude One of the Opinions of Dr. Anthony Lowman (Public Version) (Curley, Andrew)
April 29, 2020 Opinion or Order Filing 568 MOTION by Plaintiff (Direct Purchaser and End-Payor)Plaintiffs' Daubert Motion to Exclude Certain Opinions of Mr. Anthony Figg (Public Version) (Curley, Andrew)
April 29, 2020 Opinion or Order Filing 567 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. in support of motion for miscellaneous relief, #545 PUBLIC REDACTED VERSION (Attachments: #1 Declaration in Support & Exhibits 1-4 (Public Version))(Allon, Devora)
April 29, 2020 Opinion or Order Filing 566 MOTION by Plaintiff (Direct Purchaser and End-Payor)Plaintiffs' Daubert Motion to Exclude Certain Opinions of Mr. Jonathan Singer (Public Version) (Curley, Andrew)
April 29, 2020 Opinion or Order Filing 565 MOTION by Plaintiff (Direct Purchaser and End-Payor)Plaintiffs' Daubert Motion to Exclude the Opinions of Dr. Nita Patel (Public Version) (Curley, Andrew)
April 29, 2020 Opinion or Order Filing 564 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. in support of motion for miscellaneous relief #541 [PUBLIC VERSION] (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7)(Liu, Angela)
April 29, 2020 Opinion or Order Filing 563 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. in support of motion for miscellaneous relief, #537 PUBLIC REDACTED VERSION (Attachments: #1 Declaration in Support & Exhibits 1-12 (Public Version))(Allon, Devora)
April 29, 2020 Opinion or Order Filing 562 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. in support of motion for summary judgment #532 [PUBLIC VERSION] (Attachments: #1 Rule 56.1 Statement, #2 Appendix of Exhibits to Rule 56.1 Statement, #3 Exhibit 1, #4 Exhibit 2, #5 Exhibit 3, #6 Exhibit 4, #7 Exhibit 5, #8 Exhibit 6, #9 Exhibit 7, #10 Exhibit 8, #11 Exhibit 9, #12 Exhibit 10, #13 Exhibit 11, #14 Exhibit 12, #15 Exhibit 13, #16 Exhibit 14, #17 Exhibit 15, #18 Exhibit 16, #19 Exhibit 17, #20 Exhibit 18, #21 Exhibit 19, #22 Exhibit 20, #23 Exhibit 21, #24 Exhibit 22, #25 Exhibit 23, #26 Exhibit 24, #27 Exhibit 25, #28 Exhibit 26, #29 Exhibit 27, #30 Exhibit 28, #31 Exhibit 29, #32 Exhibit 30, #33 Exhibit 31, #34 Exhibit 32, #35 Exhibit 33, #36 Exhibit 34, #37 Exhibit 35, #38 Exhibit 36, #39 Exhibit 37, #40 Exhibit 38, #41 Exhibit 39, #42 Exhibit 40, #43 Exhibit 41, #44 Exhibit 42, #45 Exhibit 43, #46 Exhibit 44, #47 Exhibit 45, #48 Exhibit 46)(Liu, Angela)
April 24, 2020 Opinion or Order Filing 561 Defendants' Notice of Supplemental Authority in Support of Their Oppositions to End-Payor and Direct Purchaser Class Plaintiffs' Motions for Class Certification by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. (Attachments: #1 Exhibit 1)(Liu, Angela)
April 15, 2020 Opinion or Order Filing 560 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. Memorandum of Law in Support of Motion to Exclude the Opinions and Proposed Testimony of Meredith Rosenthal Regarding Damages (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4)(Allon, Devora)
April 15, 2020 Opinion or Order Filing 559 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. Memorandum of Law in Support of Motion to Partially Exclude the Opinions and Proposed Testimony of Dr. Thomas McGuire (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5)(Allon, Devora)
April 15, 2020 Opinion or Order Filing 558 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. (Attachments: #1 Declaration, #2 Exhibit A, #3 Exhibit B, #4 Exhibit C, #5 Exhibit D, #6 Exhibit E, #7 Exhibit F, #8 Exhibit G, #9 Exhibit H, #10 Exhibit I, #11 Exhibit J, #12 Exhibit K, #13 Exhibit L, #14 Rule 56.1 Statement, #15 Appendix of Exhibits to Rule 56.1 Statement, #16 Exhibit 1, #17 Exhibit 2, #18 Exhibit 3, #19 Exhibit 4, #20 Exhibit 5, #21 Exhibit 6, #22 Exhibit 7, #23 Exhibit 8, #24 Exhibit 9, #25 Exhibit 10, #26 Exhibit 11, #27 Exhibit 12, #28 Exhibit 13, #29 Exhibit 14, #30 Exhibit 15, #31 Exhibit 16, #32 Exhibit 17, #33 Exhibit 18, #34 Exhibit 19, #35 Exhibit 20, #36 Exhibit 21, #37 Exhibit 22, #38 Exhibit 23, #39 Exhibit 24, #40 Exhibit 25, #41 Exhibit 26, #42 Exhibit 27, #43 Exhibit 28, #44 Exhibit 29, #45 Exhibit 30, #46 Exhibit 31, #47 Exhibit 32, #48 Exhibit 33, #49 Exhibit 34, #50 Exhibit 35, #51 Exhibit 36, #52 Exhibit 37, #53 Exhibit 38, #54 Exhibit 39, #55 Exhibit 40, #56 Exhibit 41, #57 Exhibit 42, #58 Exhibit 43, #59 Exhibit 44, #60 Exhibit 45, #61 Exhibit 46, #62 Exhibit 47, #63 Exhibit 48, #64 Exhibit 49, #65 Exhibit 50, #66 Exhibit 51, #67 Exhibit 52, #68 Exhibit 53, #69 Exhibit 54, #70 Exhibit 55, #71 Exhibit 56, #72 Exhibit 57)(Chapman, Julia)
April 15, 2020 Opinion or Order Filing 557 NOTICE of Motion by Devora Whitman Allon for presentment of motion for miscellaneous relief, #556 before Honorable Harry D. Leinenweber on 9/10/2020 at 09:30 AM. (Allon, Devora)
April 15, 2020 Opinion or Order Filing 556 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. To Partially Exclude the Opinions and Proposed Testimony of Dr. Thomas McGuire (Attachments: #1 Text of Proposed Order)(Allon, Devora)
April 15, 2020 Opinion or Order Filing 555 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. Memorandum of Law in Support of Defendants' Motion to Partially Exclude the Opinions and Proposed Testimony of Dr. Keith Leffler (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9)(Liu, Angela)
April 15, 2020 Opinion or Order Filing 554 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. Memorandum of Law in Support of Motion to Exclude the Opinions and Proposed Testimony of Patricia Zettler and Martin Lessem (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11)(Allon, Devora)
April 15, 2020 Opinion or Order Filing 553 NOTICE of Motion by Angela M. Liu for presentment of motion for miscellaneous relief, #552 before Honorable Harry D. Leinenweber on 9/10/2020 at 09:30 AM. (Liu, Angela)
April 15, 2020 Opinion or Order Filing 552 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. Motion to Partially Exclude the Opinions and Proposed Testimony of Dr. Keith Leffler (Attachments: #1 Text of Proposed Order)(Liu, Angela)
April 15, 2020 Opinion or Order Filing 551 NOTICE of Motion by Devora Whitman Allon for presentment of motion for miscellaneous relief, #550 before Honorable Harry D. Leinenweber on 9/10/2020 at 09:30 AM. (Allon, Devora)
April 15, 2020 Opinion or Order Filing 550 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. To Exclude the Opinions and Proposed Testimony of Patricia Zettler and Martin Lessem (Attachments: #1 Text of Proposed Order)(Allon, Devora)
April 15, 2020 Opinion or Order Filing 549 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. Memorandum of Law In Support of Endo's Motion to Exclude the Opinions and Proposed Testimony of Stephen Byrn (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9)(Liu, Angela)
April 15, 2020 Opinion or Order Filing 548 NOTICE of Motion by Angela M. Liu for presentment of motion for miscellaneous relief #546 before Honorable Harry D. Leinenweber on 9/10/2020 at 09:30 AM. (Liu, Angela)
April 15, 2020 Opinion or Order Filing 547 NOTICE of Motion by Devora Whitman Allon for presentment of motion for miscellaneous relief, #545 before Honorable Harry D. Leinenweber on 9/10/2020 at 09:30 AM. (Allon, Devora)
April 15, 2020 Opinion or Order Filing 546 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. To Exclude the Opinions and Proposed Testimony of Stephen Byrn (Attachments: #1 Text of Proposed Order)(Liu, Angela)
April 15, 2020 Opinion or Order Filing 545 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. To Exclude The Opinions and Proposed Testimony of Meredith Rosenthal Regarding Damages (Attachments: #1 Text of Proposed Order)(Allon, Devora)
April 15, 2020 Opinion or Order Filing 544 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. Memorandum of Law In Support of Endo's Motion to Partially Exclude Opinons and Proposed Testimony of Glen Belvis (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7)(Liu, Angela)
April 15, 2020 Opinion or Order Filing 543 NOTICE of Motion by Angela M. Liu for presentment of motion for miscellaneous relief #541 before Honorable Harry D. Leinenweber on 9/10/2020 at 09:30 AM. (Liu, Angela)
April 15, 2020 Opinion or Order Filing 542 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. Memorandum of Law in Support of Motion to Exclude the Opinion and Proposed Testimony of James Bruno (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11, #13 Exhibit 12)(Allon, Devora)
April 15, 2020 Opinion or Order Filing 541 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. To Partially Exclude the Opinions and Proposed Testimony of Glen Belvis (Attachments: #1 Text of Proposed Order)(Liu, Angela)
April 15, 2020 Opinion or Order Filing 540 NOTICE of Motion by Julia Chapman for presentment of motion for summary judgment #539 before Honorable Harry D. Leinenweber on 9/10/2020 at 09:30 AM. (Chapman, Julia)
April 15, 2020 Opinion or Order Filing 539 MOTION by Defendants Penwest Pharmaceuticals Co., Impax Laboratories, Inc., Endo Pharmaceuticals Inc., Endo Health Solutions Inc. for summary judgment (Causation/Damages) (Attachments: #1 Text of Proposed Order)(Chapman, Julia)
April 15, 2020 Opinion or Order Filing 538 NOTICE of Motion by Devora Whitman Allon for presentment of motion for miscellaneous relief, #537 before Honorable Harry D. Leinenweber on 9/10/2020 at 09:30 AM. (Allon, Devora)
April 15, 2020 Opinion or Order Filing 537 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. To Exclude The Opinions and Proposed Testimony of James Bruno (Attachments: #1 Text of Proposed Order)(Allon, Devora)
April 15, 2020 Opinion or Order Filing 536 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. (Attachments: #1 Exhibit 26, #2 Exhibit 27, #3 Exhibit 28, #4 Exhibit 29, #5 Exhibit 30, #6 Exhibit 31, #7 Exhibit 32, #8 Exhibit 33, #9 Exhibit 34, #10 Exhibit 35, #11 Exhibit 36, #12 Exhibit 37, #13 Exhibit 38, #14 Exhibit 39, #15 Exhibit 40, #16 Exhibit 41, #17 Exhibit 42, #18 Exhibit 43, #19 Exhibit 44, #20 Exhibit 45, #21 Exhibit 46)(Liu, Angela)
April 15, 2020 Opinion or Order Filing 535 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. (Attachments: #1 Rule 56.1 Statement, #2 Appendix of Exhibits to Rule 56.1 Statement, #3 Exhibit 1, #4 Exhibit 2, #5 Exhibit 3, #6 Exhibit 4, #7 Exhibit 5, #8 Exhibit 6, #9 Exhibit 7, #10 Exhibit 8, #11 Exhibit 9, #12 Exhibit 10, #13 Exhibit 11, #14 Exhibit 12, #15 Exhibit 13, #16 Exhibit 14, #17 Exhibit 15, #18 Exhibit 16, #19 Exhibit 17, #20 Exhibit 18, #21 Exhibit 19, #22 Exhibit 20, #23 Exhibit 21, #24 Exhibit 22, #25 Exhibit 23, #26 Exhibit 24, #27 Exhibit 25)(Liu, Angela)
April 15, 2020 Opinion or Order Filing 534 SEALED DOCUMENT by Plaintiff (Direct Purchaser and End-Payor) Declaration of Andrew C. Curley in Support of Plaintiffs' Motions (ECF Nos. 519-528) to Exclude Various Expert Opinions (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19, #20 Exhibit 20, #21 Exhibit 21, #22 Exhibit 22, #23 Exhibit 23, #24 Exhibit 24, #25 Exhibit 25 - Part 1, #26 Exhibit 25 - Part 2, #27 Exhibit 25 - Part 3, #28 Exhibit 25 - Part 4, #29 Exhibit 25 - Part 5, #30 Exhibit 26, #31 Exhibit 27, #32 Exhibit 28, #33 Exhibit 29, #34 Exhibit 30, #35 Exhibit 31, #36 Exhibit 32, #37 Exhibit 33, #38 Exhibit 34, #39 Exhibit 35, #40 Exhibit 36, #41 Exhibit 37, #42 Exhibit 38, #43 Exhibit 39, #44 Exhibit 40, #45 Exhibit 41, #46 Exhibit 42, #47 Exhibit 43, #48 Exhibit 44, #49 Exhibit 45, #50 Exhibit 46, #51 Exhibit 47, #52 Exhibit 48, #53 Exhibit 49, #54 Exhibit 50, #55 Exhibit 51, #56 Exhibit 52, #57 Exhibit 53, #58 Exhibit 54, #59 Exhibit 55, #60 Exhibit 56, #61 Exhibit 57, #62 Exhibit 58, #63 Exhibit 59, #64 Exhibit 60, #65 Exhibit 61, #66 Exhibit 62, #67 Exhibit 63, #68 Exhibit 64, #69 Exhibit 65, #70 Exhibit 66, #71 Exhibit 67, #72 Exhibit 68, #73 Exhibit 69, #74 Exhibit 70, #75 Exhibit 71, #76 Exhibit 72, #77 Exhibit 73, #78 Exhibit 74, #79 Exhibit 75, #80 Exhibit 76, #81 Exhibit 77, #82 Exhibit 78, #83 Exhibit 79, #84 Exhibit 80, #85 Exhibit 81, #86 Exhibit 82, #87 Exhibit 83, #88 Exhibit 84, #89 Exhibit 85, #90 Exhibit 86, #91 Exhibit 87, #92 Exhibit 88, #93 Exhibit 89, #94 Exhibit 90)(Curley, Andrew)
April 15, 2020 Opinion or Order Filing 533 NOTICE of Motion by Angela M. Liu for presentment of motion for summary judgment #532 before Honorable Harry D. Leinenweber on 9/10/2020 at 09:30 AM. (Liu, Angela)
April 15, 2020 Opinion or Order Filing 532 MOTION by Defendants Penwest Pharmaceuticals Co., Endo Pharmaceuticals Inc., Endo Health Solutions Inc. for summary judgment with respect to certain patent issues (Attachments: #1 Text of Proposed Order)(Liu, Angela)
April 15, 2020 Opinion or Order Filing 531 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. Memorandum of Law in Support of Motion To Partially Exclude the Opinions and Proposed Testimony of Dr. Jeffrey Leitzinger (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10)(Liu, Angela)
April 15, 2020 Opinion or Order Filing 530 NOTICE of Motion by Angela M. Liu for presentment of motion for miscellaneous relief, #529 before Honorable Harry D. Leinenweber on 9/10/2020 at 09:30 AM. (Liu, Angela)
April 15, 2020 Opinion or Order Filing 529 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. To Partially Exclude the Opinions and Proposed Testimony of Dr. Jeffrey Leitzinger (Attachments: #1 Text of Proposed Order)(Liu, Angela)
April 15, 2020 Opinion or Order Filing 528 SEALED MOTION by Plaintiff (Direct Purchaser and End-Payor) Plaintiffs' Daubert Motion to Exclude the Expert Opinion of Dr. Louis Berneman Regarding "Fair Value" (Curley, Andrew)
April 15, 2020 Opinion or Order Filing 527 SEALED MOTION by Plaintiff (Direct Purchaser and End-Payor) Plaintiffs' Daubert Motion to Exclude the Expert Opinions of Dr. Jody L. Green (Curley, Andrew)
April 15, 2020 Opinion or Order Filing 526 SEALED MOTION by Plaintiff (Direct Purchaser and End-Payor) Plaintiffs' Daubert Motion to Exclude Certain Opinions of Dr. Sumanth Addanki (Curley, Andrew)
April 15, 2020 Opinion or Order Filing 525 SEALED MOTION by Plaintiff (Direct Purchaser and End-Payor) Plaintiffs' Daubert Motion to Exclude Certain Expert Opinions of Dr. Christopher J. Gilligan (Curley, Andrew)
April 15, 2020 Opinion or Order Filing 524 SEALED MOTION by Plaintiff (Direct Purchaser and End-Payor) Plaintiffs' Daubert Motion to Exclude One of the Opinions of Dr. Reza Fassihi (Curley, Andrew)
April 15, 2020 Opinion or Order Filing 523 SEALED MOTION by Plaintiff (Direct Purchaser and End-Payor) Plaintiffs' Daubert Motion to Exclude Certain Expert Opinions Concerning Patents and Lawsuits That Post-Date the Challenged Reverse Payment Agreement (Curley, Andrew)
April 15, 2020 Opinion or Order Filing 522 SEALED MOTION by Plaintiff (Direct Purchaser and End-Payor) Plaintiffs' Daubert Motion to Exclude One of the Opinions of Dr. Anthony Lowman (Curley, Andrew)
April 15, 2020 Opinion or Order Filing 521 SEALED MOTION by Plaintiff (Direct Purchaser and End-Payor) Plaintiffs' Daubert Motion to Exclude Certain Opinions of Mr. Anthony Figg (Curley, Andrew)
April 15, 2020 Opinion or Order Filing 520 SEALED MOTION by Plaintiff (Direct Purchaser and End-Payor) Plaintiffs' Daubert Motion to Exclude Certain Opinions of Mr. Jonathan Singer (Curley, Andrew)
April 15, 2020 Opinion or Order Filing 519 SEALED MOTION by Plaintiff (Direct Purchaser and End-Payor) Plaintiffs' Daubert Motion to Exclude the Opinions of Dr. Nita Patel (Curley, Andrew)
April 15, 2020 Opinion or Order Filing 518 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. Memorandum of Law in Support of Defendants' Motion To Exclude the Opinions and Proposed Testimony of Luis A. Molina (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11, #13 Exhibit 12, #14 Exhibit 13, #15 Exhibit 14, #16 Exhibit 15, #17 Exhibit 16)(Liu, Angela)
April 15, 2020 Opinion or Order Filing 517 NOTICE of Motion by Angela M. Liu for presentment of motion for miscellaneous relief, #516 before Honorable Harry D. Leinenweber on 9/10/2020 at 09:30 AM. (Liu, Angela)
April 15, 2020 Opinion or Order Filing 516 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. To Exclude the Opinions and Proposed Testimony of Luis A. Molina (Attachments: #1 Text of Proposed Order)(Liu, Angela)
April 15, 2020 Opinion or Order Filing 515 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. Memorandum of Law in Support of Defendants' Motion to Partially Exclude the Opinions and Proposed Testimony of Janet K. DeLeon (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11, #13 Exhibit 12)(Liu, Angela)
April 15, 2020 Opinion or Order Filing 514 NOTICE of Motion by Angela M. Liu for presentment of motion for miscellaneous relief, #513 before Honorable Harry D. Leinenweber on 9/10/2020 at 09:30 AM. (Liu, Angela)
April 15, 2020 Opinion or Order Filing 513 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. To Partially Exclude the Opinions and Proposed Testimony of Janet K. DeLeon (Attachments: #1 Text of Proposed Order)(Liu, Angela)
April 15, 2020 Opinion or Order Filing 512 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. Memorandum of Law in Support of Motion to Exclude The Opinions and Proposed Testimony of John R. Tupman, Jr. (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5)(Liu, Angela)
April 15, 2020 Opinion or Order Filing 511 NOTICE of Motion by Angela M. Liu for presentment of motion for miscellaneous relief, #510 before Honorable Harry D. Leinenweber on 9/10/2020 at 09:30 AM. (Liu, Angela)
April 15, 2020 Opinion or Order Filing 510 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. To Exclude The Opinions and Proposed Testimony of John R. Tupman, Jr. (Attachments: #1 Text of Proposed Order)(Liu, Angela)
April 14, 2020 Opinion or Order Filing 509 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-16931576. (Rhoad, Robert)
April 14, 2020 Opinion or Order Filing 508 ORDER: Pro hac vice motion is granted #507 . Signed by the Honorable Harry D. Leinenweber on 4/14/2020. Mailed notice (aee, )
April 13, 2020 Opinion or Order Filing 507 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-16929262. (Gagliardi, Sharon)
March 30, 2020 Opinion or Order Filing 506 ORDER Seconded Amended General Order 20-0012 IN RE: CORONAVIRUS COVID-19 PUBLIC EMERGENCY Signed by the Chief Judge Rebecca R. Pallmeyer on March 30, 2020. All open cases are impacted by this Second Amended General Order. Amended General Order 20-0012, entered on March 17, 2020, and General Order 20-0014, entered on March 20, 2020, are vacated and superseded by this Second Amended General. See attached Order for guidance.Signed by the Honorable Rebecca R. Pallmeyer on 3/30/2020: Mailed notice. (docket5, )
March 18, 2020 Opinion or Order Filing 505 Notice of Supplemental Authority in Support of Motion for Class Certification by End-Payor Plaintiffs (Attachments: #1 Exhibit A, #2 Exhibit B)(Freed, Michael)
March 16, 2020 Opinion or Order Filing 504 ORDER Amended General Order 20-0012 IN RE: CORONAVIRUS COVID-19 PUBLIC EMERGENCY Signed by the Chief Judge Rebecca R. Pallmeyer on March 16, 2020. All open cases are impacted by this Amended General Order. See attached Order for guidance.Signed by the Honorable Rebecca R. Pallmeyer on 3/16/2020: Mailed notice. (docket1, )
February 25, 2020 Opinion or Order Filing 503 Notice of Supplemental Authority in Support of Motions for Class Certification by (Direct Purchaser and End-Payor) (Attachments: #1 Exhibit A (7th Circuit Order))(Freed, Michael)
February 18, 2020 Opinion or Order Filing 502 ORDER: Pro hac vice motion is granted #498 . Signed by the Honorable Harry D. Leinenweber on 2/18/2020. Mailed notice (aee, )
February 18, 2020 Opinion or Order Filing 501 Enter modified scheduling order. Jury Trial set for 3/15/21 at 10:00 AM. Pretrial Conference set for 3/11/21 at 10:30 AM. Signed by the Honorable Harry D. Leinenweber on 2/18/20: Mailed notice(maf)
February 18, 2020 Opinion or Order Filing 500 Enter stipulated order concerning page limits. Signed by the Honorable Harry D. Leinenweber on 2/18/2020: Mailed notice(maf)
February 12, 2020 Opinion or Order Filing 499 STIPULATION CONCERNING PAGE LIMITS [PROPOSED] (Falls, Craig)
February 10, 2020 Opinion or Order Filing 498 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-16711534. (Blacklock, Evelyn)
February 10, 2020 Opinion or Order Filing 497 ATTORNEY Appearance for Defendant Impax Laboratories, Inc. by James R.P. Hileman (Hileman, James)
February 7, 2020 Opinion or Order Filing 496 RESPONSE by Plaintiff End-Payor Plaintiffs to sealed document #485 (PUBLIC VERSION) (Attachments: #1 Ex. A (Response to Proposed Surreply) & Ex. A-1 (Craft Deposition Excerpts))(Freed, Michael)
February 6, 2020 Opinion or Order Filing 495 RESPONSE by Plaintiff Direct Purchaser Plaintiffs to sealed document #485 Direct Purchaser Class Plaintiffs' Opposition To Defendants' Motion For Leave To File A Surreply Brief In Opposition To Direct Purchaser Plaintiffs' Motion For Class Certification And To Schedule Class Certification Hearing [PUBLIC VERSION] (Attachments: #1 Exhibit Exhibit A (Response to Proposed Surreply- public version), #2 Exhibit 55 (public version))(Gerstein, Bruce)
February 5, 2020 Opinion or Order Filing 494 MINUTE entry before the Honorable Harry D. Leinenweber: The previous order declining the Motion to Modify Case Schedule #487 was entered in error. The parties' Motion to Modify Case Schedule #487 is granted and the schedule will be adopted as proposed by the parties. The Court declines to schedule a hearing on class certification, and will rule by mail on the parties' class certification motions. Mailed notice(maf)
February 4, 2020 Opinion or Order Filing 493 MINUTE entry before the Honorable Harry D. Leinenweber: Defendants' Motion for Leave to File Surreply [485, 492] is granted. The Court will take Defendants' Surreply #485 and Plaintiffs' Response #490 under advisement. The parties shall file no further briefing related to class certification unless the Court so orders. Further, Defendants' Motion to Modify Case Schedule #487 is denied. The case will proceed as originally scheduled. Mailed notice(maf)
January 31, 2020 Opinion or Order Filing 492 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. for leave to file Surreply Briefs in Opposition to Plaintiffs' Motions for Class Certification and to Schedule Class Certification Hearing [PUBLIC VERSION] (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Text of Proposed Order)(Liu, Angela)
January 29, 2020 Opinion or Order Filing 491 MINUTE entry before the Honorable Harry D. Leinenweber: Status hearing set for 2/12/20 is vacated. The Court will rule by mail re: MOTION by Defendants To Modify Case Schedule #487 . No appearance is needed on 2/5/20. Mailed notice(maf)
January 24, 2020 Opinion or Order Filing 490 SEALED RESPONSE by Direct Purchaser Plaintiffs to sealed document #485 (Attachments: #1 Exhibit A (Response to Proposed Surreply), #2 Exhibit 55)(Curley, Andrew)
January 24, 2020 Opinion or Order Filing 489 SEALED DOCUMENT by Plaintiff End-Payor Plaintiffs [Response to ECF No. 485] (Attachments: #1 Ex. A (Response to Proposed Surreply) & Ex. A-1 (Craft Deposition Excerpts))(Freed, Michael)
January 17, 2020 Opinion or Order Filing 488 NOTICE of Motion by Angela M. Liu for presentment of motion for miscellaneous relief #487 before Honorable Harry D. Leinenweber on 2/5/2020 at 09:30 AM. (Liu, Angela)
January 17, 2020 Opinion or Order Filing 487 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. To Modify Case Schedule (Attachments: #1 Text of Proposed Order)(Liu, Angela)
January 17, 2020 Opinion or Order Filing 486 NOTICE of Motion by Angela M. Liu for presentment of (Liu, Angela)
January 17, 2020 Opinion or Order Filing 485 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Text of Proposed Order)(Liu, Angela)
January 15, 2020 Opinion or Order Filing 484 NOTICE by David Lesht of Change of Address (Lesht, David)
January 15, 2020 Opinion or Order Filing 483 Notice of Supplmental Authority in Support of Motions for Class Certification by (Direct Purchaser and End-Payor) (Attachments: #1 Exhibit A)(Freed, Michael)
January 9, 2020 Opinion or Order Filing 482 MINUTE entry before the Honorable Harry D. Leinenweber: If Defendants wish to file a motion for leave to file a surreply, they must do so on or before 1/17/20. If Defendants file such a motion, Plaintiffs shall respond on or before 1/24/20. The Court will rule by mail. No appearance is needed. Mailed notice(maf)
December 30, 2019 Opinion or Order Filing 481 ORDER: Pro hac vice motions are granted #470 , #471 , #477 . Motion to withdraw attorney is granted #480 . Signed by the Honorable Harry D. Leinenweber on 12/30/2019. Mailed notice (aee, )
December 20, 2019 Opinion or Order Filing 480 MOTION to withdraw as attorney for Impax Laboratories, Inc.. No party information provided (Baldridge, James)
December 20, 2019 Opinion or Order Filing 479 RESPONSE by Plaintiff (Direct Purchaser and End-Payor) to other #478 [Response to Defendants' Notice of Intent to Move for Leave to File Surreplies in Opposition to Class Certification] (Freed, Michael)
December 19, 2019 Opinion or Order Filing 478 Notice of Intent to Move for Leave to File Surreplies by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. (Falls, Craig)
November 26, 2019 Opinion or Order Filing 477 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-16480135. (Chapman, Julia)
November 25, 2019 Opinion or Order Filing 476 MINUTE entry before the Honorable Harry D. Leinenweber: Status hearing set for 12/12/19 is re-set to 2/12/20 at 9:00 a.m. Mailed notice(maf)
November 21, 2019 Opinion or Order Filing 475 ATTORNEY Appearance for Defendant Impax Laboratories, Inc. by Jay P. Lefkowitz (Lefkowitz, Jay)
November 21, 2019 Opinion or Order Filing 474 ATTORNEY Appearance for Defendant Impax Laboratories, Inc. by Devora Whitman Allon (Allon, Devora)
November 20, 2019 Opinion or Order Filing 473 REPLY by Plaintiff End-Payor Plaintiffs to motion to certify class #438 PUBLIC VERSION (Attachments: #1 Index of Exhibits with Exhibits A-J [PUBLIC VERSION])(Freed, Michael)
November 19, 2019 Opinion or Order Filing 472 REPLY by Direct Purchaser Plaintiffs to SEALED MOTION by Plaintiff Direct Purchaser Plaintiffs memorandum in support of motion for class certification #437 PUBLIC VERSION (Attachments: #1 Affidavit Declaration of Andrew C. Curley - PUBLIC VERSION, #2 Exhibit 49, #3 Exhibit 50, #4 Exhibit 51, #5 Exhibit 52, #6 Exhibit 53, #7 Exhibit 54)(Gerstein, Bruce)
November 15, 2019 Opinion or Order Filing 471 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-16442353. (Attachments: #1 Exhibit A - Addendum)(Lefkowitz, Jay)
November 15, 2019 Opinion or Order Filing 470 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-16442336. (Attachments: #1 Exhibit A - Addendum)(Allon, Devora)
November 5, 2019 Opinion or Order Filing 469 SEALED REPLY by End-Payor Plaintiffs to MOTION by Plaintiff End-Payor Plaintiffs to certify class #438 (Attachments: #1 Index of Exhibits with Exhibits A-J)(Freed, Michael)
November 5, 2019 Opinion or Order Filing 468 SEALED REPLY by Direct Purchaser Plaintiffs to SEALED MOTION by Plaintiff Direct Purchaser Plaintiffs memorandum in support of motion for class certification #437 (Attachments: #1 Declaration of Andrew C. Curley, #2 Exhibit 49, #3 Exhibit 50, #4 Exhibit 51, #5 Exhibit 52, #6 Exhibit 53, #7 Exhibit 54)(Curley, Andrew)
October 16, 2019 Opinion or Order Filing 467 TRANSCRIPT OF PROCEEDINGS held on 10-9-19 before the Honorable Harry D. Leinenweber. Order Number: 36360. Court Reporter Contact Information: KRISTA BURGESON, krista_burgeson@ilnd.uscourts.gov, 312-435-5567. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 11/6/2019. Redacted Transcript Deadline set for 11/18/2019. Release of Transcript Restriction set for 1/14/2020. (Burgeson, Krista)
October 11, 2019 Opinion or Order Filing 466 NOTICE by Natalie Finkelman Bennett of Change of Address (Bennett, Natalie)
October 9, 2019 Opinion or Order Filing 465 MINUTE entry before the Honorable Harry D. Leinenweber: Ruling on motion hearing held. SEALED MOTION by Defendant Impax Laboratories, Inc. for Entry of Protective Order Precluding Plaintiffs from Using Martin Lessem as an Expert #460 is denied. Mailed notice(maf)
October 8, 2019 Opinion or Order Filing 464 SEALED RESPONSE by (Direct Purchaser and End-Payor) to SEALED MOTION by Defendant Impax Laboratories, Inc. Defendants' Motion for Entry of Protective Order Precluding Plaintiffs from Using Martin Lessem as an Expert #460 (Attachments: #1 Exhibit 1 (Interrogatory Response), #2 Exhibit 2 (Dep. Tr. Excerpts), #3 Exhibit 3 (Declaration), #4 Exhibit 4 (Email and agreement), #5 Exhibit 5 (Redacted document))(Maas, Thomas)
October 7, 2019 Opinion or Order Filing 463 ATTORNEY Appearance for Plaintiff Plumbers & Pipefitters Local 178 Health & Welfare Trust Fund by Kimberly Ann Justice (Justice, Kimberly)
October 7, 2019 Opinion or Order Filing 462 MINUTE entry before the Honorable Harry D. Leinenweber: Defendants' Motion for Entry of Protective Order Precluding Plaintiffs from Using Martin Lessem as an Expert #460 set for 10/9/19 at 9:30 a.m. will be heard on 10/9/19 at 9:15 a.m. Mailed notice(maf)
October 3, 2019 Opinion or Order Filing 461 NOTICE of Motion by James Douglas Baldridge for presentment of Sealed motion, #460 before Honorable Harry D. Leinenweber on 10/9/2019 at 09:30 AM. (Baldridge, James)
October 3, 2019 Opinion or Order Filing 460 SEALED MOTION by Defendant Impax Laboratories, Inc. Defendants' Motion for Entry of Protective Order Precluding Plaintiffs from Using Martin Lessem as an Expert (Attachments: #1 Exhibit A-M, #2 Text of Proposed Order)(Baldridge, James)
September 26, 2019 Opinion or Order Filing 459 WITHDRAWING Ryan J. McEwan as counsel for Plaintiff Kim Mahaffay and substituting Joseph R. Saveri as counsel of record (Saveri, Joseph)
September 12, 2019 Opinion or Order Filing 458 MEMORANDUM by Impax Laboratories, Inc. in Opposition to motion to certify class #438 [PUBLIC VERSION] (Attachments: #1 Declaration)(Baldridge, James)
September 12, 2019 Opinion or Order Filing 457 MEMORANDUM by Endo Pharmaceuticals Inc. in Opposition to Sealed motion,,,, #437 [PUBLIC VERSION] (Attachments: #1 Exhibit)(Liu, Angela)
September 11, 2019 Opinion or Order Filing 456 STATUS Report (Joint) by Direct Purchaser Plaintiffs (Curley, Andrew)
September 9, 2019 Opinion or Order Filing 455 MINUTE entry before the Honorable Harry D. Leinenweber: Motion to withdraw as attorney #453 is granted. Mailed notice(maf)
September 5, 2019 Opinion or Order Filing 454 NOTICE of Motion by Thomas Arthur Doyle for presentment of motion to withdraw as attorney #453 before Honorable Harry D. Leinenweber on 9/12/2019 at 09:30 AM. (Doyle, Thomas)
September 5, 2019 Opinion or Order Filing 453 MOTION by Attorney Thomas A Doyle to withdraw as attorney for End-Payor Plaintiffs. No party information provided (Doyle, Thomas)
September 3, 2019 Opinion or Order Filing 452 MINUTE entry before the Honorable Harry D. Leinenweber: By agreement, the 9/5/19 status hearing is vacated. Status hearing set for 12/12/19 at 9:00 a.m. to stand. Mailed notice(maf)
August 29, 2019 Opinion or Order Filing 451 SEALED RESPONSE by Impax Laboratories, Inc. to sealed document, #439 , MOTION by Plaintiff End-Payor Plaintiffs to certify class #438 Defendants Memorandum of Law in Opposition to End-Payor Plaintiffs Motion for Class Certification (Attachments: #1 Declaration and Exhibits in support of Defendants' Memorandum of Law Opposing EPP Class Certification)(Baldridge, James)
August 29, 2019 Opinion or Order Filing 450 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. Defendants Memorandum of Law in Opposition to Direct Purchaser Plaintiffs Motion for Class Certification (Attachments: #1 Declaration and Exhibits in support of Defendants Memorandum of Law Opposing DPP Class Certification)(Liu, Angela)
July 30, 2019 Opinion or Order Filing 449 ORDER: Pro hac vice motion is granted #440 . Signed by the Honorable Harry D. Leinenweber on 7/30/2019. Mailed notice (aee, )
July 30, 2019 Opinion or Order Filing 448 Enter stipulated amended scheduling order. Signed by the Honorable Harry D. Leinenweber on 7/30/19:Mailed notice(maf)
July 18, 2019 Opinion or Order Filing 447 NOTICE by CVS Pharmacy, Inc., Rite Aid Corporation, Rite Aid Hdqtrs. Corp. Maureen S. Lawrence Withdrawal of Appearance (Lawrence, Maureen)
July 10, 2019 Opinion or Order Filing 446 WITHDRAWING Morgan J. Feder as counsel for Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. and substituting Angela M. Liu as counsel of record (Liu, Angela)
July 2, 2019 Opinion or Order Filing 445 WITHDRAWING Miranda Y. Jones as counsel for Plaintiff Value Drug Company and substituting Russell A. Chorush as counsel of record (Chorush, Russell)
May 14, 2019 Opinion or Order Filing 444 SEALED RESPONSE by Direct Purchaser Plaintiffs to Response #443 Exhibit 1 (Curley, Andrew)
May 14, 2019 Opinion or Order Filing 443 RESPONSE by Plaintiff Direct Purchaser Plaintiffs to other #386 DEFENDANTS NOTICE OF RELEVANT AUTHORITY (Attachments: #1 Exhibit)(Curley, Andrew)
April 9, 2019 Opinion or Order Filing 442 MEMORANDUM by Direct Purchaser Plaintiffs in support of Sealed motion,,,, #437 PUBLIC VERSION (Attachments: #1 Public Version of Declaration of Andrew C. Curley in Support of DPCP's Motion for Class Certification w. Exhibits)(Gerstein, Bruce)
April 8, 2019 Opinion or Order Filing 441 MEMORANDUM by End-Payor Plaintiffs in support of motion to certify class #438 PUBLIC REDACTED VERSION (Attachments: #1 Declaration of Michael J. Freed in Support of End-Payor Plaintiffs' Motion for Class Certification with Exhibits 1-16))(Freed, Michael)
April 2, 2019 Opinion or Order Filing 440 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-15661081. (Coslett, Caitlin) Modified on 4/2/2019 (bg, ).
March 25, 2019 Opinion or Order Filing 439 SEALED DOCUMENT by Plaintiff End-Payor Plaintiffs Memorandum of Law in Support of their Motion for Class Certification (Attachments: #1 Declaration of Michael J. Freed in Support of End-Payor Plaintiffs' Motion for Class Certification with Exhibits 1-16)(Freed, Michael)
March 25, 2019 Opinion or Order Filing 438 MOTION by Plaintiff End-Payor Plaintiffs to certify class Responses due by 8/8/2019 (Freed, Michael)
March 25, 2019 Opinion or Order Filing 437 SEALED MOTION by Plaintiff Direct Purchaser Plaintiffs memorandum in support of motion for class certification (Attachments: #1 Declaration, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11, #13 Exhibit 12, #14 Exhibit 13, #15 Exhibit 14, #16 Exhibit 15, #17 Exhibit 16, #18 Exhibit 17, #19 Exhibit 18, #20 Exhibit 19, #21 Exhibit 20, #22 Exhibit 21, #23 Exhibit 22, #24 Exhibit 23, #25 Exhibit 24, #26 Exhibit 25, #27 Exhibit 26, #28 Exhibit 27, #29 Exhibit 28, #30 Exhibit 29, #31 Exhibit 30, #32 Exhibit 31, #33 Exhibit 32, #34 Exhibit 33, #35 Exhibit 34, #36 Exhibit 35, #37 Exhibit 36, #38 Exhibit 37, #39 Exhibit 38, #40 Exhibit 39, #41 Exhibit 40, #42 Exhibit 41, #43 Exhibit 42, #44 Exhibit 43, #45 Exhibit 44, #46 Exhibit 45, #47 Exhibit 46, #48 Exhibit 47, #49 Errata 48)(Curley, Andrew)
March 25, 2019 Opinion or Order Filing 436 MOTION by Plaintiff Direct Purchaser Plaintiffs to certify class Responses due by 8/8/2019 (Attachments: #1 Text of Proposed Order, #2 Proposed Trial Plan)(Curley, Andrew)
March 18, 2019 Opinion or Order Filing 435 Enter stipulated order concerning class cert briefing page limits. Signed by the Honorable Harry D. Leinenweber on 3/18/2019:Mailed notice(maf)
February 8, 2019 Opinion or Order Filing 434 ORDER: Pro hac vice motion is granted #429 . Signed by the Honorable Harry D. Leinenweber on 2/8/2019. Mailed notice. (bg, )
February 8, 2019 Opinion or Order Filing 433 For the foregoing reasons, Plaintiff's Motion to Compel (Dkt No. 417) is granted. Status hearing/ruling set for 2/12/19 is vacated. No appearance is needed. Signed by the Honorable Harry D. Leinenweber on 2/8/2019:Mailed notice(maf)
February 6, 2019 Opinion or Order Filing 432 Enter stipulated amended scheduling order. Signed by the Honorable Harry D. Leinenweber on 2/6/2019:Mailed notice(maf)
January 29, 2019 Opinion or Order Filing 431 NOTICE by John Angelo Macoretta of Change of Address for Spector Roseman & Kodroff PC (Macoretta, John)
January 23, 2019 Opinion or Order Filing 430 Notice of Change of Firm Affiliation by Meijer Distribution, Inc., Meijer, Inc., Opana ER Antitrust Litigation (Vanek, Joseph)
January 14, 2019 Opinion or Order Filing 429 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-15366798. (Dugan, ii, James)
January 11, 2019 Opinion or Order Filing 428 REPLY by End-Payor Plaintiffs to memorandum in opposition to motion #426 and in Further Support of Motion to Compel (ECF No. 417) (Attachments: #1 Declaration of Robert J. Wozniak & Exhibits 1-3)(Wozniak, Robert)
January 11, 2019 Opinion or Order Filing 427 WITHDRAWING Chad Preimeaux as counsel for Plaintiff End-Payor Plaintiffs and substituting James R. Dugan, ii as counsel of record (Dugan, ii, James)
January 4, 2019 Opinion or Order Filing 426 MEMORANDUM by Express Scripts Holding Company in Opposition to motion to compel #417 (Attachments: #1 Declaration of Adriana Riviere-Badell, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4)(Mandel, Jay)
December 17, 2018 Opinion or Order Filing 425 MINUTE entry before the Honorable Harry D. Leinenweber: The Court's 12/14/2018 order is amended as follows: Plaintiff's motion to compel #417 is entered and briefed as follows: response by 1/4/19, reply by 1/11/19. Status hearing/ruling is set for 2/12/19 at 9:00 a.m. Mailed notice (maf)
December 14, 2018 Opinion or Order Filing 424 ORDER: Pro hac vice motions are granted #421 , #422 . Plaintiff's motion to compel #417 is entered and briefed as follows: response by 1/3/19, reply by 1/11/19. Status hearing/ruling is set for 2/12/19 at 9:00 a.m. No appearance is needed on 1/15/19. Signed by the Honorable Harry D. Leinenweber on 12/14/2018. Mailed notice (aee, )
December 14, 2018 Opinion or Order Filing 423 STIPULATION and Order. Signed by the Honorable Harry D. Leinenweber on 12/14/2018:Mailed notice(maf)
December 12, 2018 Opinion or Order Filing 422 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-15271151. (Montas, Alana)
December 12, 2018 Opinion or Order Filing 421 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-15270949. (Attachments: #1 Exhibit A)(Riviere-Badell, Adriana)
December 12, 2018 Opinion or Order Filing 420 Amended NOTICE of Motion by Robert J. Wozniak for presentment of motion to compel #417 before Honorable Harry D. Leinenweber on 1/15/2019 at 09:30 AM. (Wozniak, Robert)
December 12, 2018 Opinion or Order Filing 419 ATTORNEY Appearance for Unknown Express Scripts Holding Company by Jay Yair Mandel (Mandel, Jay)
December 7, 2018 Opinion or Order Filing 418 NOTICE of Motion by Robert J. Wozniak for presentment of motion to compel #417 before Honorable Harry D. Leinenweber on 12/13/2018 at 09:30 AM. (Wozniak, Robert)
December 7, 2018 Opinion or Order Filing 417 MOTION by Plaintiff End-Payor Plaintiffs to compel Third Party Express Scripts to Comply with Document Subpoena (Attachments: #1 Exhibit A (Subpoena & Schedule A), #2 Exhibit B (FedEx Delivery Confirmation))(Wozniak, Robert)
December 4, 2018 Opinion or Order Filing 416 STIPULATION AND FOURTH AMENDMENT TO PROTECTIVE ORDER (Liu, Angela)
November 16, 2018 Opinion or Order Filing 415 MINUTE entry before the Honorable Harry D. Leinenweber: Pursuant to the notice of withdrawal, Motion for extension of time to complete discovery #408 is withdrawn. Mailed notice(maf)
November 15, 2018 Opinion or Order Filing 414 NOTICE by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. re MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. for extension of time to complete discovery (Motion to Modify Scheduling Order to Extend Time for Non-Parties to Comply #408 NOTICE OF WITHDRAWAL (Baldridge, James)
November 15, 2018 Opinion or Order Filing 413 Enter stipulation and third amendment to the protective order. Signed by the Honorable Harry D. Leinenweber on 11/15/2018:Mailed notice(maf)
November 14, 2018 Opinion or Order Filing 412 Enter stipulated amended scheduling order. Signed by the Honorable Harry D. Leinenweber on 11/14/2018:Mailed notice(maf)
November 8, 2018 Opinion or Order Filing 411 Second Amended NOTICE of Motion by James Douglas Baldridge for presentment of motion for extension of time to complete discovery, #408 before Honorable Harry D. Leinenweber on 11/27/2018 at 09:30 AM. (Baldridge, James)
November 2, 2018 Opinion or Order Filing 410 Amended NOTICE of Motion by James Douglas Baldridge for presentment of motion for extension of time to complete discovery, #408 before Honorable Harry D. Leinenweber on 11/13/2018 at 09:30 AM. (Baldridge, James)
October 24, 2018 Opinion or Order Filing 409 NOTICE of Motion by James Douglas Baldridge for presentment of motion for extension of time to complete discovery, #408 before Honorable Harry D. Leinenweber on 11/6/2018 at 09:30 AM. (Baldridge, James)
October 24, 2018 Opinion or Order Filing 408 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. for extension of time to complete discovery (Motion to Modify Scheduling Order to Extend Time for Non-Parties to Comply with Defendants' Timely Served Third-Party Subpoenas) (Attachments: #1 Text of Proposed Order)(Baldridge, James)
September 27, 2018 Opinion or Order Filing 405 TRANSCRIPT OF PROCEEDINGS held on 09/25/2018 before the Honorable Harry D. Leinenweber. Order Number: 32300, 32313. Court Reporter Contact Information: Judith A. Walsh, CSR, RDR, F/CRR. Official Court Reporter. judith_walsh@ilnd.uscourts.gov.
September 25, 2018 Opinion or Order Filing 407 STIPULATION AND SECOND AMENDMENT TO PROTECTIVE Order: Signed by the Honorable Harry D. Leinenweber on 9/25/2018. Mailed notice. (Received for docketing 10/15/2018) (bg, )
September 25, 2018 Opinion or Order Filing 406 Status hearing and ruling on motion hearing held. Agreed motion by Plaintiff Mary Davenport to Voluntarily Dismiss With Prejudice #402 is granted. Enter scheduling order. Signed by the Honorable Harry D. Leinenweber on 9/25/2018:Mailed notice(maf)
September 21, 2018 Opinion or Order Filing 404 STATUS Report (Joint) by Impax Laboratories, Inc. (Baldridge, James)
September 21, 2018 Opinion or Order Filing 403 NOTICE of Motion by Michael Jerry Freed for presentment of motion for miscellaneous relief #402 before Honorable Harry D. Leinenweber on 9/25/2018 at 09:00 AM. (Freed, Michael)
September 21, 2018 Opinion or Order Filing 402 MOTION by Plaintiff Mary Davenport to Voluntarily Dismiss With Prejudice [Unopposed] (Freed, Michael)
August 31, 2018 Opinion or Order Filing 401 STIPULATION AND SECOND AMENDMENT TO PROTECTIVE ORDER (Falls, Craig)
August 17, 2018 Opinion or Order Filing 400 TRANSCRIPT OF PROCEEDINGS held on 08/16/2018 before the Honorable Harry D. Leinenweber. Order Number: 31826, 31830. Court Reporter Contact Information: Judith A. Walsh, CSR, RDR, F/CRR. Official Court Reporter. judith_walsh@ilnd.uscourts.gov.
August 17, 2018 Opinion or Order Filing 399 RESPONSE by Plaintiff Direct Purchaser Plaintiffs Plaintiffs' Response to Defendants' Motion for Clarification (ECF No. 393) - Redacted, Public Version #397 (Baxter, James)
August 16, 2018 Opinion or Order Filing 398 MINUTE entry before the Honorable Harry D. Leinenweber: Ruling on motion hearing held. Motions [349, 393] are denied.Mailed notice(maf)
August 14, 2018 Opinion or Order Filing 397 SEALED RESPONSE by Direct Purchaser Plaintiffs to MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. to clarify #393 (Attachments: #1 Exhibit A)(Baxter, James)
August 14, 2018 Opinion or Order Filing 396 MINUTE entry before the Honorable Harry D. Leinenweber: MOTION by Defendants to clarify #393 will be heard on 8/16/18 at 9:00 a.m. Mailed notice(maf)
August 7, 2018 Opinion or Order Filing 395 Joinder by Impax Laboratories, Inc. in Endo Pharmaceuticals' Motion for Clarification (Baldridge, James)
August 7, 2018 Opinion or Order Filing 394 NOTICE of Motion by Craig G. Falls for presentment of motion to clarify #393 before Honorable Harry D. Leinenweber on 8/16/2018 at 09:30 AM. (Falls, Craig)
August 6, 2018 Opinion or Order Filing 393 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. to clarify (Falls, Craig)
August 2, 2018 Opinion or Order Filing 392 Letter by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. From C. Falls to Judge Leinenweber dated August 2, 2018 (Falls, Craig)
August 2, 2018 Opinion or Order Filing 391 TRANSCRIPT OF PROCEEDINGS held on 7/26/2018 before the Honorable Harry D. Leinenweber. Order Number: 31591, 31594, 31607. Court Reporter Contact Information: ALEXANDRA ROTH, alexandra_roth@ilnd.uscourts.gov, (312) 408-5038. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 8/23/2018. Redacted Transcript Deadline set for 9/4/2018. Release of Transcript Restriction set for 10/31/2018. (Roth, Alexandra)
July 26, 2018 Opinion or Order Filing 390 MINUTE entry before the Honorable Harry D. Leinenweber: Motion hearing held on 7/26/2018. For the reasons and in the manner stated on the record, the Court rules as follows: Plaintiffs' Motion to Compel [ECF No. 262] is granted; Plaintiffs' Motion to Compel [ECF No. 283] is granted in part and denied in part; Plaintiffs' Motion to Compel [ECF No. 293] is granted in part and denied in part; Plaintiffs' Motion to Compel [ECF No. 287] is granted in part and denied in part; and Plaintiffs' Motion to Compel [ECF No. 359] is granted in part and denied in part. Plaintiffs' Motion to Compel [ECF No. 349] is entered and continued pending in camera review of the documents at issue. Endo shall provide the documents to the Court on or before 8/2/2018. The Court shall rule on Plaintiffs' Motion to Compel [ECF No. 349] on 8/16/2018 at 9:00 a.m. In accordance with the December 12, 2017 Scheduling Order, fact discovery will close on 10/24/2018. Status hearing set for 9/25/2018 at 9:00 a.m.Mailed notice(maf)
July 25, 2018 Opinion or Order Filing 389 RESPONSE by Defendant Impax Laboratories, Inc. to Sealed motion, #287 (Second Supplemental Response) (Baldridge, James)
July 23, 2018 Opinion or Order Filing 388 RESPONSE by Plaintiffs Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Retailer Plaintiffs to other #386 PLAINTIFFS RESPONSE TO DEFENDANTS NOTICE OF RELEVANT AUTHORITY (Attachments: #1 Index of Exhibits, #2 A - FTC v Lidoderm Stip and Injunction, #3 B - FTC Appeal of Initial Decision)(Asciolla, Gregory)
July 17, 2018 Opinion or Order Filing 387 MINUTE entry before the Honorable Harry D. Leinenweber: Status hearing/ruling set for 7/19/18 is re-set to 7/26/18 at 9:00 a.m. Mailed notice(maf)
July 16, 2018 Opinion or Order Filing 386 DEFENDANTS' NOTICE OF RELEVANT AUTHORITY by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. (Attachments: #1 Exhibit 1)(Liu, Angela)
July 9, 2018 Opinion or Order Filing 385 STATUS Report (Joint) by Impax Laboratories, Inc. (Baldridge, James)
June 25, 2018 Opinion or Order Filing 384 MINUTE entry before the Honorable Harry D. Leinenweber:Motion hearing set for 6/27/2018 is stricken. Defendant Impax Laboratories, Inc.'s motion to withdraw Kenneth R. O'Rourke, Anna Maria Fabish and Stephen McIntyre as its counsel #380 is granted.Mailed notice (clw, )
June 21, 2018 Opinion or Order Filing 383 MINUTE entry before the Honorable Harry D. Leinenweber: By oral motion, Plaintiffs withdrew (1) their Motion to Compel Responses to Interrogatories 15 and 16 from Defendant Endo (ECF No. 372) and, (2) only the portion of Plaintiffs Motion to Compel Testimony Under Fed. R. Civ. P. 30(b)(6) and Interrogatories Response from Defendant Endo (ECF No. 283) seeking Endo's response to Plaintiffs; Interrogatory 11. Plaintiffs did not withdraw the portions of ECF No. 283 seeking an Endo corporate designee for Rule 30(b)(6) Topics 9, 13-21 and Endos response to Plaintiffs' Interrogatory 10. Status hearing/ruling set for 6/27/18 is re-set to 7/19/18 at 9:00 a.m. Mailed notice(maf)
June 20, 2018 Opinion or Order Filing 382 Impax's Supplemental Corporate Disclsoure Statement STATEMENT by Impax Laboratories, Inc. (Baldridge, James)
June 18, 2018 Opinion or Order Filing 381 NOTICE of Motion by Kenneth R. O'rourke for presentment of motion to withdraw as attorney #380 before Honorable Harry D. Leinenweber on 6/27/2018 at 09:30 AM. (O'rourke, Kenneth)
June 18, 2018 Opinion or Order Filing 380 MOTION to withdraw as attorney for Impax Laboratories, Inc.. No party information provided (O'rourke, Kenneth)
June 11, 2018 Opinion or Order Filing 379 SECOND AMENDED NOTICE of Motion by Andrew C. Curley for presentment of Sealed motion #372 before Honorable Harry D. Leinenweber on 6/27/2018 at 09:30 AM. (Curley, Andrew)
June 11, 2018 Opinion or Order Filing 378 MINUTE entry before the Honorable Harry D. Leinenweber: Plaintiff RDC's agreed motion to voluntarily dismiss with prejudice, RDC's complaint against the defendants #375 is granted. No appearance is needed on 6/12/18. Mailed notice(maf)
June 8, 2018 Opinion or Order Filing 377 REPLY by Direct Purchaser Plaintiffs to MOTION by Plaintiff Direct Purchaser Plaintiffs to compel Defendant Impax to Provide Responses to Plaintiffs Interrogatories No. 14 and 15 and to Produce Relevant Documents - PUBLIC VERSION #365 (Gerstein, Bruce)
June 6, 2018 Opinion or Order Filing 376 NOTICE of Motion by Peter R. Kohn for presentment of motion to dismiss #375 before Honorable Harry D. Leinenweber on 6/12/2018 at 09:30 AM. (Kohn, Peter)
June 6, 2018 Opinion or Order Filing 375 MOTION by Plaintiff Rochester Drug Co-Operative, Inc. to dismiss voluntarily (Attachments: #1 Text of Proposed Order)(Kohn, Peter)
June 4, 2018 Opinion or Order Filing 374 Amended NOTICE of Motion by Andrew C. Curley for presentment of Sealed motion #372 before Honorable Harry D. Leinenweber on 6/14/2018 at 09:30 AM. (Curley, Andrew)
May 29, 2018 Opinion or Order Filing 373 NOTICE of Motion by Andrew C. Curley for presentment of Sealed motion #372 before Honorable Harry D. Leinenweber on 6/5/2018 at 09:30 AM. (Curley, Andrew)
May 29, 2018 Opinion or Order Filing 372 SEALED MOTION by Plaintiff Direct Purchaser Plaintiffs to Compel Responses to Interrogatories 15 and 16 from Defendant Endo (Attachments: #1 Exhibit A-M)(Curley, Andrew)
May 25, 2018 Opinion or Order Filing 371 SEALED REPLY by Direct Purchaser Plaintiffs to SEALED MOTION by Plaintiff Direct Purchaser Plaintiffs Motion to Compel Defendant Impax Laboratories, Inc. to Provide Responses to Plaintiffs Interrogatories No. 14 and 15 and to Produce Relevant Documents #359 (Gerstein, Bruce)
May 25, 2018 Opinion or Order Filing 370 MEMORANDUM by Impax Laboratories, Inc. in Opposition to motion to compel, #365 - PUBLIC VERSION (Baldridge, James)
May 24, 2018 Opinion or Order Filing 369 REPLY by Plaintiff Direct Purchaser Plaintiffs IN SUPPORT OF MOTION TO COMPEL DEFENDANT ENDO TO PRODUCE CERTAIN FORECASTING-RELATED DOCUMENTS LISTED ON ENDO'S PRIVILEGE LOG #349 (Public Version) (Curley, Andrew)
May 11, 2018 Opinion or Order Filing 368 SEALED REPLY by Direct Purchaser Plaintiffs to SEALED MOTION by Plaintiff Direct Purchaser Plaintiffs MOTION TO COMPEL DEFENDANT ENDO TO PRODUCE CERTAIN FORECASTING-RELATED DOCUMENTS LISTED ON ENDOS PRIVILEGE LOG #349 (Attachments: #1 Exhibit 1-2)(Curley, Andrew)
May 11, 2018 Opinion or Order Filing 367 SEALED DOCUMENT by Defendant Impax Laboratories, Inc. Opposition to Plaintiffs' Motion to Compel Impax to Provide Responses to Interrogatories 14 and 15 and to Produce Relevant Documents (Attachments: #1 Exhibit Combined Exhibits 1-4)(Baldridge, James)
May 11, 2018 Opinion or Order Filing 366 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. in Opposition to Plaintiffs' Motion to Compel Endo to Produce Privileged Documents (Attachments: #1 Exhibit A, #2 Exhibit B)(Liu, Angela)
May 4, 2018 Opinion or Order Filing 365 MOTION by Plaintiff Direct Purchaser Plaintiffs to compel Defendant Impax to Provide Responses to Plaintiffs Interrogatories No. 14 and 15 and to Produce Relevant Documents - PUBLIC VERSION (Attachments: #1 Exhibit Index of and Exhibits A - I PUBLIC VERSION)(Gerstein, Bruce)
April 27, 2018 Opinion or Order Filing 364 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. (Attachments: #1 Exhibit A, #2 Exhibit B)(Liu, Angela)
April 26, 2018 Opinion or Order Filing 363 ORDER: ENTER STIPULATION AND AMENDMENTS TO PROTECTIVE ORDER. Signed by the Honorable Harry D. Leinenweber on 4/26/2018:Mailed notice(maf)
April 24, 2018 Opinion or Order Filing 362 ORDER: Pro hac vice motions are granted [ #355 , #356 ]. Motion to seal is granted #347 . Parties do not need to seek future leave to file documents under seal. Leave is granted to file all future documents under seal. Motions to Compel [ECF Nos. #359 , #361 ] are entered and briefed as follows: response by 5/11/18, reply by 5/25/18. Ruling on all pending motions to compel set for 6/27/18 at 9:00 a.m. Signed by the Honorable Harry D. Leinenweber on 4/24/2018. Mailed notice. (bg, )
April 20, 2018 Opinion or Order Filing 361 MOTION by Plaintiff Direct Purchaser Plaintiffs to compel DEFENDANT ENDO TO PRODUCE CERTAIN FORECASTING-RELATED DOCUMENTS LISTED ON ENDO'S PRIVILEGE LOG (PUBLIC VERSION) (Attachments: #1 Exhibit (Public))(Curley, Andrew)
April 20, 2018 Opinion or Order Filing 360 NOTICE of Motion by Bruce E. Gerstein for presentment of Sealed motion, #359 before Honorable Harry D. Leinenweber on 5/1/2018 at 09:30 AM. (Gerstein, Bruce)
April 20, 2018 Opinion or Order Filing 359 SEALED MOTION by Plaintiff Direct Purchaser Plaintiffs Motion to Compel Defendant Impax Laboratories, Inc. to Provide Responses to Plaintiffs Interrogatories No. 14 and 15 and to Produce Relevant Documents (Attachments: #1 Index of and Exhibits A - I)(Gerstein, Bruce)
April 20, 2018 Opinion or Order Filing 358 NOTICE of Motion by Bruce E. Gerstein for presentment of motion to seal #357 before Honorable Harry D. Leinenweber on 5/1/2018 at 09:30 AM. (Gerstein, Bruce)
April 20, 2018 Opinion or Order Filing 357 MOTION by Plaintiff Direct Purchaser Plaintiffs to seal Motion to Compel Defendant Impax Laboratories, Inc. to Provide Responses to Plaintiffs Interrogatories No. 14 and 15 and to Produce Relevant Documents (Gerstein, Bruce)
April 18, 2018 Opinion or Order Filing 356 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-14368139. (McClam, John)
April 18, 2018 Opinion or Order Filing 355 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-14368042. (Attachments: #1 Exhibit A)(Miller, Thomas)
April 17, 2018 Opinion or Order Filing 354 ORDER: Pro hac vice motions are granted [ #343 , #344 , #345 , #346 , #353 ]. Motion to seal is granted #347 . Motion to compel #349 is entered and briefed as follows: response by 4/27/18, reply by 5/11/18. Ruling by mail. No appearance is needed on 4/19/18. Signed by the Honorable Harry D. Leinenweber on 4/17/2018. Mailed notice. (bg, )
April 16, 2018 Opinion or Order Filing 353 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-14355454. (Attachments: #1 Exhibit A)(Falls, Craig)
April 13, 2018 Opinion or Order Filing 352 ATTORNEY Appearance for Plaintiff Value Drug Company by Thomas Jon Maas (Maas, Thomas)
April 10, 2018 Opinion or Order Filing 351 STATUS Report (Joint) by Impax Laboratories, Inc. (Baldridge, James)
April 6, 2018 Opinion or Order Filing 350 NOTICE of Motion by Andrew C. Curley for presentment of Sealed motion #349 before Honorable Harry D. Leinenweber on 4/19/2018 at 09:30 AM. (Curley, Andrew)
April 6, 2018 Opinion or Order Filing 349 SEALED MOTION by Plaintiff Direct Purchaser Plaintiffs MOTION TO COMPEL DEFENDANT ENDO TO PRODUCE CERTAIN FORECASTING-RELATED DOCUMENTS LISTED ON ENDOS PRIVILEGE LOG (Attachments: #1 Exhibit 1-12)(Curley, Andrew)
April 6, 2018 Opinion or Order Filing 348 NOTICE of Motion by Andrew C. Curley for presentment of motion to seal #347 before Honorable Harry D. Leinenweber on 4/19/2018 at 09:30 AM. (Curley, Andrew)
April 6, 2018 Opinion or Order Filing 347 MOTION by Plaintiff Direct Purchaser Plaintiffs to seal Plaintiffs Motion to Compel Defendant Endo to Produce Certain Forecasting-Related Documents Listed on Endos Privilege Log (Curley, Andrew)
March 22, 2018 Opinion or Order Filing 346 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-14268517. (Yeager, Christopher)
March 22, 2018 Opinion or Order Filing 345 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-14266723. (Greenblum, Benjamin)
March 2, 2018 Opinion or Order Filing 344 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-14185194. (Aaron, Schwartz)
March 1, 2018 Opinion or Order Filing 343 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-14178204. (Schmidt, Anne)
February 15, 2018 Opinion or Order Filing 342 ORDER: Pro hac vice motions are granted [ #340 , #341 ]. Signed by the Honorable Harry D. Leinenweber on 2/15/2018. Mailed notice. (bg, )
February 7, 2018 Opinion or Order Filing 341 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-14094569. (Garvey, Karen)
February 7, 2018 Opinion or Order Filing 340 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-14094246. Maureen S. Lawrence for Rite Aid Corp., Rite Aid Hdqtrs. Corp., and CVS Pharmacy, Inc. (Lawrence, Maureen)
February 2, 2018 Opinion or Order Filing 339 REPLY by Direct Purchaser Plaintiffs to Response #338 (Attachments: #1 Exhibit A-B)(Curley, Andrew)
January 30, 2018 Opinion or Order Filing 338 RESPONSE by Defendant Impax Laboratories, Inc. to Sealed motion, #287 (Supplemental Response) (Baldridge, James)
January 25, 2018 Opinion or Order Filing 337 MINUTE entry before the Honorable Harry D. Leinenweber: The Court will enter an order regarding the motions to compel noticed for 1/25/18. No appearance is needed on 1/25/18. Mailed notice(maf)
January 24, 2018 Opinion or Order Filing 336 MINUTE entry before the Honorable Harry D. Leinenweber: Motions to seal [291, 315, 318, 322, 331] are granted. Plaintiff's motion to compel is withdrawn #279 Mailed notice(maf)
January 23, 2018 Opinion or Order Filing 335 ORDER: Pro hac vice motions are granted [ #295 , #326 ]. Signed by the Honorable Harry D. Leinenweber on 1/23/2018. Mailed notice. (bg, )
January 22, 2018 Opinion or Order Filing 334 RESPONSE by Impax Laboratories, Inc.in Opposition to SEALED MOTION by Plaintiff Direct Purchaser Plaintiffs To Compel Testimony Under Fed. R. Civ. P. 30(B)(6) and Interrogatory Responses from Defendant Impax Laboratories Inc. #293 (Public Version of Dkt. 324) (Attachments: #1 Exhibit (Public Version of Combined Exhibits 1-5))(Baldridge, James)
January 18, 2018 Opinion or Order Filing 333 SEALED REPLY by Direct Purchaser Plaintiffs to SEALED MOTION by Plaintiff Direct Purchaser Plaintiffs To Compel Testimony Under Fed. R. Civ. P. 30(B)(6) and Interrogatory Responses from Defendant Impax Laboratories Inc. #293 (Attachments: #1 Combined Exhibits F-J)(Baxter, James)
January 18, 2018 Opinion or Order Filing 332 NOTICE of Motion by James Boone Baxter for presentment of motion to seal document #331 before Honorable Harry D. Leinenweber on 1/25/2018 at 09:30 AM. (Baxter, James)
January 18, 2018 Opinion or Order Filing 331 MOTION by Plaintiff Direct Purchaser Plaintiffs to seal document Plaintiffs' Reply In Support of Motion to Compel (ECF No. 293) (Baxter, James)
January 17, 2018 Opinion or Order Filing 330 NOTICE of Motion by Michael Jerry Freed for presentment of Sealed motion, #293 before Honorable Harry D. Leinenweber on 1/25/2018 at 09:30 AM. (Freed, Michael)
January 17, 2018 Opinion or Order Filing 329 NOTICE of Motion by Michael Jerry Freed for presentment of Sealed motion, #287 before Honorable Harry D. Leinenweber on 1/25/2018 at 09:30 AM. (Freed, Michael)
January 17, 2018 Opinion or Order Filing 328 NOTICE of Motion by Michael Jerry Freed for presentment of Sealed motion #283 before Honorable Harry D. Leinenweber on 1/25/2018 at 09:30 AM. (Freed, Michael)
January 17, 2018 Opinion or Order Filing 327 NOTICE of Motion by Michael Jerry Freed for presentment of Sealed motion, #262 before Honorable Harry D. Leinenweber on 1/25/2018 at 09:30 AM. (Freed, Michael)
January 10, 2018 Opinion or Order Filing 326 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-13991099. (Gately, Caroline)
January 10, 2018 Opinion or Order Filing 325 STATUS Report (Joint) by Direct Purchaser Plaintiffs (Curley, Andrew)
January 8, 2018 Opinion or Order Filing 324 SEALED RESPONSE by Impax Laboratories, Inc. to SEALED MOTION by Plaintiff Direct Purchaser Plaintiffs To Compel Testimony Under Fed. R. Civ. P. 30(B)(6) and Interrogatory Responses from Defendant Impax Laboratories Inc. #293 (Attachments: #1 Exhibit Exhibits 1-5)(Baldridge, James)
January 8, 2018 Opinion or Order Filing 323 NOTICE of Motion by James Douglas Baldridge for presentment of motion to seal #322 before Honorable Harry D. Leinenweber on 1/25/2018 at 09:30 AM. (Baldridge, James)
January 8, 2018 Opinion or Order Filing 322 MOTION by Defendant Impax Laboratories, Inc. to seal Opposition to Plaintiffs' November 27, 2017 Motion to Compel (Baldridge, James)
January 8, 2018 Opinion or Order Filing 321 MINUTE entry before the Honorable Harry D. Leinenweber: By agreement, the joint status report shall be filed by 1/10/18. Mailed notice(maf)
December 20, 2017 Opinion or Order Filing 320 SEALED REPLY by Direct Purchaser Plaintiffs to SEALED MOTION by Plaintiff Direct Purchaser Plaintiffs TO COMPEL TESTIMONY UNDER FED. R. CIV. P. 30(B)(6) AND INTERROGATORY RESPONSES FROM DEFENDANT ENDO #283 (Attachments: #1 Exhibit)(Schwartz, Richard)
December 20, 2017 Opinion or Order Filing 319 NOTICE of Motion by Richard Daniel Schwartz for presentment of motion to seal document #318 before Honorable Harry D. Leinenweber on 1/25/2018 at 09:30 AM. (Schwartz, Richard)
December 20, 2017 Opinion or Order Filing 318 MOTION by Plaintiff Direct Purchaser Plaintiffs to seal document PLAINTIFFS REPLY IN SUPPORT OF MOTION TO COMPEL (ECF NO. 283) (Schwartz, Richard)
December 19, 2017 Opinion or Order Filing 317 SEALED REPLY by Direct Purchaser Plaintiffs to memorandum in opposition to motion #307 , SEALED MOTION by Plaintiff Direct Purchaser Plaintiffs TO COMPEL TESTIMONY AND DOCUMENTS FROM DEFENDANTS ENDO HEALTH SOLUTIONS INC., ENDO PHARMACEUTICALS, INC., AND PENWEST PHARMACEUTICALS INC. (ENDO) AND IMPAX LABORATORIES INC. (IMPAX) #287 , sealed response, #302 and Ex. A (filed under seal) (Gerstein, Bruce)
December 19, 2017 Opinion or Order Filing 316 NOTICE of Motion by Bruce E. Gerstein for presentment of motion to seal #315 before Honorable Harry D. Leinenweber on 1/25/2018 at 09:30 AM. (Gerstein, Bruce)
December 19, 2017 Opinion or Order Filing 315 MOTION by Plaintiff Direct Purchaser Plaintiffs to seal PLAINTIFFS REPLY IN SUPPORT OF MOTION TO COMPEL (ECF NO. 287) TESTIMONY AND DOCUMENTS FROM DEFENDANTS ENDO AND IMPAX (Gerstein, Bruce)
December 19, 2017 Opinion or Order Filing 314 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. in Opposition to Sealed motion #283 (Public Version) (Attachments: #1 Exhibit 1-6)(Liu, Angela)
December 19, 2017 Opinion or Order Filing 313 RESPONSE by Defendant Impax Laboratories, Inc. to motion to compel, #299 (Public Version of Dkt. 302) (Attachments: #1 Exhibit Combined Exhibits 1-8)(Baldridge, James)
December 12, 2017 Opinion or Order Filing 312 Enter Stipulation and Order Amended Schedule Signed by the Honorable Harry D. Leinenweber on 12/12/2017:Mailed notice(wp, )
December 12, 2017 Opinion or Order Filing 311 MINUTE entry before the Honorable Harry D. Leinenweber: Motions for leave to file under seal #300 , #304 are granted. Mailed notice(maf)
December 11, 2017 Opinion or Order Filing 310 MOTION by Plaintiff Direct Purchaser Plaintiffs to compel Testimony Under Fed. R. Civ. P. 30(b)(6) and Interrogatory Responses from Defendant Impax Laboratories Inc. (ECF 293) (Public Version) (Baxter, James)
December 7, 2017 Opinion or Order Filing 309 NOTICE by Direct Purchaser Plaintiffs re MOTION by Plaintiff Direct Purchaser Plaintiffs to compel Compliance with Non-Party Subpoena Decus Tecum Served on Actavis South Atlantic LLC and Actavis Elizabeth LLC #279 NOTICE OF WITHDRAWAL (Caplan, Zachary)
December 7, 2017 Opinion or Order Filing 308 AMENDED NOTICE of Motion by Richard Daniel Schwartz for presentment of Sealed motion, #293 before Honorable Harry D. Leinenweber on 12/20/2017 at 09:30 AM. (Schwartz, Richard)
December 5, 2017 Opinion or Order Filing 307 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. in Opposition to Sealed motion, #287 (Liu, Angela)
December 5, 2017 Opinion or Order Filing 306 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. (Attachments: #1 Exhibit Exhibits 1-6)(Liu, Angela)
December 5, 2017 Opinion or Order Filing 305 NOTICE of Motion by Angela M. Liu for presentment of motion to seal document #304 before Honorable Harry D. Leinenweber on 12/12/2017 at 09:30 AM. (Liu, Angela)
December 5, 2017 Opinion or Order Filing 304 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. to seal document (Liu, Angela)
December 5, 2017 Opinion or Order Filing 303 STIPULATION WITH RESPECT TO PAGE LIMIT (Liu, Angela)
December 5, 2017 Opinion or Order Filing 302 SEALED RESPONSE by Impax Laboratories, Inc. to SEALED MOTION by Plaintiff Direct Purchaser Plaintiffs TO COMPEL TESTIMONY AND DOCUMENTS FROM DEFENDANTS ENDO HEALTH SOLUTIONS INC., ENDO PHARMACEUTICALS, INC., AND PENWEST PHARMACEUTICALS INC. (ENDO) AND IMPAX LABORATORIES INC. (IMPAX) #287 (Attachments: #1 Exhibit Exhibits 1 - 8)(Baldridge, James)
December 5, 2017 Opinion or Order Filing 301 NOTICE of Motion by James Douglas Baldridge for presentment of motion to seal #300 before Honorable Harry D. Leinenweber on 12/19/2017 at 09:30 AM. (Baldridge, James)
December 5, 2017 Opinion or Order Filing 300 MOTION by Defendant Impax Laboratories, Inc. to seal Response to Plaintiffs' November 21, 2017 Motion to Compel (Baldridge, James)
December 5, 2017 Opinion or Order Filing 299 MOTION by Plaintiff Direct Purchaser Plaintiffs to compel TESTIMONY AND DOCUMENTS FROM DEFENDANTS ENDO HEALTH SOLUTIONS INC., ENDO PHARMACEUTICALS, INC., AND PENWEST PHARMACEUTICALS INC. (ENDO) AND IMPAX LABORATORIES INC. (IMPAX) (ECF 287) (public version) (Attachments: #1 Exhibit Public Version)(Gerstein, Bruce)
December 4, 2017 Opinion or Order Filing 298 MOTION by Plaintiff Direct Purchaser Plaintiffs to compel TESTIMONY UNDER FED. R. CIV. P. 30(B)(6) AND INTERROGATORY RESPONSES FROM DEFENDANT ENDO (ECF 281) (public version) (Attachments: #1 Exhibit A-P)(Curley, Andrew)
December 4, 2017 Opinion or Order Filing 297 NOTICE by Monica L. Kiley of Change of Address (Kiley, Monica)
November 28, 2017 Opinion or Order Filing 296 Stipulation and Scheduling Order Signed by the Honorable Harry D. Leinenweber on 11/28/2017:Actavis' response to plaintiffs' motion shall be due 12/6/2017. Plaintiffs' reply to be filed by 12/11/2017. Mailed notice(wp, )
November 28, 2017 Opinion or Order Filing 295 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-13837298. (McCahill, Matthew)
November 27, 2017 Opinion or Order Filing 294 NOTICE of Motion by James Boone Baxter for presentment of Sealed motion, #293 before Honorable Harry D. Leinenweber on 12/12/2017 at 09:30 AM. (Baxter, James)
November 27, 2017 Opinion or Order Filing 293 SEALED MOTION by Plaintiff Direct Purchaser Plaintiffs To Compel Testimony Under Fed. R. Civ. P. 30(B)(6) and Interrogatory Responses from Defendant Impax Laboratories Inc. (Attachments: #1 Exhibit Combined Exhibits A - E)(Baxter, James)
November 27, 2017 Opinion or Order Filing 292 NOTICE of Motion by James Boone Baxter for presentment of motion for miscellaneous relief #291 before Honorable Harry D. Leinenweber on 12/12/2017 at 09:30 AM. (Baxter, James)
November 27, 2017 Opinion or Order Filing 291 MOTION by Plaintiff Direct Purchaser Plaintiffsto seal Plaintiffs' Motion to Compel Testimony and Interrogatory Responses from Defendant Impax Laboratories, Inc. (Baxter, James)
November 27, 2017 Opinion or Order Filing 290 Stipulation and Scheduling Order Signed by the Honorable Harry D. Leinenweber on 11/27/2017: Endo's response to plaintiffs' motion to compel testimony and interrogatory responses to be filed by 12/5/2017.Mailed notice(wp, )
November 27, 2017 Opinion or Order Filing 289 Stipulation and Scheduling Order Signed by the Honorable Harry D. Leinenweber on 11/27/2017:Defendants' response to plaintiffs' motion to compel testimony and interrogatory responses by 12/5/2017.Mailed notice(wp, )
November 21, 2017 Opinion or Order Filing 288 NOTICE of Motion by Bruce E. Gerstein for presentment of Sealed motion, #287 before Honorable Harry D. Leinenweber on 11/28/2017 at 09:30 AM. (Gerstein, Bruce)
November 21, 2017 Opinion or Order Filing 287 SEALED MOTION by Plaintiff Direct Purchaser Plaintiffs TO COMPEL TESTIMONY AND DOCUMENTS FROM DEFENDANTS ENDO HEALTH SOLUTIONS INC., ENDO PHARMACEUTICALS, INC., AND PENWEST PHARMACEUTICALS INC. (ENDO) AND IMPAX LABORATORIES INC. (IMPAX) (Attachments: #1 Exhibit Combined Exhibits A - V)(Gerstein, Bruce)
November 21, 2017 Opinion or Order Filing 286 NOTICE of Motion by Bruce E. Gerstein for presentment of motion to seal, #285 before Honorable Harry D. Leinenweber on 11/28/2017 at 09:30 AM. (Gerstein, Bruce)
November 21, 2017 Opinion or Order Filing 285 MOTION by Plaintiff Direct Purchaser Plaintiffs to seal Plaintiffs Motion to Compel Testimony and Documents from Defendants Endo Health Solutions Inc., Endo Pharmaceuticals, Inc., and Penwest Pharmaceuticals Co. and Impax Laboratories, Inc. (Gerstein, Bruce)
November 20, 2017 Opinion or Order Filing 284 NOTICE of Motion by Andrew C. Curley for presentment of Sealed motion #283 before Honorable Harry D. Leinenweber on 11/28/2017 at 09:30 AM. (Curley, Andrew)
November 20, 2017 Opinion or Order Filing 283 SEALED MOTION by Plaintiff Direct Purchaser Plaintiffs TO COMPEL TESTIMONY UNDER FED. R. CIV. P. 30(B)(6) AND INTERROGATORY RESPONSES FROM DEFENDANT ENDO (Attachments: #1 Exhibit A-P)(Curley, Andrew)
November 20, 2017 Opinion or Order Filing 282 NOTICE of Motion by Andrew C. Curley for presentment of motion to seal #281 before Honorable Harry D. Leinenweber on 11/28/2017 at 09:30 AM. (Curley, Andrew)
November 20, 2017 Opinion or Order Filing 281 MOTION by Plaintiff Direct Purchaser Plaintiffs to seal PLAINTIFFS MOTION TO COMPEL TESTIMONY UNDER FED. R. CIV. P. 30(B)(6) AND INTERROGATORY RESPONSES FROM DEFENDANT ENDO (Curley, Andrew)
November 17, 2017 Opinion or Order Filing 280 NOTICE of Motion by Zachary David Caplan for presentment of motion to compel, #279 before Honorable Harry D. Leinenweber on 11/28/2017 at 09:30 AM. (Caplan, Zachary)
November 17, 2017 Opinion or Order Filing 279 MOTION by Plaintiff Direct Purchaser Plaintiffs to compel Compliance with Non-Party Subpoena Decus Tecum Served on Actavis South Atlantic LLC and Actavis Elizabeth LLC (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16)(Caplan, Zachary)
November 8, 2017 Opinion or Order Filing 278 MEMORANDUM by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. in Opposition to motion to compel #268 (Public Version) (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4)(Liu, Angela)
November 6, 2017 Opinion or Order Filing 277 MINUTE entry before the Honorable Harry D. Leinenweber:Plaintiffs' Unopposed Motion for leave to file under seal #274 is granted.Mailed notice (wp, )
November 3, 2017 Opinion or Order Filing 276 SEALED REPLY by Direct Purchaser Plaintiffs to SEALED MOTION by Plaintiff Direct Purchaser Plaintiffs to Compel Endo Defendants to Produce Certain Documents #262 (Attachments: #1 Exhibit M)(Curley, Andrew)
November 3, 2017 Opinion or Order Filing 275 NOTICE of Motion by Andrew C. Curley for presentment of motion for miscellaneous relief #274 before Honorable Harry D. Leinenweber on 11/8/2017 at 09:30 AM. (Curley, Andrew)
November 3, 2017 Opinion or Order Filing 274 MOTION by Plaintiff Direct Purchaser Plaintiffs FOR LEAVE TO FILE UNDER SEAL (UNOPPOSED) (Curley, Andrew)
October 31, 2017 Opinion or Order Filing 273 MINUTE entry before the Honorable Harry D. Leinenweber:Jennings F. Durand's Application to appear pro hac vice #148 is granted.Chris Letter's Application to appear pro hac vice #166 is granted. Andrew W. Kelly's Application to appear pro hac vice #167 is granted. Christopher T. Stow-Serge's Application to appear pro hac vice #269 is granted. Endo's Motion for leave to file under seal #270 is granted.Mailed notice (wp, )
October 26, 2017 Opinion or Order Filing 272 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4)(Liu, Angela)
October 26, 2017 Opinion or Order Filing 271 NOTICE of Motion by Angela M. Liu for presentment of motion for miscellaneous relief #270 before Honorable Harry D. Leinenweber on 10/31/2017 at 09:30 AM. (Liu, Angela)
October 26, 2017 Opinion or Order Filing 270 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co.For Leave to File Under Seal (Liu, Angela)
October 26, 2017 Opinion or Order Filing 269 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-13725909. (Stow-Serge, Christopher)
October 25, 2017 Opinion or Order Filing 268 MOTION by Plaintiff Direct Purchaser Plaintiffs to compel Endo Defendants to Produce Certain Documents [Public Version of ECF No. 262] (Attachments: #1 Exhibit A-L)(Curley, Andrew)
October 11, 2017 Opinion or Order Filing 267 MINUTE entry before the Honorable Harry D. Leinenweber:Plaintiffs' Motion for leave to file under seal #260 is grantedMailed notice (wp, )
October 11, 2017 Opinion or Order Filing 266 Enter Stipulation and Scheduling Order Signed by the Honorable Harry D. Leinenweber on 10/11/2017: Endo's response to plaintiffs' motion to compel to be filed by 10/26/2017. Plaintiffs' reply brief to be filed by 11/3/2017. Mailed notice(wp, )
October 10, 2017 Opinion or Order Filing 264 STATUS Report - Quarterly Joint Status Report by Opana ER Antitrust Litigation (Levin, Christine)
October 9, 2017 Opinion or Order Filing 265 NOTICE OF EMAIL NOTIFICATION FAILURE, for document #263 , #262 , #261 , #260 sent to Attorney James Patrick Schaefer returned as: Unknown Address Error. The Clerk telephoned [name], no contact made. Document [] mailed to attorney [ ] with Letter re: bounce back email and a Notification of Change of Address form. Notices have been set to No. Counsel must email the Clerk's Office at Docketing_ILND@uscourts.gov when a Notification of Change of Address has been filed to ensure electronic notification is reset. (ek, )
October 9, 2017 Opinion or Order Filing 263 NOTICE of Motion by Andrew C. Curley for presentment of Sealed motion, #262 before Honorable Harry D. Leinenweber on 10/12/2017 at 09:30 AM. (Curley, Andrew)
October 9, 2017 Opinion or Order Filing 262 SEALED MOTION by Plaintiff Direct Purchaser Plaintiffs to Compel Endo Defendants to Produce Certain Documents (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Exhibit J, #11 Exhibit K, #12 Exhibit L)(Curley, Andrew)
October 9, 2017 Opinion or Order Filing 261 NOTICE of Motion by Andrew C. Curley for presentment of motion for miscellaneous relief #260 before Honorable Harry D. Leinenweber on 10/12/2017 at 09:30 AM. (Curley, Andrew)
October 9, 2017 Opinion or Order Filing 260 MOTION by Plaintiff Direct Purchaser Plaintiffsfor Leave to File Under Seal (Curley, Andrew)
August 7, 2017 Opinion or Order Filing 259 WITHDRAWING Andrew M. Purdy as counsel for Plaintiff Kim Mahaffay and substituting Joseph R. Saveri as counsel of record (Saveri, Joseph)
August 7, 2017 Opinion or Order Filing 258 WITHDRAWING Andrew M. Purdy as counsel for Plaintiff Kim Mahaffay and substituting Joseph R. Saveri as counsel of record (Saveri, Joseph)
July 18, 2017 Opinion or Order Filing 257 MINUTE entry before the Honorable Harry D. Leinenweber:Attorney Morgan Feder's Application to appear pro hac vice #245 is grantedMailed notice (wp, )
July 10, 2017 Opinion or Order Filing 256 STATUS Report of the Parties (Joint) by All Plaintiffs and Defendants (Caplan, Zachary)
July 7, 2017 Opinion or Order Filing 255 WITHDRAWING Matthew S. Weiler as counsel for Plaintiff Kim Mahaffay and substituting Joseph R. Saveri as counsel of record (Saveri, Joseph)
July 6, 2017 Opinion or Order Filing 254 REQUEST for Clerk of Court to refund filing fee in the amount of $50.00, receipt no. 0752- 13249325, (Baxter, James)
June 28, 2017 Opinion or Order Filing 253 MINUTE entry before the Honorable Harry D. Leinenweber:Per the withdrawal of Plaintiffs' motion to compel Defendant Endo to amend privilege log [ECF No. 252], the following motions are ECF Nos. 236 and 246 are deemed withdrawn. The motion by Attorney Jennings F. Durand to withdraw as attorney [ECF No. 230] is granted nunc pro tunc. The motion by Attorney James B. Baxter to appear pro hac vice [ECF No. 248] is granted.Mailed notice (wp, )
June 23, 2017 Opinion or Order Filing 252 Notice of Withdrawal of Plaintiffs' Motion to Compel Defendant Endo to Amend Privilege Log and Produce Certain Documents (ECF No. 236) by End-Payor Plaintiffs [on behalf of All Plaintiffs] (Freed, Michael)
June 15, 2017 Opinion or Order Filing 251 NOTICE OF FIRM NAME CHANGE by Pennsylvania Employees Benefit Trust Fund (Kodroff, Jeffrey)
June 13, 2017 Opinion or Order Filing 250 Stipulation and Order extending time to 6/23/2017 for plaintiffs to file reply in support of motion to compel Endo to amend its priviledge log and produce certain documents Signed by the Honorable Harry D. Leinenweber on 6/13/2017:Mailed notice(wp, )
June 12, 2017 Opinion or Order Filing 249 NOTICE OF EMAIL NOTIFICATION FAILURE, for document #246 #247 sent to Attorney Jennings F. Durand returned as: Unknown Address Error. The Clerk telephoned Jennings F. Durand returned, no contact made. Document #246 #247 mailed to attorney Jennings F. Durand returned with Letter re: bounce back email and a Notification of Change of Address form. Notices have been set to No. Counsel must email the Clerk's Office at Docketing_ILND@uscourts.gov when a Notification of Change of Address has been filed to ensure electronic notification is reset. (cc, )
June 6, 2017 Opinion or Order Filing 248 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-13249404. (Attachments: #1 Certificate of Service)(Baxter, James)
June 2, 2017 Opinion or Order Filing 247 RESPONSE by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. to motion to compel, #246 (Liu, Angela)
June 2, 2017 Opinion or Order Filing 246 MOTION by Plaintiff End-Payor Plaintiffs to compel Defendant Endo to Amend its Privilege Log and Produce Certain Documents [Public Unredacted Version of ECF No. 236] (Attachments: #1 Declaration of Karin E. Garvey & Exhibits A-K)(Freed, Michael)
June 1, 2017 Opinion or Order Filing 245 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-13234491. (Feder, Morgan)
May 31, 2017 Opinion or Order Filing 244 ATTORNEY Appearance for Plaintiff Rochester Drug Co-Operative, Inc. by Richard Daniel Schwartz (Schwartz, Richard)
May 26, 2017 Opinion or Order Filing 243 ATTORNEY Appearance for Plaintiff Plumbers & Pipefitters Local 178 Health & Welfare Trust Fund by Brian M. Hogan (Hogan, Brian)
May 19, 2017 Opinion or Order Filing 242 WITHDRAWING David B. Franco as counsel for Plaintiffs (Direct Purchaser and End-Payor), Albertsons LLC, Albertsons LLC, CVS Pharmacy, Inc., Mary Davenport, Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Fraternal Order of Police, Miami Lodge 20 Insurance Trust Fund, HEB Grocery Company L.P., International Union of Operating Engineers, Local 138 Welfare Fund, Louisiana Health Service and Indemnity Company, Kim Mahaffay, Massachusetts Bricklayers & Masons Health and Welfare Fund, Meijer, Inc., Pennsylvania Employees Benefit Trust Fund, Plumbers & Pipefitters Local 178 Health & Welfare Trust Fund, Rite Aid Corporation, Rite Aid Hdqtrs. Corp., Rochester Drug Co-Operative, Inc., Safeway Inc., The Kroger Co., Value Drug Company, Walgreen Co, Wisconsin Masons' Health Care Fund and substituting James R. Dugan, ii as counsel of record (Dugan, ii, James)
May 18, 2017 Opinion or Order Filing 241 MINUTE entry before the Honorable Harry D. Leinenweber:Plaintiffs' Motion for leave to file under seal #234 is granted. Kristin M. Koger's Application to appear pro hac vice #238 is granted.Mailed notice (wp, )
May 18, 2017 Opinion or Order Filing 240 Stipulation and Scheduling Order Signed by the Honorable Harry D. Leinenweber on 5/18/2017:Mailed notice(wp, )
May 18, 2017 Opinion or Order Filing 239 MINUTE entry before the Honorable Harry D. Leinenweber:Endo's response to plaintiffs' motion to compel #236 to be filed by 6/2/2017. Plaintiffs' reply brief due by 6/13/2017. The court will by mail. Mailed notice (wp, )
May 18, 2017 Opinion or Order Filing 238 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-13187242. (Koger, Kristin)
May 15, 2017 Opinion or Order Filing 237 NOTICE of Motion by Michael Jerry Freed for presentment of Sealed motion #236 before Honorable Harry D. Leinenweber on 5/18/2017 at 09:30 AM. (Freed, Michael)
May 15, 2017 Opinion or Order Filing 236 SEALED MOTION by Plaintiff End-Payor Plaintiffs to Compel Defendant Endo to Amend Its Privilege Log and Produce Certain Documents (Attachments: #1 Declaration of Karin E. Garvey & Exhibits A-K)(Freed, Michael)
May 15, 2017 Opinion or Order Filing 235 NOTICE of Motion by Michael Jerry Freed for presentment of motion for miscellaneous relief #234 before Honorable Harry D. Leinenweber on 5/18/2017 at 09:30 AM. (Freed, Michael)
May 15, 2017 Opinion or Order Filing 234 MOTION by Plaintiff End-Payor Plaintiffs for Leave to File Under Seal (Freed, Michael)
May 2, 2017 Opinion or Order Filing 233 MAIL RETURNED, for document #229 sent to Quinn Colleen Shean returned as undeliverable, return to sender. No new contact information received; therefore future mailings will not be sent until a new address is provided to the Clerk's Office using a Notification of Change of Address or Pro Se Appearance form (ek, )
May 1, 2017 Opinion or Order Filing 232 NOTICE by Monica L. Kiley of Change of Address (Kiley, Monica)
April 10, 2017 Opinion or Order Filing 231 STATUS Report JOINT STATUS REPORT OF THE PARTIES by Impax Laboratories, Inc., Opana ER Antitrust Litigation (Baldridge, James)
March 24, 2017 Opinion or Order Filing 230 MOTION by Attorney Jennings F. Durand to withdraw as attorney for Opana ER Antitrust Litigation. No party information provided (Durand, Jennings)
March 17, 2017 Opinion or Order Filing 229 NOTICE OF EMAIL NOTIFICATION FAILURE, for document #228 sent to Attorney Quinn Colleen Shean returned as: Unknown Address Error. Mailed to attorney Quinn Colleen Shean a Letter re: bounce back email and a Notification of Change of Address form. Notices have been set to No. Counsel must email the Clerk's Office at Docketing_ILND@uscourts.gov when a Notification of Change of Address has been filed to ensure electronic notification is reset. (ek, )
March 17, 2017 Opinion or Order Filing 228 Notice by CVS Pharmacy, Inc., Rite Aid Corporation, Rite Aid Hdqtrs. Corp. Notice of Name Change (Monica, Rebuck)
February 27, 2017 Opinion or Order Filing 227 NOTICE by Danielle R Foley of Change of Address (Foley, Danielle)
February 27, 2017 Opinion or Order Filing 226 NOTICE by Lisa Jose Fales of Change of Address (Fales, Lisa)
February 27, 2017 Opinion or Order Filing 225 NOTICE by James Douglas Baldridge of Change of Address (Baldridge, James)
January 17, 2017 Opinion or Order Filing 224 MINUTE entry before the Honorable Harry D. Leinenweber:Cohen Milstein Sellers & Toll PLLC Motion to withdraw the appearance of J. Douglas Richards on behalf of plaintiff International Union of Operating Engineers Local 138 Welfare Fund #222 is granted.Mailed notice (wp, )
January 11, 2017 Opinion or Order Filing 223 NOTICE of Motion by Sharon K Robertson for presentment of motion to withdraw as attorney #222 before Honorable Harry D. Leinenweber on 1/17/2017 at 09:30 AM. (Robertson, Sharon)
January 11, 2017 Opinion or Order Filing 222 MOTION by Attorney J. Douglas Richards to withdraw as attorney for International Union of Operating Engineers, Local 138 Welfare Fund. No party information provided (Richards, Douglas)
January 10, 2017 Opinion or Order Filing 221 NOTICE by Jayne Goldstein of Change of Address and Firm Affiliation (Goldstein, Jayne)
January 9, 2017 Opinion or Order Filing 220 STATUS Report OF THE PARTIES (JOINT) by (Direct Purchaser and End-Payor) (Curley, Andrew)
November 7, 2016 Opinion or Order Filing 219 NOTICE of Correction re: document number #217 . (ks, )
November 7, 2016 Opinion or Order Filing 218 ORDER Signed by the Honorable Harry D. Leinenweber on 11/7/2016:The Court authorizes each side to take 20 depositions, each not to exceed 7 hours.Mailed notice(wp, )
November 7, 2016 Opinion or Order Filing 217 ORDER Signed by the Honorable Harry D. Leinenweber on 11/7/2016: The Court authorizes each side to take 20 depositions, each not to exceed 7 hours.Mailed notice(wp, )
October 11, 2016 Opinion or Order Filing 216 STATUS Report Joint Status Report of the Parties by (Direct Purchaser and End-Payor), Albertsons LLC, CVS Pharmacy, Inc., Mary Davenport, Direct Purchaser Plaintiffs, End-Payor Plaintiffs, Fraternal Order of Police, Miami Lodge 20 Insurance Trust Fund, HEB Grocery Company L.P., International Union of Operating Engineers, Local 138 Welfare Fund, Louisiana Health Service and Indemnity Company, Kim Mahaffay, Massachusetts Bricklayers & Masons Health and Welfare Fund, Meijer, Inc., Opana ER Antitrust Litigation, Pennsylvania Employees Benefit Trust Fund, Plumbers & Pipefitters Local 178 Health & Welfare Trust Fund, Rite Aid Corporation, Rite Aid Hdqtrs. Corp., Rochester Drug Co-Operative, Inc., Safeway Inc., Service List, The Kroger Co., Value Drug Company, Walgreen Co, Wisconsin Masons' Health Care Fund (Gerstein, Bruce)
September 27, 2016 Opinion or Order Filing 215 MINUTE entry before the Honorable Harry D. Leinenweber:Plaintiffs Motion to withdraw the appearance of Donald L. Sawyer on behalf of Plumbers & Pipefitters Local 178 Health & Welfare Trust Fund #213 is granted.Mailed notice (wp, )
September 16, 2016 Opinion or Order Filing 214 NOTICE of Motion by Michael Jerry Freed for presentment of motion to withdraw as attorney #213 before Honorable Harry D. Leinenweber on 9/27/2016 at 09:30 AM. (Freed, Michael)
September 16, 2016 Opinion or Order Filing 213 MOTION by Attorney Donald L. Sawyer to withdraw as attorney for Plumbers & Pipefitters Local 178 Health & Welfare Trust Fund. No party information provided (Freed, Michael)
September 12, 2016 Opinion or Order Filing 212 ANSWER to amended complaint Second Consolidated by Impax Laboratories, Inc.(Baldridge, James)
September 12, 2016 Opinion or Order Filing 211 ANSWER to amended complaint Second Consolidated by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co.(Liu, Angela)
August 11, 2016 Opinion or Order Filing 210 MEMORANDUM OPINION AND ORDER Signed by the Honorable Harry D. Leinenweber on 8/11/2016:Mailed notice(wp, )
August 11, 2016 Opinion or Order Filing 209 MINUTE entry before the Honorable Harry D. Leinenweber:Defendants' Motion to Dismiss EPPs' Second Consolidated Amended Class Action Complaint #188 is granted in part and denied in part. EPPs' unjust enrichment claims under the laws of California, Illinois and Rhode Island are dismissed with prejudice.Mailed notice (wp, )
July 11, 2016 Opinion or Order Filing 208 STATUS Report (JOINT) OF THE PARTIES by Albertsons LLC, CVS Pharmacy, Inc., Fraternal Order of Police, Miami Lodge 20 Insurance Trust Fund, HEB Grocery Company L.P., International Union of Operating Engineers, Local 138 Welfare Fund, Louisiana Health Service and Indemnity Company, Kim Mahaffay, Massachusetts Bricklayers & Masons Health and Welfare Fund, Meijer, Inc., Opana ER Antitrust Litigation, Pennsylvania Employees Benefit Trust Fund, Plumbers & Pipefitters Local 178 Health & Welfare Trust Fund, Rite Aid Corporation, Rite Aid Hdqtrs. Corp., Rochester Drug Co-Operative, Inc., Safeway Inc., The Kroger Co., Value Drug Company, Walgreen Co, Wisconsin Masons' Health Care Fund (Gerstein, Bruce)
June 1, 2016 Opinion or Order Filing 207 RESPONSE by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co.in Support of MOTION TO DISMISS FOR FAILURE TO STATE A CLAIMMemorandum of Law in Support of Defendants' Partial Motion to Dismiss #188 , MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM #187 (Baldridge, James)
May 26, 2016 Opinion or Order Filing 206 Enter Stipulation and Order regarding the non-disclosure of certain information regarding expert witnesses Signed by the Honorable Harry D. Leinenweber on 5/26/2016:Mailed notice(wp, )
May 19, 2016 Opinion or Order Filing 205 NOTICE OF EMAIL NOTIFICATION FAILURE, for document #204 sent to Attorney Chad Joseph Primeaux returned as: Unknown Address Error. Mailed to attorney Chad Joseph Primeaux a Letter re: bounce back email and a Notification of Change of Address form. Notices have been set to No. Counsel must email the Clerk's Office at Docketing_ILND@uscourts.gov when a Notification of Change of Address has been filed to ensure electronic notification is reset. (ek, )
May 19, 2016 Opinion or Order Filing 204 Stipulation and Order Extending Time for Defendants to file reply in further support of partial motion to dismiss end-payor plaintiffs' second consolidated amended class action complaint. Signed by the Honorable Harry D. Leinenweber on 5/19/2016:Mailed notice(wp, )
May 9, 2016 Opinion or Order Filing 203 RESPONSE by End-Payor Plaintiffsin Opposition to MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM #187 (Freed, Michael)
May 3, 2016 Opinion or Order Filing 202 ORDER GRANTING LEAVE TO FILE REDACTED VERSIONS OF ENDO'S ANSWER TO OPT-OUT PLAINTIFFS' AMENDED COMPLAINTS: Upon consideration of Defendants Endo Health Solutions Inc., and Penwest Pharmaceuticals Co.'s Unopposed Motion for Leave to File Redacted Versions of Endo's Answers to Opt-Out Plaintiffs' Amended Complaint (Doc. 197), the Court hereby GRANTS Endo's Motion for Leave to File Redacted Versions of Endo's Answers to Op-Out Plaintiffs' Amended Complaint. SO ORDERED Signed by the Honorable Harry D. Leinenweber on 5/3/2016. MAILED notice(ks, )
May 3, 2016 Opinion or Order Filing 201 MINUTE entry before the Honorable Harry D. Leinenweber:Endo's Motion for leave to file redacted versions of its answers to opt-out plaintiffs' amended complaint #197 is granted. Impax's Unopposed Motion for leave to file redacted versions of its answers to opt-out plaintiffs' amended complaint #199 is granted.Mailed notice (wp, )
April 29, 2016 Opinion or Order Filing 200 NOTICE of Motion by Kevin Fitzgerald Wolff for presentment of motion for miscellaneous relief, #199 before Honorable Harry D. Leinenweber on 5/3/2016 at 09:30 AM. (Wolff, Kevin)
April 29, 2016 Opinion or Order Filing 199 MOTION by Defendant Impax Laboratories, Inc. for Leave to File Redacted Versions of its Answers to Opt-Out Plaintiffs' Amended Complaints (Unopposed) (Attachments: #1 Index of Exhibits, #2 Exhibit A, #3 Exhibit B, #4 Exhibit C)(Wolff, Kevin)
April 27, 2016 Opinion or Order Filing 198 NOTICE of Motion by Angela M. Liu for presentment of motion for leave to file, #197 before Honorable Harry D. Leinenweber on 5/3/2016 at 09:30 AM. (Liu, Angela)
April 27, 2016 Opinion or Order Filing 197 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. for leave to file Redacted Versions of Endo's Answers to Opt-Out Plainitffs' Amended Complaints (Unopposed) (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Liu, Angela)
April 18, 2016 Opinion or Order Filing 196 SEALED DOCUMENT by Defendant Impax Laboratories, Inc. ANSWER TO CVS (ECF 170) (Baldridge, James)
April 18, 2016 Opinion or Order Filing 195 SEALED DOCUMENT by Defendant Impax Laboratories, Inc. ANSWER to Rite Aid (ECF 169) (Baldridge, James)
April 18, 2016 Opinion or Order Filing 194 SEALED DOCUMENT by Defendant Impax Laboratories, Inc. ANSWER to Walgreen (ECF 168) (Baldridge, James)
April 18, 2016 Opinion or Order Filing 192 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. Answer to Amended Complaint (Liu, Angela)
April 18, 2016 Opinion or Order Filing 191 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. Answer to Amended Complaint (Liu, Angela)
April 18, 2016 Opinion or Order Filing 190 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. Answer to Amended Complaint (Liu, Angela)
April 18, 2016 Opinion or Order Filing 189 TRANSCRIPT OF PROCEEDINGS held on 04/12/2016 before the Honorable Harry D. Leinenweber. Court Reporter Contact Information: Judith A. Walsh, CSR, RDR, CRR, judith_walsh@ilnd.uscourts.gov, 312.702.8865.
April 12, 2016 Opinion or Order Filing 193 MINUTE entry before the Honorable Harry D. Leinenweber: End-Payor Plaintiffs' response to Defendants' Partial Motion to Dismiss #188 is due 5/9/2016; reply due 5/23/2016. The Court will rule by mail thereafter. Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., and Penwest Pharmaceuticals Co's unopposed motion for leave to file a redacted answer #183 is granted. Defendant Impax Laboratories' unopposed motion for leave to file a redacted answer #185 is granted. The Court adopts in part the joint Rule 26(f) report of the parties. Fact discovery to close 2/9/2018. The Court will address schedule for class and expert discovery at the status hearing set for 12/7/2017 at 09:00 AM.Mailed notice (wp, )
April 8, 2016 Opinion or Order Filing 188 MOTION TO DISMISS FOR FAILURE TO STATE A CLAIMMemorandum of Law in Support of Defendants' Partial Motion to Dismiss (Attachments: #1 Text of Proposed Order Proposed Order)(Baldridge, James)
April 8, 2016 Opinion or Order Filing 187 MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM (Baldridge, James)
April 8, 2016 Opinion or Order Filing 186 NOTICE of Motion by Kevin Fitzgerald Wolff for presentment of motion for miscellaneous relief #185 before Honorable Harry D. Leinenweber on 4/12/2016 at 09:30 AM. (Wolff, Kevin)
April 8, 2016 Opinion or Order Filing 185 MOTION by Defendant Impax Laboratories, Inc.for Leave to File Redacted Version of its Answer to Direct Purchaser Plaintiffs' First Amended Consolidated Class Action Complaint (Unopposed) (Attachments: #1 Exhibit A)(Wolff, Kevin)
April 8, 2016 Opinion or Order Filing 184 NOTICE of Motion by Angela M. Liu for presentment of motion for leave to file, #183 before Honorable Harry D. Leinenweber on 4/12/2016 at 09:30 AM. (Liu, Angela)
April 8, 2016 Opinion or Order Filing 183 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. for leave to file A Redacted Version of Endo's Answer to Direct Purchaser Plaintiffs' Amended Complaint (Unopposed) (Attachments: #1 Exhibit A)(Liu, Angela)
April 5, 2016 Opinion or Order Filing 182 JOINT Rule 26(f) Report of the Parties. (Attachments: #1 Exhibit A) (Sorensen, David) Docket Text Modified by Clerk's Office on 4/6/2016 (jh, ).
April 5, 2016 Opinion or Order Filing 181 MINUTE entry before the Honorable Harry D. Leinenweber: Motion hearing held. Defendants' Unopposed Motion for Leave To File Redacted Versions of Opt-Out Plaintiffs' Amended Complaints #175 is granted. Mailed notice. (lxs, )
April 4, 2016 Opinion or Order Filing 180 NOTICE by Scott E Perwin of Change of Address (Perwin, Scott)
March 30, 2016 Opinion or Order Filing 177 Stipulation and Order Extending Time for Defendants to Answer or Otherwise Respond to End-Payor Plaintiffs' Complaint Signed by the Honorable Harry D. Leinenweber on 3/30/2016:Mailed notice(wp, )
March 29, 2016 Opinion or Order Filing 176 NOTICE of Motion by Angela M. Liu for presentment of motion for leave to file #175 before Honorable Harry D. Leinenweber on 4/5/2016 at 09:30 AM. (Liu, Angela)
March 29, 2016 Opinion or Order Filing 175 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. for leave to file (Unopposed) (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Liu, Angela)
March 28, 2016 Opinion or Order Filing 174 STIPULATION and ORDER: Signed by the Honorable Harry D. Leinenweber on 3/28/2016. MAILED notice(ks, )
March 28, 2016 Opinion or Order Filing 173 STIPULATION and ORDER: Signed by the Honorable Harry D. Leinenweber on 3/28/2016. MAILED notice(ks, )
March 25, 2016 Opinion or Order Filing 179 NOTICE OF EMAIL NOTIFICATION FAILURE, for document #172 , #171 #173 , #174 , #175 , #176 #177 sent to Attorney Andrew M. Purdy returned as: Unknown Address Error. Mailed to attorney Andrew M. Purdy a Letter re: bounce back email and a Notification of Change of Address form. Notices have been set to No. Counsel must email the Clerk's Office at Docketing_ILND@uscourts.gov when a Notification of Change of Address has been filed to ensure electronic notification is reset. (ek, ) (Main Document 179 replaced on 3/31/2016) (ek, ). Modified on 3/31/2016 (ek, ).
March 25, 2016 Opinion or Order Filing 178 NOTICE OF EMAIL NOTIFICATION FAILURE, for document #172 , #171 , #173 , #174 , #175 , #176 , #177 , sent to Attorney Lewis Scott Joanen returned as: Unknown Address Error. Mailed to attorney Lewis Scott Joanen a Letter re: bounce back email and a Notification of Change of Address form. Notices have been set to No. Counsel must email the Clerk's Office at Docketing_ILND@uscourts.gov when a Notification of Change of Address has been filed to ensure electronic notification is reset. (ek, ) . Modified on 3/31/2016 (ek, ). (Main Document 178 replaced on 3/31/2016) (ek, ).
March 25, 2016 Opinion or Order Filing 172 SEALED DOCUMENT by Defendant Impax Laboratories, Inc. ANSWER to Direct Purchaser Plaintiffs' First Amended Consolidated Class Action Complaint (Baldridge, James)
March 25, 2016 Opinion or Order Filing 171 SEALED DOCUMENT by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. Answer to Amended Complaint (Liu, Angela)
March 17, 2016 Opinion or Order Filing 170 SEALED DOCUMENT by Plaintiff CVS Pharmacy, Inc. Amended Complaint and Demand for Jury Trial (Bloom, Eric)
March 17, 2016 Opinion or Order Filing 169 SEALED DOCUMENT by Plaintiffs Rite Aid Corporation, Rite Aid Hdqtrs. Corp. Amended Complaint and Demand for Jury Trial (Bloom, Eric)
March 17, 2016 Opinion or Order Filing 168 SEALED DOCUMENT by Plaintiffs Albertsons LLC, HEB Grocery Company L.P., Safeway Inc., The Kroger Co., Walgreen Co Amended Complaint and Demand for Jury Trial (Perwin, Scott)
March 10, 2016 Opinion or Order Filing 167 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-11703239. (Kelly, Andrew)
March 10, 2016 Opinion or Order Filing 166 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-11703154. (Letter, Chris)
March 10, 2016 Opinion or Order Filing 165 Stipulation and Order extending time for defendants to answer Direct Purchaser Plaintiffs' first amended consolidated class action complaint Signed by the Honorable Harry D. Leinenweber on 3/10/2016:Mailed notice(wp, )
March 2, 2016 Opinion or Order Filing 164 Second Consolidated AMENDED complaint by End-Payor Plaintiffs against All Defendants (Freed, Michael)
February 25, 2016 Opinion or Order Filing 162 MEMORANDUM OPINION AND ORDER Signed by the Honorable Harry D. Leinenweber on 2/25/2016:Mailed notice(wp, )
February 25, 2016 Opinion or Order Filing 161 MINUTE entry before the Honorable Harry D. Leinenweber: Defendants Motion to Dismiss Opt-Out Plaintiffs Complaints [ECF No. 119] is granted. Opt-Out Plaintiffs are granted leave to replead within twenty-one (21) days of the date of this Memorandum Opinion and Order. Mailed notice (wp, )
February 24, 2016 Opinion or Order Filing 163 MINUTE entry before the Honorable Harry D. Leinenweber:The Joint Motion for an order finding of relatedness and reassignment of the case captioned CVS Pharmacy, Inc. v. Endo Health Solutions Inc., et al., No. 16 C 1832 (the "CVS Action"), assigned to Judge Norgle is related to the Walgreen Action pursuant to Local Rule 40.4, and request that the Executive Committee reassign the CVS Action to this Court's docket for coordination with the Walgreen Action and other actions currently pending in this Court as part of In re Opana ER Antitrust Litigation, MDL No. 2580, Lead Case No. 14 C 10150 #154 is granted.Mailed notice (wp, )
February 24, 2016 Opinion or Order Filing 160 Stipulation and Order extending time to 4/1/2016 for defendants to answer or otherwise respond to End-Payor Plaintiffs' Complaint. In the event that defendants file a motion to dismiss in response to the Second Consolidated Amended Class Action Complaint, End-Payor Plaintiffs shall file an opposition thereto on or before 5/2/2016. Signed by the Honorable Harry D. Leinenweber on 2/24/2016:Mailed notice(wp, )
February 24, 2016 Opinion or Order Filing 159 MINUTE entry before the Honorable Harry D. Leinenweber: By agreement, Rule 16 conference set for 4/12/2016 at 09:00 AM.Mailed notice (wp, )
February 22, 2016 Opinion or Order Filing 158 ORDER Signed by the Honorable Harry D. Leinenweber on 2/22/2016:The date for all parties to exchange initial disclosures under Rule 26(a)(1)(A)(ii) - (iv) is extended from 2/22/2016 to 3/3/2016.Mailed notice(wp, )
February 22, 2016 Opinion or Order Filing 157 ORDER Signed by the Honorable Harry D. Leinenweber on 2/22/2016: The time for all Defendants to answer the Direct Purchaser Plaintiffs' First Amended Consolidated Class Action Complaint is extended to and including 3/11/2016.Mailed notice(wp, )
February 22, 2016 Opinion or Order Filing 156 Letter requesting Rule 16 conference by Direct Purchaser Plaintiffs (Sorensen, David)
February 19, 2016 Opinion or Order Filing 155 NOTICE of Motion by Eric L. Bloom for presentment of motion to consolidate cases #154 before Honorable Harry D. Leinenweber on 2/24/2016 at 09:30 AM. (Bloom, Eric)
February 19, 2016 Opinion or Order Filing 154 MOTION by Plaintiff CVS Pharmacy, Inc. to consolidate cases Joint for Finding of Relatedness and Reassignment (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Text of Proposed Order)(Bloom, Eric)
February 12, 2016 Opinion or Order Filing 153 ATTORNEY Appearance for Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co. by Angela M. Liu (Liu, Angela)
February 12, 2016 Opinion or Order Filing 152 MOTION by Attorney Quinn Shean to withdraw as attorney for Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co.. No party information provided (Shean, Quinn)
February 10, 2016 Opinion or Order Filing 151 MEMORANDUM OPINION AND ORDER Signed by the Honorable Harry D. Leinenweber on 2/10/2016:Mailed notice(wp, )
February 10, 2016 Opinion or Order Filing 150 MINUTE entry before the Honorable Harry D. Leinenweber:Defendants Motion to Dismiss DPPs First Amended Consolidated Complaint [ECF No. 118] is denied. Defendants Motion to Dismiss EPPs First Amended Consolidated Complaint [ECF No. 121] is granted in part and denied in part. EPPs antitrust claims under the state laws of Illinois, Puerto Rico, Rhode Island, Kansas, and Mississippi are dismissed with prejudice. EPPs antitrust claims under Utah state law, and all of their consumer protection and unjust enrichment claims are dismissed with leave to replead within twenty-one (21) days from the date of this memorandum opinion and order. Mailed notice (wp, )
December 22, 2015 Opinion or Order Filing 149 NOTICE OF EMAIL NOTIFICATION FAILURE, for document #148 sent to Attorney lbrennan@kkbs-law.com returned as: Unknown address error. Mailed to attorney Lynne Marie Brennan Letter re: bounce back email and a Notification of Change of Address form. Notices have been set to No. Counsel must email the Clerk's Office at Docketing_ILND@uscourts.gov when a Notification of Change of Address has been filed to ensure electronic notification is reset. (sxn, )
December 22, 2015 Opinion or Order Filing 148 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-11424444. (Durand, Jennings)
November 20, 2015 Opinion or Order Filing 147 SUPPLEMENT to sealed response, #129 (Supplemental Authority in Support of Plaintiffs' Opposition to Motions to Dismiss) (Attachments: #1 Exhibit A)(Freed, Michael)
November 10, 2015 Opinion or Order Filing 146 MINUTE entry before the Honorable Harry D. Leinenweber:Defendants Motion to withdraw the appearance of Brian P. Savage as attorney #143 is granted.Mailed notice (wp, )
November 6, 2015 Opinion or Order Filing 145 Impax's Notice of Correction to Defendants' Memorandum of Law in Support of their Motion to Dismiss Direct Purchaser Plaintiffs' First Amended Consolidated Complaint by Impax Laboratories, Inc. (Wolff, Kevin)
November 4, 2015 Opinion or Order Filing 144 NOTICE of Motion by Quinn Colleen Shean for presentment of motion to withdraw as attorney #143 before Honorable Harry D. Leinenweber on 11/10/2015 at 09:30 AM. (Shean, Quinn)
November 4, 2015 Opinion or Order Filing 143 MOTION by Attorney Brian P. Savage to withdraw as attorney for Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Co.. No party information provided (Shean, Quinn)
November 2, 2015 Opinion or Order Filing 142 REPLY by Plaintiff (Direct Purchaser and End-Payor) to Response, #141 (Sorensen, David)
October 15, 2015 Opinion or Order Filing 141 RESPONSE by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to supplement #135 (Defendants' Response to Plaintiffs' Notice of Supplemental Authority) (Attachments: #1 Exhibit A, #2 Exhibit B)(Savage, Brian)
October 8, 2015 Opinion or Order Filing 140 MINUTE entry before the Honorable Harry D. Leinenweber:Defendants Unopposed Motion for leave to file redacted version of their reply #138 is granted.Mailed notice (wp, )
October 6, 2015 Opinion or Order Filing 139 NOTICE of Motion by Kevin Fitzgerald Wolff for presentment of motion for leave to file, #138 before Honorable Harry D. Leinenweber on 10/8/2015 at 09:30 AM. (Wolff, Kevin)
October 6, 2015 Opinion or Order Filing 138 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. for leave to file Redacted Version of Their Reply Memorandum of Law in Further Support of Their Motions to Dismiss Direct Purchaser Plaintiffs' and End Payer Plaintiffs' Consolidated Class Action Complaints (UNOPPOSED) (Attachments: #1 Exhibit A)(Wolff, Kevin)
September 22, 2015 Opinion or Order Filing 137 REPLY by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to memorandum in opposition to motion, #128 (Defendants Reply Memorandum of Law in Further Support of Their Motion to Dismiss or Stay Opt-Out Complaints) (Savage, Brian)
September 22, 2015 Opinion or Order Filing 136 SEALED REPLY by Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. to sealed response, #129 Reply to Direct Purchaser and End Payor Class Opposition to Defendants' Motions to Dismiss (Baldridge, James)
September 22, 2015 Opinion or Order Filing 135 SUPPLEMENT to sealed response, #129 (Attachments: #1 Exhibit A)(Sorensen, David)
September 9, 2015 Opinion or Order Filing 134 MINUTE entry before the Honorable Harry D. Leinenweber:Defendants' Unopposed Motion for leave to file redacted version of plaintiffs' memorandum of law in opposition to defendants' motion to dismiss #132 is granted.Mailed notice (wp, )
September 4, 2015 Opinion or Order Filing 133 NOTICE of Motion by Kevin Fitzgerald Wolff for presentment of motion for leave to file, #132 before Honorable Harry D. Leinenweber on 9/9/2015 at 09:30 AM. (Wolff, Kevin)
September 4, 2015 Opinion or Order Filing 132 MOTION by Defendants Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. for leave to file Redacted Version of Plaintiffs' Memorandum of Law in Opposition to Defendants' Motion to Dismiss (UNOPPOSED) (Attachments: #1 Exhibit A)(Wolff, Kevin)
September 4, 2015 Opinion or Order Filing 131 NOTICE by Albertsons LLC, HEB Grocery Company L.P., Rite Aid Corporation, Rite Aid Hdqtrs. Corp., Safeway Inc., The Kroger Co., Walgreen Co Notice of Filing Aggrenox Hearing Transcript (Attachments: #1 Exhibit Hearing Transcript)(Perwin, Scott)
September 4, 2015 Opinion or Order Filing 130 ATTORNEY Appearance for Defendant Impax Laboratories, Inc. by Kevin Fitzgerald Wolff (Wolff, Kevin)
August 21, 2015 Opinion or Order Filing 129 SEALED RESPONSE by Direct Purchaser Plaintiffs, End-Payor Plaintiffs to MOTION TO DISMISS FOR FAILURE TO STATE A CLAIMEnd-Payor Plaintiffs' Consolidated Amended Class Action Complaint #121 , MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM - Defendants' Motion to Dismiss Direct Purchaser Plaintiffs' First Amended Consolidated Complaint (Doc. 101) #117 (Attachments: #1 Exhibit A, #2 Exhibit B)(Sorensen, David)
August 21, 2015 Opinion or Order Filing 128 MEMORANDUM by Albertsons LLC, HEB Grocery Company L.P., Rite Aid Corporation, Rite Aid Hdqtrs. Corp., Safeway Inc., The Kroger Co., Walgreen Co in Opposition to Motion to Dismiss for Failure to State a Claim #119 or Stay Complaints (Perwin, Scott)
August 12, 2015 Opinion or Order Filing 127 ENTER STIPULATION AND ORDER regarding extension of time for Motion to Dismiss Briefing Schedule, The deadline for Plaintiffs oppositions to Defendants motions to dismiss is extended from August 14, 2015 to August 21, 2015. The deadline for Defendants replies in support of their motions to dismiss is extended from September 11, 2015 to September 22, 2015. The page limitations remain in place.Signed by the Honorable Harry D. Leinenweber on 8/12/2015:Mailed notice(wp, )
July 29, 2015 Opinion or Order Filing 126 NOTICE by Joseph R. Saveri of Change of Address (Saveri, Joseph)
July 23, 2015 Opinion or Order Filing 125 MINUTE entry before the Honorable Harry D. Leinenweber: Defendants' Motion for Leave To File Redacted Versions of Memoranda of Law in Support of Motions to Dismiss #123 is granted. Appearance not required on 7/23/2015. Mailed notice (lxs, )
July 17, 2015 Opinion or Order Filing 124 NOTICE of Motion by Joanna Rubin Travalini for presentment of motion for leave to file, #123 before Honorable Harry D. Leinenweber on 7/23/2015 at 09:30 AM. (Travalini, Joanna)
July 17, 2015 Opinion or Order Filing 123 MOTION by Defendants ENDO HEALTH SOLUTIONS INC., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co. for leave to file Redacted Versions of Memoranda of Law in Support of Motions to Dismiss (Attachments: #1 Index of Exhibits, #2 Exhibit A, #3 Exhibit B, #4 Exhibit C)(Travalini, Joanna)
July 3, 2015 Opinion or Order Filing 122 SEALED MOTION by Defendants ENDO HEALTH SOLUTIONS INC., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co., In Re Opana ER Antitrust Litigation Memorandum of Law in Support of Motion to Dismiss End-Payor Plaintiffs' Consolidated Amended Class Action Complaint (Baldridge, James)
July 3, 2015 Opinion or Order Filing 121 MOTION TO DISMISS FOR FAILURE TO STATE A CLAIMEnd-Payor Plaintiffs' Consolidated Amended Class Action Complaint (Baldridge, James)
July 3, 2015 Opinion or Order Filing 120 SEALED MOTION by Defendants ENDO HEALTH SOLUTIONS INC., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co., In Re Opana ER Antitrust Litigation Memorandum in Support of Motion to Dismiss or Stay Opt-Out Complaints (Attachments: #1 Declaration of Jody Travis, #2 Exhibit Exhibit A, #3 Exhibit Exhibit B, #4 Exhibit Exhibit C, #5 Exhibit Exhibit D)(Baldridge, James)
July 3, 2015 Opinion or Order Filing 119 MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM or to stay Opt-Out Complaints (Baldridge, James)
July 3, 2015 Opinion or Order Filing 118 MOTION TO DISMISS FOR FAILURE TO STATE A CLAIMmemorandum in support of Motion to Dismiss Direct Purchaser Plaintiffs' First Amended Complaint, SEALED MOTION by Defendants ENDO HEALTH SOLUTIONS INC., Endo Pharmaceuticals Inc., Impax Laboratories, Inc., Penwest Pharmaceuticals Co., In Re Opana ER Antitrust Litigation (Attachments: #1 Exhibit Exhibit 1, #2 Exhibit Exhibit 2, #3 Exhibit Exhibit 3, #4 Exhibit Exhibit 4, #5 Exhibit Exhibit 5, #6 Exhibit Exhibit 6, #7 Exhibit Exhibit 7, #8 Declaration Declaration of Christine Levin)(Baldridge, James)
July 3, 2015 Opinion or Order Filing 117 MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM - Defendants' Motion to Dismiss Direct Purchaser Plaintiffs' First Amended Consolidated Complaint (Doc. 101) (Levin, Christine)
June 30, 2015 Opinion or Order Filing 116 STIPULATION and ORDER REGARDING BRIEFING SCHEDULE AND PAGE LIMITATIONS Signed by the Honorable Harry D. Leinenweber on 6/30/2015.(gcy, )
June 30, 2015 Opinion or Order Filing 115 MINUTE entry before the Honorable Harry D. Leinenweber:Pursuant to the Stipulation and Proposed Order: Defendants shall file their motions to dismiss by 7/3/2015 and the briefs supporting the motions shall be briefs or a single consolidated brief, totaling no more than 60 pages addressing issues common to the Direct Purchaser Plaintiffs' amended complaint and the End Payor Plaintiffs' amended complaint and a separate brief of no more than 15 pages addressing issues that are unique to the Retailer Plaintiffs' complaints. Direct Purchaser Plaintiffs and End Payor Purchaser Plaintiffs shall file opposition briefs, or a single consolidated brief, totaling no more than 60 pages by 8/14/2015. Retailer Plaintiffs shall file a single consolidated opposition brief of no more than 30 pages by 8/14/2015. Defendants' reply briefs, or a single consolidated reply brief, totaling no more than 25 pages addressing the issues indicated in the stipulation to be filed by 9/11/2015. Mailed notice (wp, )
June 25, 2015 Opinion or Order Filing 114 MINUTE entry before the Honorable Harry D. Leinenweber:There being no objection, Defendant Impax Laboratories, Inc.'s Motion for Susan J. Harriman, Benedict Y. Hur, and David W. Rizk from Keker & Van Nest LLP to withdraw as attorney and substitute attorneys J. Douglas Baldridge, Lisa J. Fales, and Danielle Foley from Venable LLP #112 is granted.Mailed notice (wp, )
June 24, 2015 Opinion or Order Filing 113 MINUTE entry before the Honorable Harry D. Leinenweber:Danielle R. Foley's Application to appear pro hac vice on behalf of Impax Laboratories Inc. #109 is granted. Lisa Jose Fales' Application to appear pro hac vice on behalf of Impax Laboratories Inc. #110 is grantedMailed notice (wp, )
June 5, 2015 Opinion or Order Filing 112 MOTION by counsel for Defendant Impax Laboratories, Inc. to withdraw as attorney (Attachments: #1 Text of Proposed Order)(Hur, Benedict)
May 22, 2015 Opinion or Order Filing 110 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10673592. (Fales, Lisa)
May 22, 2015 Opinion or Order Filing 109 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10672281. (Foley, Danielle)
May 21, 2015 Opinion or Order Filing 111 MINUTE entry before the Honorable Harry D. Leinenweber:Defendants' Motion for leave to file redacted version of direct purchaser plaintiffs' first amended consolidated class action complaint #106 is granted.Mailed notice (wp, )
May 20, 2015 Opinion or Order Filing 108 ATTORNEY Appearance for Defendant Impax Laboratories, Inc. by James Douglas Baldridge (Baldridge, James)
May 18, 2015 Opinion or Order Filing 107 NOTICE of Motion by Joanna Rubin Travalini for presentment of motion for leave to file #106 before Honorable Harry D. Leinenweber on 5/21/2015 at 09:30 AM. (Travalini, Joanna)
May 18, 2015 Opinion or Order Filing 106 MOTION by Defendant Impax Laboratories, Inc. for leave to file Redacted Version of Direct Purchaser Plaintiffs' First Amended Consolidated Class Action Complaint (Attachments: #1 Exhibit A)(Travalini, Joanna)
May 14, 2015 Opinion or Order Filing 105 MINUTE entry before the Honorable Harry D. Leinenweber:Barry L. Refsin, Monica L. Rebuck and Eric L. Bloom's Applications to appear pro hac vice on behalf of Rite Aid Corporation and Rite Aid HDQTRS, Corp.[ #96 , #97 , #103 ] are granted. Mailed notice (wp, )
May 7, 2015 Opinion or Order Filing 103 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10618210. Eric L. Bloom for Rite Aid Corporation and Rite Aid HDQTRS Corp. (Bloom, Eric)
May 6, 2015 Opinion or Order Filing 104 STIPULATION and Consent Order Regarding Service Signed by the Honorable Harry D. Leinenweber on 5/6/2015. Mailed notice (cc, )
May 4, 2015 Opinion or Order Filing 102 END-PAYORS PLAINTIFFS' CONSOLIDATED AMENDED complaint by Fraternal Order of Police, Miami Lodge 20 Insurance Trust Fund, Louisiana Health Service and Indemnity Company, Wisconsin Masons' Health Care Fund, Plumbers & Pipefitters Local 178 Health & Welfare Trust Fund, Pennsylvania Employees Benefit Trust Fund, International Union of Operating Engineers, Local 138 Welfare Fund, Mary Davenport against All Defendants (Freed, Michael)
May 4, 2015 Opinion or Order Filing 101 SEALED DOCUMENT by Plaintiffs Meijer, Inc., Rochester Drug Co-Operative, Inc., Value Drug Company FIRST AMENDED CONSOLIDATED CLASS ACTION COMPLAINT (Sorensen, David)
May 1, 2015 Opinion or Order Filing 100 STIPULATION and Consent Order Regarding Service (Refsin, Barry)
May 1, 2015 Opinion or Order Filing 99 ATTORNEY Appearance for Plaintiffs Rite Aid Corporation, Rite Aid Hdqtrs. Corp. by David Lesht (Lesht, David)
May 1, 2015 Opinion or Order Filing 97 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10598365. (Refsin, Barry)
April 30, 2015 Opinion or Order Filing 96 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10596007. (Monica, Rebuck)
April 29, 2015 Opinion or Order Filing 98 STIPULATION and Order regarding production of electronically stored information: Signed by the Honorable Harry D. Leinenweber on 4/29/2015. Mailed notice. (sxn, )
April 27, 2015 Opinion or Order Filing 94 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by HEB Grocery Company L.P., Safeway Inc., The Kroger Co., Walgreen Co Supplemental Corp. Disclosure (Lesht, David)
April 24, 2015 Opinion or Order Filing 95 STIPULATION and consent Order regarding service. Signed by the Honorable Harry D. Leinenweber on 4/24/2015. Mailed notice. (sxn, )
April 24, 2015 Opinion or Order Filing 93 ATTORNEY Appearance for Defendant Impax Laboratories, Inc. by Joanna Rubin Travalini (Travalini, Joanna)
April 24, 2015 Opinion or Order Filing 92 ATTORNEY Appearance for Defendant Impax Laboratories, Inc. by Maureen L Rurka (Rurka, Maureen)
April 24, 2015 Opinion or Order Filing 91 ATTORNEY Appearance for Defendant Impax Laboratories, Inc. by Lawrence R. Desideri (Desideri, Lawrence)
April 17, 2015 Opinion or Order Filing 90 STIPULATION and Consent Order Regarding Service (Perwin, Scott)
April 17, 2015 Opinion or Order Filing 89 Regarding Case Management Order No. 1 STATEMENT by Albertsons LLC, HEB Grocery Company L.P., Safeway Inc., The Kroger Co., Walgreen Co (Perwin, Scott)
April 17, 2015 Opinion or Order Filing 88 MINUTE entry before the Honorable Harry D. Leinenweber:Scott E. Perwin's Application to appear pro hac vice #80 is granted. Lauren C. Ravkind's Application to appear pro hac vice #81 is granted. Anna T. Neill's Application to appear pro hac vice #82 is granted.Mailed notice (wp, )
April 16, 2015 Opinion or Order Filing 86 CASE Management Order No. 1 signed by the Honorable Harry D. Leinenweber on 4/16/2015. (jh, )
April 14, 2015 Opinion or Order Filing 87 MINUTE entry before the Honorable Harry D. Leinenweber:Defendant Impax Laboratories, Inc.'s Motion to substitute attorney and withdraw appearance #83 is granted. Michael Klinger and Todd Jacobs are granted leave to withdraw their appearances on behalf of Impax. Attorneys from Winston & Strawn, LLP, are granted leave to enter appearances on behalf of Impax.Mailed notice (wp, )
April 8, 2015 Opinion or Order Filing 85 NOTICE of Motion by Michael K Klinger for presentment of motion to substitute attorney #83 before Honorable Harry D. Leinenweber on 4/14/2015 at 09:30 AM. (Klinger, Michael)
April 7, 2015 Opinion or Order Filing 84 NOTICE of Motion by Michael K Klinger for presentment of (Klinger, Michael)
April 7, 2015 Opinion or Order Filing 83 MOTION by Defendant Impax Laboratories, Inc. to substitute attorney (Attachments: #1 Text of Proposed Order)(Klinger, Michael)
April 7, 2015 Opinion or Order Filing 82 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10516022. On behalf of Walgreen Co., The Kroger Co., Safeway Inc., HEB Grocery Company L.P. and Albertsons LLC Plaintiffs (Neill, Anna)
April 7, 2015 Opinion or Order Filing 81 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10515940. On behalf of Walgreen Co., The Kroger Co., Safeway Inc., HEB Grocery Company L.P. and Albertsons LLC Plaintiffs (Ravkind, Lauren)
April 7, 2015 Opinion or Order Filing 80 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10515809. On behalf of Walgreen Co., The Kroger Co., Safeway Inc., HEB Grocery Company L.P. and Albertsons LLC Plaintiffs (Perwin, Scott)
April 2, 2015 Opinion or Order Filing 79 MINUTE entry before the Honorable Harry D. Leinenweber:The following Applications to appear pro hac vice are granted: Joseph R. Saveri, Ryan J. McEwan, Matthew S. Weiler, Joshua P. Davis, Ralph B. Kalfayan and Lynne M. Brennan on behalf of Kim Mahaffay [33, 34, 35, 36, 44, 57], Jay L Himes on behalf of Massachusetts Bricklayers & Mason Health and Welfare Fund #62 ; Frank R. Schirripa for International Union of Operating Engineers, Local 138 Welfare Fund #71 ; David W. Rizik for Impax Laboratories, Inc. #75 Archana Tamoshunas for Rochester Drug Co-Operative Inc. #76 and Brian P. Savage for Endo Health Solutions Inc., Endo Pharmaceuticals Inc., and Penwest Pharmaceuticals Co. #77 . Mailed notice (wp, )
April 2, 2015 Opinion or Order Filing 78 MINUTE entry before the Honorable Harry D. Leinenweber:Pursuant to the Courts Order on 2/17/2015, (ECF No. 31), counsel seeking appointment as interim lead counsel for the End-Payor class have submitted four motions, (ECF Nos. 43, 45, 47, 48). For the following reasons, the Court grants Freed Kanner London & Millen LLC (Freed Kanner) and Labaton Sucharow LLPs motion for appointment as interim co-lead counsel, (ECF No. 43), and denies the remaining motions, (ECF Nos. 45, 47, 48). Mailed notice (wp, )
April 2, 2015 Opinion or Order Filing 77 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10501596. (Savage, Brian)
March 30, 2015 Opinion or Order Filing 76 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10486295. (Tamoshunas, Archana)
March 26, 2015 Opinion or Order Filing 75 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10481466. (Rizk, David)
March 24, 2015 Opinion or Order Filing 74 ATTORNEY Appearance for Plaintiff Kim Mahaffay by Joseph R. Saveri (Saveri, Joseph)
March 17, 2015 Opinion or Order Filing 73 STIPULATED PROTECTIVE Order. Signed by the Honorable Harry D. Leinenweber on 3/17/2015. Mailed notice. (sxn, )
March 12, 2015 Opinion or Order Filing 72 LETTER by Rochester Drug Co-Operative, Inc., Value Drug Company, Meijer, Inc. (Curley, Andrew)
March 10, 2015 Opinion or Order Filing 71 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10427598. Frank Schirripa (Schirripa, Frank)
March 10, 2015 Opinion or Order Filing 70 NOTICE by Michael K Klinger of Change of Address Notice of Firm Name Change (Klinger, Michael)
March 9, 2015 Opinion or Order Filing 69 TRANSCRIPT OF PROCEEDINGS held on 02/17/2015 before the Honorable Harry D. Leinenweber. Court Reporter Contact Information: Judith A. Walsh, CSR, RDR, CRR. 312-702-8865. judith_walsh@ilnd.uscourts.gov.
March 9, 2015 Opinion or Order Filing 68 MINUTE entry before the Honorable Harry D. Leinenweber: The Court has received a motion for leave to file excess pages by Plaintiffs Massachusetts Bricklayers & Masons Health and Welfare Fund, [ECF No. 39] and a similar motion by Plaintiffs Fraternal Order of Police et. al., [ECF No. 41]. Those motions are granted. The Court has also received four motions from the various end-payor Plaintiffs to appoint their respective attorneys as interim lead counsel, [ECF Nos. 43, 45, 47, and 48], as well as four responses to those motions. In the interest of judicial economy, the Court hereby waives Local Rule 5.3(b)'s notice and presentment requirement as to these motions. The parties need not appear in court to present these motions, which is currently scheduled to occur on 3/11/2015. That date is hereby stricken, and the Court will consider the parties' motions and responses and rule accordingly by mail. Mailed notice (wp, )
March 4, 2015 Opinion or Order Filing 67 STIPULATION of Dismissal Without Prejudice (Saveri, Joseph)
March 3, 2015 Opinion or Order Filing 66 RESPONSE by Louisiana Health Service and Indemnity Company to MOTION by Plaintiff Kim MahaffayAppointment of Joseph Saveri Law Firm, Inc. as Interim Lead California Counsel #47 , MOTION by Plaintiff Louisiana Health Service and Indemnity Company Plaintiff's Motion for Appointment as Interim Co-Lead Counsel for the End-Payor Class #48 , MOTION by Plaintiffs MASSACHUSETTS BRICKLAYERS & MASONS HEALTH AND WELFARE FUND, Plumbers & Pipefitters Local 178 Health & Welfare Trust Fund to Appoint the Law Firms of Freed Kanner London & Millen LLC and Labaton Sucharow LLP as Interim Co-Lead Counse #43 , MOTION #45 (Dugan, ii, James)
March 3, 2015 Opinion or Order Filing 65 RESPONSE by Fraternal Order of Police, Miami Lodge 20 Insurance Trust Fund, Pennsylvania Employees Benefit Trust Fund, Wisconsin Masons' Health Care Fundin Opposition to MOTION by Plaintiff Kim MahaffayAppointment of Joseph Saveri Law Firm, Inc. as Interim Lead California Counsel #47 , MOTION by Plaintiff Louisiana Health Service and Indemnity Company Plaintiff's Motion for Appointment as Interim Co-Lead Counsel for the End-Payor Class #48 , MOTION by Plaintiffs MASSACHUSETTS BRICKLAYERS & MASONS HEALTH AND WELFARE FUND, Plumbers & Pipefitters Local 178 Health & Welfare Trust Fund to Appoint the Law Firms of Freed Kanner London & Millen LLC and Labaton Sucharow LLP as Interim Co-Lead Counse #43 Opposition to Motions for Appointment as Interim Class Counsel Submitted by Messrs. Freed and Asciolla, Dugan, and Saveri (Wexler, Kenneth)
March 3, 2015 Opinion or Order Filing 64 RESPONSE by Massachusetts Bricklayers & Masons Health and Welfare Fund, Plumbers & Pipefitters Local 178 Health & Welfare Trust Fund to MOTION by Plaintiff Kim MahaffayAppointment of Joseph Saveri Law Firm, Inc. as Interim Lead California Counsel #47 , MOTION by Plaintiff Louisiana Health Service and Indemnity Company Plaintiff's Motion for Appointment as Interim Co-Lead Counsel for the End-Payor Class #48 , MOTION #45 (Attachments: #1 Index of Exhibits w/ Exs. A-E)(Freed, Michael)
March 3, 2015 Opinion or Order Filing 63 RESPONSE by Kim Mahaffayin Support of MOTION by Plaintiff Kim MahaffayAppointment of Joseph Saveri Law Firm, Inc. as Interim Lead California Counsel #47 (Saveri, Joseph)
March 2, 2015 Opinion or Order Filing 62 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10394261. (Himes, Jay)
February 26, 2015 Opinion or Order Filing 61 ATTORNEY Appearance for Plaintiff Pennsylvania Employees Benefit Trust Fund by John Angelo Macoretta (Macoretta, John)
February 26, 2015 Opinion or Order Filing 60 ATTORNEY Appearance for Plaintiff Pennsylvania Employees Benefit Trust Fund by Jeffrey L. Kodroff (Kodroff, Jeffrey)
February 26, 2015 Opinion or Order Filing 59 ATTORNEY Appearance for Plaintiff Massachusetts Bricklayers & Masons Health and Welfare Fund by Matthew J Perez (Perez, Matthew)
February 26, 2015 Opinion or Order Filing 58 ATTORNEY Appearance for Plaintiff Massachusetts Bricklayers & Masons Health and Welfare Fund by Gregory Asciolla (Asciolla, Gregory)
February 25, 2015 Opinion or Order Filing 57 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10382618. (Brennan, Lynne)
February 25, 2015 Opinion or Order Filing 56 ATTORNEY Appearance for Plaintiff Plumbers & Pipefitters Local 178 Health & Welfare Trust Fund by Donald Lewis Sawyer (Sawyer, Donald)
February 25, 2015 Opinion or Order Filing 55 ATTORNEY Appearance for Plaintiff Plumbers & Pipefitters Local 178 Health & Welfare Trust Fund by Robert J. Wozniak (Wozniak, Robert)
February 25, 2015 Opinion or Order Filing 54 ATTORNEY Appearance for Plaintiff Plumbers & Pipefitters Local 178 Health & Welfare Trust Fund by Steven A Kanner (Kanner, Steven)
February 25, 2015 Opinion or Order Filing 53 ATTORNEY Appearance for Plaintiff Plumbers & Pipefitters Local 178 Health & Welfare Trust Fund by Michael Jerry Freed (Freed, Michael)
February 25, 2015 Opinion or Order Filing 52 MINUTE entry before the Honorable Harry D. Leinenweber: The following motions are rescheduled by the court to be heard on 3/11/2015 at 9:30 a.m.; Plaintiffs Motion to file in excess #39 , Plaintiffs motion for leave to file #41 and Plaintiffs motion for appointment #48 . Mailed notice (wp, )
February 25, 2015 Opinion or Order Filing 51 [PROPOSED] CASE MANAGEMENT ORDER NO. 1 by ROCHESTER DRUG CO-OPERATIVE, INC. (Sorensen, David)
February 24, 2015 Opinion or Order Filing 50 NOTICE of Motion by James R. Dugan, ii for presentment of motion for miscellaneous relief #48 before Honorable Harry D. Leinenweber on 3/5/2015 at 09:30 AM. (Dugan, ii, James)
February 24, 2015 Opinion or Order Filing 49 MEMORANDUM by Louisiana Health Service and Indemnity Company in support of motion for miscellaneous relief #48 Memorandum of Law in Support of Motion for Appointment as Interim Co-Lead Counsel for the End-Payor Class (Attachments: #1 Exhibit A)(Dugan, ii, James)
February 24, 2015 Opinion or Order Filing 48 MOTION by Plaintiff Louisiana Health Service and Indemnity Company Plaintiff's Motion for Appointment as Interim Co-Lead Counsel for the End-Payor Class (Dugan, ii, James)
February 24, 2015 Opinion or Order Filing 47 MOTION by Plaintiff Kim MahaffayAppointment of Joseph Saveri Law Firm, Inc. as Interim Lead California Counsel (Attachments: #1 Declaration Declaration of Joseph R. Saveri in Support of Motion for Appointment of Joseph Saveri Law Firm, Inc. as Interim Lead California Counsel, #2 Exhibit Exhibit A, #3 Exhibit B, #4 Exhibit C, #5 Exhibit D, #6 Exhibit E)(Saveri, Joseph)
February 24, 2015 Opinion or Order Filing 46 MEMORANDUM Memorandum of Law in Support of Motion for Appointment as Interim Co-Lead Counsel for the End-Payor Class (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D)(Wexler, Kenneth)
February 24, 2015 Opinion or Order Filing 45 MOTION by Fraternal Order of Police, Miami Lodge 20 Insurance Trust Fund, Pennsylvania Employees Benefit Trust Fund, Wisconsin Masons' Health Care Fund Plaintiffs' Motion for Appointment as Interim Co-Lead Counsel for the End-Payor Class (Wexler, Kenneth)
February 24, 2015 Opinion or Order Filing 44 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10378435. (Kalfayan, Ralph)
February 24, 2015 Opinion or Order Filing 43 MOTION by Plaintiffs MASSACHUSETTS BRICKLAYERS & MASONS HEALTH AND WELFARE FUND, Plumbers & Pipefitters Local 178 Health & Welfare Trust Fund to Appoint the Law Firms of Freed Kanner London & Millen LLC and Labaton Sucharow LLP as Interim Co-Lead Counsel for the End-Payor Class (Attachments: #1 Index of Exhibits w/ Exhibits A & B (Firm Resumes))(Freed, Michael)
February 24, 2015 Opinion or Order Filing 42 NOTICE of Motion by Kenneth A. Wexler for presentment of motion to file instanter, #41 before Honorable Harry D. Leinenweber on 3/4/2015 at 09:30 AM. (Wexler, Kenneth)
February 24, 2015 Opinion or Order Filing 41 MOTION by Plaintiffs Fraternal Order of Police, Miami Lodge 20 Insurance Trust Fund, Wisconsin Masons' Health Care Fund, Pennsylvania Employees Benefit Trust Fund to file instanter Plaintiffs' Motion for Leave to File Instanter a Memorandum of Law in Excess of 15 Pages in Support of Their Motion for Appointment as Interim Co-Lead Counsel (Wexler, Kenneth)
February 24, 2015 Opinion or Order Filing 40 NOTICE of Motion by Michael Jerry Freed for presentment of motion for leave to file excess pages #39 before Honorable Harry D. Leinenweber on 3/5/2015 at 09:30 AM. (Freed, Michael)
February 24, 2015 Opinion or Order Filing 39 MOTION by Plaintiffs MASSACHUSETTS BRICKLAYERS & MASONS HEALTH AND WELFARE FUND, Plumbers & Pipefitters Local 178 Health & Welfare Trust Fund for leave to file excess pages (Freed, Michael)
February 24, 2015 Opinion or Order Filing 38 ATTORNEY Appearance for Plaintiff Fraternal Order of Police, Miami Lodge 20 Insurance Trust Fund by Jayne Goldstein (Goldstein, Jayne)
February 24, 2015 Opinion or Order Filing 37 ORDER: Any future filings in this MDL case should be docketed under lead case number 14 C 10150. The caption for such filings should indicate the case name, the MDL Number, the lead case number, and which case or group of cases the document refers to. Signed by the Honorable Harry D. Leinenweber on 2/24/2015. Mailed notice (ao,)
February 20, 2015 Opinion or Order Filing 36 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10368432. (Davis, Joshua)
February 20, 2015 Opinion or Order Filing 35 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10368383. (Weiler, Matthew)
February 20, 2015 Opinion or Order Filing 34 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10368251. (Mcewan, Ryan)
February 20, 2015 Opinion or Order Filing 33 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10367187. (Saveri, Joseph)
February 19, 2015 Opinion or Order Filing 32 MINUTE entry before the Honorable Harry D. Leinenweber:Susan J. Harriman's Application to appear pro hac vice #17 is granted. Russell A. Chorush's Application to appear pro hac vice #19 is granted.Miranda Y. Jones' Application to appear pro hac vice #20 is granted.Benedict Y. Hur's Application to appear pro hac vice #2 is granted. Susan C. Segura's Application to appear pro hac vice #10 is granted. Erin R. Leger's Application to appear pro hac vice #11 is granted. David C. Raphael, Jr.'s Application to appear pro hac vice #12 is granted. Bruce E. Gerstein's Application to appear pro hac vice #13 is granted. Joseph Opper's Application to appear pro hac vice #14 is granted. Jonathan M. Gerstein's Application to appear pro hac vice #15 is granted.Mailed notice (wp, )
February 19, 2015 Opinion or Order Filing 29 NOTICE of Correction regarding document #26 . (ym, )
February 18, 2015 Opinion or Order Filing 30 CONDITIONAL TRANSFER ORDER (CTO-2) from the Judicial Panel on Multidistrict Litigation, transferring cases to become part of MDL 2580. (ym, )
February 17, 2015 Opinion or Order Filing 31 MINUTE entry before the Honorable Harry D. Leinenweber:Organization conference held 2/17/2015. Pursuant to that conference, it is hereby ordered that: (1) the parties related to the direct-purchaser cases shall file a new, corrected Case Management Order, [ECF No. 5], that corrects the date for filing a consolidated amended complaint to 5/4/2015 instead of the 2/27/2014 date that currently appears in the order; (2) in the event that counsel for end-payors cannot agree to case organization and management, such counsel must file their respective Rule 23(g) motions by 2/24/2015, with any responses filed by 3/3/2015; (3) both end-payor and direct-purchaser plaintiffs have until 5/4/2015 to file consolidated amended complaints; (4) Defendants have until 7/3/2015 in which to answer or otherwise plead to the consolidated complaints; (5) if Defendants file a motion to dismiss, the motion must be filed by 7/3/2015 and the brief supporting the motion will be a consolidated brief of not more than 60 pages, with Plaintiffs' response of no more than 60 pages due by 8/14/2015, and Defendants' reply of no more than 25 pages due 9/11/2015; (6) the parties have until 3/26/2015 to exchange Rule 26(a)(1)(A) initial disclosures, with all other disclosures due within 10 day of the Court's ruling on any motion to dismiss; (7) the parties shall submit a proposed protective order by 2/24/2015; (8) the parties will file joint or competing ESI protocols by 4/24/2015; (9) after the Court enters the parties' protective order, Defendants will produce un-redacted copies of the various settlement agreements and litigation documents noted in the joint agenda at item 6, [ECF No. 21], on or before 3/19/2015; (10) the parties will meet and confer within 10 days of the Court ruling on any motion to dismiss regarding a discovery plan to present to the Court; and (11) the parties will request a Rule 16 conference within 10 days of the Court's ruling on any motion to dismiss and will also file a Rule 26(f) report seven days in advance of that conference. Mailed notice (wp, )
February 16, 2015 Opinion or Order Filing 28 ATTORNEY Appearance for In Re Opana ER Antitrust Litigation by James R. Dugan, ii Lewis "Scott" Joanen (Dugan, ii, James)
February 12, 2015 Opinion or Order Filing 27 MINUTE entry before the Honorable Harry D. Leinenweber:In preparation for the Organization Conference on 2/17/2015, and for all future such conferences in this case, it shall be the parties' responsibilities to coordinate and initiate any necessary phone calls to appear telephonically.After the parties have crafted a plan for all the parties who seek to appear telephonically, inform the Court as to whether the Court will need to dial into a conference call. Mailed notice (wp, )
February 10, 2015 Opinion or Order Filing 26 ENTERED In Error. (ym, ) . Modified on 2/19/2015 (ym, ).
February 10, 2015 Opinion or Order Filing 25 NOTICE of Motion by Michael K Klinger for presentment of motion to consolidate cases #24 before Honorable Harry D. Leinenweber on 2/17/2015 at 09:30 AM. (Klinger, Michael)
February 10, 2015 Opinion or Order Filing 24 MOTION by Defendant Impax Laboratories, Inc. to consolidate cases (Attachments: #1 Exhibit A, #2 Exhibit B)(Klinger, Michael)
February 6, 2015 Opinion or Order Filing 23 NOTICE of Motion by Michael K Klinger for presentment of motion to consolidate cases #22 before Honorable Harry D. Leinenweber on 2/17/2015 at 09:30 AM. (Klinger, Michael)
February 6, 2015 Opinion or Order Filing 22 MOTION by Defendant Impax Laboratories, Inc. to consolidate cases (JOINT) FOR FINDING OF RELATEDNESS AND REASSIGNMENT PURSUANT TO LOCAL RULE 40.4 (Attachments: #1 Exhibit A)(Klinger, Michael)
January 30, 2015 Opinion or Order Filing 21 PROPOSED JOINT AGENDA FOR FEBRUARY 17, 2015 ORGANIZATIONAL CONFERENCE by ROCHESTER DRUG CO-OPERATIVE, INC. (Sorensen, David)
January 27, 2015 Opinion or Order Filing 20 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10283463. (Attachments: #1 Certificate of Service)(Jones, Miranda)
January 27, 2015 Opinion or Order Filing 19 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10283318. (Attachments: #1 Certificate of Service)(Chorush, Russell)
January 22, 2015 Opinion or Order Filing 18 PAYMENT by Impax Laboratories, Inc. of Pro Hac Fee $ 50, receipt number 0752-10268311. (Harriman, Susan)
January 22, 2015 Opinion or Order Filing 17 MOTION for Leave to Appear Pro Hac Vice (Harriman, Susan)
January 20, 2015 Opinion or Order Filing 16 MINUTE entry before the Honorable Harry D. Leinenweber:Motion hearing held on 1/20/2015. The Joint Motion for finding of relatedness and reassignment pursuant to Local Rule 40.4 and to consolidate cases 14 C 7320 pending before Judge Lee and case 14 C 5416 with the Value Drug Action and the other direct-purchaser class actions currently pending in this Court as part of In re: Opana ER Antitrust Litigation, MDL No. 2580, Lead Case No. 14 C 10150 #8 is granted. Mailed notice (wp, )
January 20, 2015 Opinion or Order Filing 15 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10253657. (Attachments: #1 Certificate of Service)(Gerstein, Jonathan)
January 20, 2015 Opinion or Order Filing 14 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10253577. (Attachments: #1 Certificate of Service)(Opper, Joseph)
January 20, 2015 Opinion or Order Filing 13 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10253245. (Attachments: #1 Certificate of Service)(Gerstein, Bruce)
January 16, 2015 Opinion or Order Filing 12 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10245303. (Raphael, David)
January 16, 2015 Opinion or Order Filing 11 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10245115. (Leger, Erin)
January 16, 2015 Opinion or Order Filing 10 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10244956. (Segura, Susan)
January 15, 2015 Opinion or Order Filing 9 NOTICE of Motion by Michael K Klinger for presentment of motion to consolidate cases, #8 before Honorable Harry D. Leinenweber on 1/20/2015 at 09:30 AM. (Klinger, Michael)
January 15, 2015 Opinion or Order Filing 8 MOTION by Defendant Impax Laboratories, Inc. to consolidate cases (JOINT) FOR FINDING OF RELATEDNESS AND REASSIGNMENT PURSUANT TO LOCAL RULE 40.4 (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Text of Proposed Order)(Klinger, Michael)
January 9, 2015 Opinion or Order Filing 7 NOTICE of Motion by Zachary David Caplan for presentment of motion for miscellaneous relief #5 before Honorable Harry D. Leinenweber on 2/17/2015 at 11:00 AM. (Caplan, Zachary)
January 9, 2015 Opinion or Order Filing 6 MEMORANDUM by ROCHESTER DRUG CO-OPERATIVE, INC. in support of motion for miscellaneous relief #5 (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Caplan, Zachary)
January 9, 2015 Opinion or Order Filing 5 MOTION by Plaintiff ROCHESTER DRUG CO-OPERATIVE, INC. for Entry of Case Management Order No. 1 (Attachments: #1 Text of Proposed Order)(Caplan, Zachary)
January 9, 2015 Opinion or Order Filing 4 ORDER: The Court will hold an Organization Conference on Tuesday, February 17, 2015 at 11:00 o'clock a.m. The Court requests that counsel submit proposed agenda items for discussion at the conference. All suggestions should be filed by Friday, January 30, 2015. Suggestions should include: (1) method for establishing lead or liaison counsel; (2) deadlines for amendments and adding new parties; (3) identifying pretrial issues; (4) possible discovery phases; and (5) any other suggestions. If any counsel wishes to appear telephonically, arrangements should be made with the Court Clerk, Ms. Wanda Parker, at 312-435-7613. Signed by the Honorable Harry D. Leinenweber on 1/9/2015. Mailed notice (ao,)
December 23, 2014 Opinion or Order Filing 3 CONDITIONAL TRANSFER ORDER (CTO-1) from the Judicial Panel on Multidistrict Litigation, transferring cases to become part of MDL 2580. (meg, )
December 18, 2014 Opinion or Order Filing 2 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 50, receipt number 0752-10170926. (Hur, Benedict)
December 12, 2014 Opinion or Order Filing 1 TRANSFER order of 12/12/2014 from MDL Panel establishing MDL 2580. Case no. 14cv10150 master docket. (td, )

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Illinois Northern District Court's Electronic Court Filings (ECF) System

Search for this case: In Re: Opana ER Antitrust Litigation
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
In re: Opana ER Antitrust Litigation
Represented By: Lewis Scott Joanen
Represented By: James R. Dugan, ii
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Rochester Drug Co-Operative, Inc.
Represented By: Richard D Schwartz
Represented By: Andrew C. Curley
Represented By: Archana Tamoshunas
Represented By: David F. Sorensen
Represented By: James R. Dugan, ii
Represented By: Joseph T. Lukens
Represented By: Peter R. Kohn
Represented By: Zachary David Caplan
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Value Drug Company
Represented By: Andrew W Kelly
Represented By: Chris Letter
Represented By: Deborah Elman
Represented By: Anne M. Schmidt
Represented By: Bruce E. Gerstein
Represented By: Caitlin G Coslett
Represented By: Christopher Taylor Stow-Serge
Represented By: David C. Raphael
Represented By: Erin R Leger
Represented By: James Boone Baxter
Represented By: James R. Dugan, ii
Represented By: Jonathan M Gerstein
Represented By: Jordan M. Cramer
Represented By: Joseph Opper
Represented By: Miranda Y Jones
Represented By: Russell A. Chorush
Represented By: Susan C Segura
Represented By: Thomas Jon Maas
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Kim Mahaffay
Represented By: Joseph R. Saveri
Represented By: James R. Dugan, ii
Represented By: Joshua P. Davis
Represented By: Lynne Marie Brennan
Represented By: Matthew S. Weiler
Represented By: Ralph B. Kalfayan
Represented By: Ryan J. Mcewan
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Fraternal Order of Police, Miami Lodge 20 Insurance Trust Fund
Represented By: James R. Dugan, ii
Represented By: Jayne Goldstein
Represented By: Michael Jerry Freed
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Massachusetts Bricklayers & Masons Health and Welfare Fund
Represented By: Gregory Asciolla
Represented By: Matthew J Perez
Represented By: James R. Dugan, ii
Represented By: Jay L Himes
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Plumbers & Pipefitters Local 178 Health & Welfare Trust Fund
Represented By: Brian M. Hogan
Represented By: Donald Lewis Sawyer
Represented By: Michael Jerry Freed
Represented By: Robert J. Wozniak
Represented By: Steven A Kanner
Represented By: James R. Dugan, ii
Represented By: Kimberly Ann Justice
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Wisconsin Masons' Health Care Fund
Represented By: James R. Dugan, ii
Represented By: Michael Jerry Freed
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Pennsylvania Employees Benefit Trust Fund
Represented By: James R. Dugan, ii
Represented By: Jeffrey L. Kodroff
Represented By: John Angelo Macoretta
Represented By: Michael Jerry Freed
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Louisiana Health Service and Indemnity Company doing business as Blue Cross Blue Shield of Louisiana
Represented By: David S. Scalia
Represented By: James R. Dugan, ii
Represented By: Lauren G. Barnes
Represented By: Thomas M Sobol
Represented By: Michael Jerry Freed
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Meijer, Inc.
Represented By: James R. Dugan, ii
Represented By: Matthew P. Mccahill
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Walgreen Co
Represented By: Anna T Neill
Represented By: David Lesht
Represented By: James R. Dugan, ii
Represented By: Lauren C Ravkind
Represented By: Scott E Perwin
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: The Kroger Co.
Represented By: Anna T Neill
Represented By: David Lesht
Represented By: James R. Dugan, ii
Represented By: Lauren C Ravkind
Represented By: Scott E Perwin
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Safeway Inc.
Represented By: Anna T Neill
Represented By: David Lesht
Represented By: James R. Dugan, ii
Represented By: Lauren C Ravkind
Represented By: Scott E Perwin
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: HEB Grocery Company L.P.
Represented By: Anna T Neill
Represented By: David Lesht
Represented By: James R. Dugan, ii
Represented By: Lauren C Ravkind
Represented By: Scott E Perwin
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Albertsons LLC
Represented By: Anna T Neill
Represented By: David Lesht
Represented By: James R. Dugan, ii
Represented By: Lauren C Ravkind
Represented By: Scott E Perwin
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Rite Aid Corporation
Represented By: Eric L. Bloom
Represented By: Alexander John Egervary
Represented By: Barry L Refsin
Represented By: David Lesht
Represented By: James R. Dugan, ii
Represented By: Maureen Smith Lawrence
Represented By: Monica L. Kiley
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Rite Aid Hdqtrs. Corp.
Represented By: Alexander John Egervary
Represented By: Barry L Refsin
Represented By: David Lesht
Represented By: Eric L. Bloom
Represented By: James R. Dugan, ii
Represented By: Maureen Smith Lawrence
Represented By: Monica L. Kiley
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: International Union of Operating Engineers, Local 138 Welfare Fund
Represented By: James R. Dugan, ii
Represented By: Michael Jerry Freed
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Mary Davenport
Represented By: James R. Dugan, ii
Represented By: Karin E. Garvey
Represented By: Michael Jerry Freed
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Direct Purchaser Plaintiffs
Represented By: James R. Dugan, ii
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: End-Payor Plaintiffs
Represented By: Eaghan Seumas Davis
Represented By: James R. Dugan, ii
Represented By: Jennings F. Durand
Represented By: Jonathan Scott Crevier
Represented By: Tyler J. Story
Represented By: Michael Jerry Freed
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: (Direct Purchaser and End-Payor)
Represented By: James R. Dugan, ii
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: CVS Pharmacy, Inc.
Represented By: Eric L. Bloom
Represented By: Alexander John Egervary
Represented By: David Lesht
Represented By: James R. Dugan, ii
Represented By: Maureen Smith Lawrence
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: All Plaintiffs and Defendants
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Meijer Distribution, Inc.
Represented By: Aaron Schwartz
Represented By: Matthew P. Mccahill
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Retailer Plaintiffs
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Impax Laboratories, Inc.
Represented By: Jay P. Lefkowitz
Represented By: Benedict Yung Hur
Represented By: Caroline Petro Gately
Represented By: Danielle R Foley
Represented By: David W. Rizk
Represented By: Devora Whitman Allon
Represented By: Evelyn Blacklock
Represented By: James Douglas Baldridge
Represented By: James R.P. Hileman
Represented By: Joanna Rubin Travalini
Represented By: Julia Chapman
Represented By: Kevin Michael Neylan
Represented By: Kevin Fitzgerald Wolff
Represented By: Kristin M. Koger
Represented By: Lawrence R. Desideri
Represented By: Lisa Jose Fales
Represented By: Maureen L Rurka
Represented By: Patrick J Gallagher
Represented By: Susan Harriman
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Endo Health Solutions Inc.
Represented By: Elise M. Baumgarten
Represented By: Brian Savage
Represented By: Angela M. Liu
Represented By: Benjamin M Greenblum
Represented By: Christine C Levin
Represented By: Christopher Alden Yeager
Represented By: Craig G. Falls
Represented By: Forrest Lovett
Represented By: George Gabriel Gordon
Represented By: Heidi K Hubbard
Represented By: Jennings F. Durand
Represented By: John McClam
Represented By: Julia Chapman
Represented By: Kari Michele Lorentson
Represented By: Katherine A Trefz
Represented By: Morgan J. Feder
Represented By: Nathan E Hoffman
Represented By: Quinn Colleen Shean
Represented By: Robert D. Rhoad
Represented By: Samuel Mathais Ford
Represented By: Sharon Kathleen Gagliardi
Represented By: Thomas Miller
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Endo Pharmaceuticals Inc.
Represented By: Brian Savage
Represented By: Angela M. Liu
Represented By: Benjamin M Greenblum
Represented By: Christine C Levin
Represented By: Christopher Alden Yeager
Represented By: Craig G. Falls
Represented By: Elise M. Baumgarten
Represented By: Forrest Lovett
Represented By: George Gabriel Gordon
Represented By: Heidi K Hubbard
Represented By: Jennings F. Durand
Represented By: John McClam
Represented By: Julia Chapman
Represented By: Kari Michele Lorentson
Represented By: Katherine A Trefz
Represented By: Morgan J. Feder
Represented By: Nathan E Hoffman
Represented By: Quinn Colleen Shean
Represented By: Robert D. Rhoad
Represented By: Samuel Mathais Ford
Represented By: Sharon Kathleen Gagliardi
Represented By: Thomas Miller
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Penwest Pharmaceuticals Co.
Represented By: Brian Savage
Represented By: Angela M. Liu
Represented By: Benjamin M Greenblum
Represented By: Christine C Levin
Represented By: Christopher Alden Yeager
Represented By: Craig G. Falls
Represented By: Elise M. Baumgarten
Represented By: Forrest Lovett
Represented By: George Gabriel Gordon
Represented By: Heidi K Hubbard
Represented By: Jennings F. Durand
Represented By: John McClam
Represented By: Julia Chapman
Represented By: Kari Michele Lorentson
Represented By: Katherine A Trefz
Represented By: Morgan J. Feder
Represented By: Nathan E Hoffman
Represented By: Quinn Colleen Shean
Represented By: Robert D. Rhoad
Represented By: Samuel Mathais Ford
Represented By: Sharon Kathleen Gagliardi
Represented By: Thomas Miller
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?